Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.8106298102371327,-2.2539227719276114,0.0,0.001012465109828193,0.001,11/19,8.22%,GRM7;GRID2;GRIA4;GRM3;GRIK2;GRM5;GRIK4;GRIA1;GRIK1;GRIA2;GRM8
prerank,ligand-gated channel activity (GO:0022834),-0.6883685891255688,-2.1752703844951533,0.0,0.0015186976647422895,0.003,13/29,9.21%,GRID2;GRIA4;GRIK2;GRIN3A;GRIK4;GRIA1;GRIN2A;GRIK1;GRIA3;GRIN2B;GRIA2;GRIN1;GABRB1
prerank,ligand-gated ion channel activity (GO:0015276),-0.6841773559904513,-2.1706620340710123,0.0,0.001012465109828193,0.003,13/30,9.21%,GRID2;GRIA4;GRIK2;GRIN3A;GRIK4;GRIA1;GRIN2A;GRIK1;GRIA3;GRIN2B;GRIA2;GRIN1;GABRB1
prerank,transmitter-gated ion channel activity (GO:0022824),-0.6813279797552108,-2.1473058653353596,0.0,0.001012465109828193,0.004,18/29,20.35%,GRID2;GRIA4;GRIK2;GRIK4;GABRA2;GABRB3;GABRA3;GRIK1;GLRA3;GABRA4;GRIA2;GABRB1;GABRG3;GABRB2;GRIK3;GABRA5;GLRA2;GABRA1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.7874424674366641,-2.135272729942278,0.0,0.0008099720878625544,0.004,12/17,9.11%,GRIA4;GRIK2;GRIN3A;GRIK4;PTK2B;GRIA1;GRIN2A;GRIK1;GRIA3;GRIN2B;GRIA2;GRIN1
prerank,retinoid binding (GO:0005501),0.7851362447185071,2.127107224131439,0.0,0.000991070430581602,0.001,5/22,3.36%,ALDH1A2;RBP1;NR2F2;ABCA4;RBP4
prerank,cell adhesion mediator activity (GO:0098631),-0.6555175184930949,-1.9689548827758327,0.0,0.010630883653196027,0.056,11/24,10.36%,LRRC4C;BSG;ESAM;CNTN4;CNTN6;BCAM;ROBO4;NPTN;JAM3;CNTN2;EMB
prerank,lysine-acetylated histone binding (GO:0070577),0.7397974843674721,1.9173832126203043,0.0,0.060455296265477715,0.156,10/20,15.46%,KMT2A;MLLT3;PHIP;BAZ2A;DPF2;TRIM24;PSME4;BRD4;CARM1;SMARCA4
prerank,acetylation-dependent protein binding (GO:0140033),0.7397974843674721,1.9173832126203043,0.0,0.060455296265477715,0.156,10/20,15.46%,KMT2A;MLLT3;PHIP;BAZ2A;DPF2;TRIM24;PSME4;BRD4;CARM1;SMARCA4
prerank,cation:chloride symporter activity (GO:0015377),-0.794316148736867,-1.9097976451318173,0.0,0.022418870289052845,0.136,5/10,10.96%,SLC12A7;SLC12A2;SLC6A1;SLC12A5;SLC12A6
prerank,phospholipase activator activity (GO:0016004),0.8283793244752051,1.8624192139172657,0.00196078431372549,0.11149542344043022,0.317,2/10,0.50%,PDPK1;ARHGAP6
prerank,voltage-gated cation channel activity (GO:0022843),-0.46382509113672593,-1.8582945119051892,0.0,0.03847367417347134,0.247,23/97,10.98%,KCNB2;KCND2;CACNA1E;KCNQ5;CACNB2;GRIN3A;KCNMA1;KCNH7;PTK2B;KCNC2;KCNQ3;CACNB4;HCN1;GRIN2A;OPRM1;GRIN2B;HCN2;KCNH1;KCNH5;GRIN1;KCND3;CACNA1D;KCNB1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.6604911232304667,-1.8551437961965502,0.0,0.03543627884398676,0.251,10/19,16.65%,GRID2;GRIK2;GRIK4;GABRA2;GABRA3;GRIK1;GABRA4;GABRG3;GRIK3;GABRA5
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.591999142903297,-1.841941673055605,0.0,0.038372427662488516,0.284,13/28,20.35%,GRID2;GRIK2;GRIK4;GABRA2;GABRA3;GRIK1;GABRA4;GABRG3;GRIK3;GABRA5;CHRNA4;CHRNA7;GABRA1
prerank,lipase activator activity (GO:0060229),0.8183368479622983,1.8324971877782639,0.0019305019305019305,0.1371641475924937,0.435,2/10,0.50%,PDPK1;ARHGAP6
prerank,phospholipase binding (GO:0043274),0.7729735972317893,1.8291513455631931,0.005836575875486381,0.11942398688508303,0.45,2/13,0.50%,PDPK1;ARHGAP6
prerank,ligand-gated anion channel activity (GO:0099095),-0.6728019809729748,-1.8174353541925827,0.0,0.047677902444636724,0.375,12/17,20.35%,GABRA2;GABRB3;GABRA3;GLRA3;GABRA4;GABRB1;GABRG3;GABRB2;GABRA5;GLRA2;GLRA1;GABRA1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.7535332809529085,1.816794971299705,0.008665511265164644,0.12091059253095543,0.505,4/15,9.22%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH2
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.7009525571039088,-1.8002810204400197,0.008658008658008658,0.054841860115693794,0.444,6/14,13.29%,KCNJ3;KCNJ2;KCND3;KCNJ8;KCNQ1;KCNE4
prerank,sialyltransferase activity (GO:0008373),-0.6279321669881215,-1.7993496610872866,0.009501187648456057,0.05147995673818736,0.448,9/20,18.70%,ST6GALNAC3;ST8SIA4;ST3GAL6;ST8SIA6;ST6GALNAC4;ST6GALNAC5;ST3GAL4;ST6GAL2;ST8SIA5
prerank,glutamate receptor binding (GO:0035254),-0.6640157198614324,-1.7972070805973672,0.0,0.048742963144585864,0.456,11/17,18.69%,SHANK3;HIP1;NSF;SYNDIG1;HOMER1;GNAS;SHANK2;CAMK2A;SHISA6;SHANK1;AKAP5
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.7612956702365102,1.7800810170324017,0.0108499095840868,0.16897750841416312,0.664,4/13,9.22%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH2
prerank,GABA receptor activity (GO:0016917),-0.6113870602759579,-1.767800779018406,0.0091324200913242,0.06520275307293563,0.571,11/21,20.35%,GABRA2;GABBR2;GABRB3;GABRA3;GABRA4;GABRB1;GPR156;GABRG3;GABRB2;GABRA5;GABRA1
prerank,chloride channel activity (GO:0005254),-0.4822172727455296,-1.7434025461891813,0.002688172043010753,0.08144016227180528,0.684,27/59,20.35%,SLC26A7;ANO1;GABRA2;ANO3;GABRB3;GABRA3;GLRA3;CLCN3;GABRA4;CLCN7;SLC1A4;ANO4;TTYH2;GABRB1;GABRG3;CLCN1;TTYH3;ANO2;GABRB2;TTYH1;FXYD1;GABRA5;CLCN5;ANO5;GLRA2;GLRA1;GABRA1
prerank,AMP binding (GO:0016208),0.7573382531574404,1.7389008927676362,0.012727272727272728,0.2475473697719379,0.819,2/11,1.15%,MPPED2;PRKAG2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.7123772164016505,-1.7316491068316622,0.010351966873706004,0.08736978330105642,0.727,5/11,13.29%,KCNJ3;KCND3;KCNJ8;KCNQ1;KCNE4
prerank,cytokine activity (GO:0005125),0.46620193462319526,1.7157327776824014,0.0,0.2853291769644432,0.889,23/131,8.47%,BMP6;WNT4;CXCL10;WNT6;IL16;CXCL16;WNT10B;WNT3A;WNT2B;OSM;IL11;IL34;BMP2;IL17D;IL6;WNT5B;BMP7;CKLF;FAM3B;BMP8B;IL18;CCL2;WNT5A
prerank,wide pore channel activity (GO:0022829),0.6335621177194914,1.7065835446121747,0.006837606837606838,0.28380653239382236,0.91,7/23,10.22%,GJB2;GJB6;PANX3;GJA1;PRF1;GJA3;PANX1
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.5408644273795209,-1.7038158893687188,0.0024691358024691358,0.11243987525258656,0.833,12/31,15.71%,SLC12A7;SLC12A2;KCNK5;ABCC9;HCN1;TMEM38B;KCNK10;TMEM175;SLC12A5;SLC12A6;KCNA2;KCNK9
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6298986713466108,-1.7035394886797788,0.006564551422319475,0.10149962726027635,0.836,6/16,3.85%,PTPRG;PTPRB;PTPRD;PTPRK;PTPRN2;PTPRM
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6298986713466108,-1.7035394886797788,0.006564551422319475,0.10149962726027635,0.836,6/16,3.85%,PTPRG;PTPRB;PTPRD;PTPRK;PTPRN2;PTPRM
prerank,LRR domain binding (GO:0030275),0.7096763231642783,1.703186648418006,0.007532956685499058,0.27039704914368035,0.918,3/14,4.72%,ROBO1;PAWR;LRRFIP2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.6536302580670305,-1.6989677380947463,0.008333333333333333,0.10129472360709683,0.851,9/13,20.35%,GABRA2;GABRA3;GLRA3;GABRA4;GABRG3;GABRA5;GLRA2;GLRA1;GABRA1
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6830398606572425,-1.680388473065181,0.008791208791208791,0.1176300373054937,0.893,9/12,20.35%,GABRA2;GABRB3;GABRA3;GABRA4;GABRB1;GABRG3;GABRB2;GABRA5;GABRA1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.6922847921320053,1.6619453151491312,0.023508137432188065,0.3720325924029398,0.973,2/14,0.80%,SLC7A11;SLC1A3
prerank,tropomyosin binding (GO:0005523),0.6514564893420817,1.6588841754632266,0.022222222222222223,0.35735168096970904,0.974,4/16,4.79%,TMOD3;CALD1;S100A6;NEBL
prerank,potassium channel activity (GO:0005267),-0.4193345815947053,-1.6564137313895326,0.0,0.14350592426260475,0.942,21/89,7.11%,KCNB2;KCND2;KCNQ5;GRIK2;KCNMB2;KCNK5;KCNMA1;ABCC9;KCNH7;GRIK4;KCNC2;KCNQ3;HCN1;GRIK1;KCNT1;TMEM38B;KCNK10;HCN2;KCNH1;TMEM175;KCNH5
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6460435933714426,1.6497729262696166,0.020146520146520148,0.3627978489549051,0.982,2/18,0.33%,ALDH1A2;ALDH1A1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5103700564398931,1.641205364689693,0.00322061191626409,0.3688020839801786,0.987,11/55,4.55%,PDPN;SLC7A2;SLC13A3;SLC6A13;SLC16A11;SLC19A1;SLC16A2;SLC16A12;SLC6A12;SLC7A14;SLC16A5
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.5186569161884806,-1.6360847200543924,0.009259259259259259,0.1658755338268523,0.975,10/32,14.85%,KCNB2;KCNQ5;KCNC2;KCNQ3;KCNH1;KCNB1;KCNQ1;KCNE4;KCNC1;KCNA2
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6942991710693028,-1.6284213499072548,0.010245901639344262,0.17122809937414402,0.981,6/10,16.65%,SHANK3;NSF;GNAS;SHANK2;SHISA6;SHANK1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.4416820227683569,-1.6202972522137404,0.0028011204481792717,0.17597422428129247,0.989,32/57,31.41%,COX4I1;NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;UQCRH;UQCR11;NDUFA1;CYBRD1;COX8A;NDUFA4;NDUFB2;NDUFA12;COX6A1;NDUFB7;NDUFB10;NDUFC2;NDUFA4L2;NDUFA13;CYB5A;NDUFA9;UQCR10;UQCRQ;CYB561A3;NDUFA10;COX4I2;NDUFS6;NDUFV3;COX5B;NDUFS1;NDUFA2
prerank,gap junction channel activity (GO:0005243),0.5989844979819973,1.6184405773287036,0.02348993288590604,0.4237700564645685,0.998,6/22,10.22%,GJB2;GJB6;PANX3;GJA1;GJA3;PANX1
prerank,GABA-A receptor activity (GO:0004890),-0.5898489394619546,-1.6181716324097124,0.017582417582417582,0.17260655187182122,0.99,9/18,20.35%,GABRA2;GABRB3;GABRA3;GABRA4;GABRB1;GABRG3;GABRB2;GABRA5;GABRA1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5364726845497345,1.614553657597048,0.018425460636515914,0.4126707154005059,0.998,10/38,12.46%,TFPI;ANXA2;SERPING1;SERPINB7;SERPINE1;TFPI2;SPINT2;SERPINE2;SERPINB8;SERPINE3
prerank,water transmembrane transporter activity (GO:0005372),0.6985708423506128,1.6041915994896896,0.03333333333333333,0.42548218432916457,0.999,2/11,5.94%,PDPN;SLC4A11
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.5824041592887881,-1.6037052064365211,0.032679738562091505,0.188824742982958,0.995,6/17,8.59%,ATP10A;PITPNC1;PITPNA;ABCA3;ATP8B2;ATP8B1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.6711727709476024,-1.6026013254160225,0.0189873417721519,0.18426864998873113,0.996,7/11,8.59%,ATP8A1;ATP10A;ABCA3;ATP8A2;ATP11A;ATP8B2;ATP8B1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.7165678605299753,1.601832492106754,0.021442495126705652,0.4116906568635974,0.999,1/10,0.24%,DPYSL3
prerank,frizzled binding (GO:0005109),0.5556999502910348,1.5948176529054405,0.01818181818181818,0.4163439685043282,1.0,10/34,15.18%,WNT4;WNT6;WNT10B;WNT3A;WNT2B;WNT5B;WNT5A;DVL3;RNF43;RYK
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6784130198062898,1.5943215606749346,0.02247191011235955,0.39899594562096585,1.0,5/13,7.34%,BMP6;CDH5;BMP2;BMP7;BMP8B
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.5011276503455215,-1.5940825148634008,0.01674641148325359,0.19061343134365447,0.997,10/30,15.35%,SLC39A10;SLC40A1;SLC39A6;SLC31A1;SLC30A1;SLC39A14;SLC39A12;SLC39A13;SLC39A8;TTYH1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.619932317912961,1.5921864429535784,0.02531645569620253,0.389145959068802,1.0,6/18,4.72%,TMOD3;ANXA2;ANXA1;RAB10;PKP3;BAIAP2L1
prerank,amyloid-beta binding (GO:0001540),-0.4084438590382669,-1.5903929466735522,0.002976190476190476,0.18975555768070326,0.998,24/79,13.57%,APBB2;NLGN1;COL25A1;GRIA4;CST3;TGFB2;INSR;GRIA1;ITM2A;GRIN2A;SORL1;GRIA3;GRIN2B;APBA2;PFDN5;BCHE;GRIA2;LDLRAP1;GRIN1;CD74;ADRB2;PFDN2;CLSTN1;FZD4
prerank,anion channel activity (GO:0005253),-0.43212478663660214,-1.5885794511009916,0.010638297872340425,0.18619866160434115,0.998,26/61,20.35%,SLC26A7;ANO1;GABRA2;ANO3;GABRB3;GABRA3;GLRA3;CLCN3;GABRA4;CLCN7;SLC1A4;ANO4;GABRB1;LRRC8C;GABRG3;TTYH3;ANO2;GABRB2;VDAC1;FXYD1;GABRA5;CLCN5;ANO5;GLRA2;GLRA1;GABRA1
prerank,BMP receptor binding (GO:0070700),0.6784176143219589,1.583955771267611,0.03512014787430684,0.40080539996770953,1.0,5/12,7.34%,BMP6;CDH5;BMP2;BMP7;BMP8B
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5965372313489924,-1.5837528641007057,0.024336283185840708,0.18782761825358174,0.999,6/15,2.67%,HS3ST1;HS6ST3;HS6ST2;NDST3;HS3ST4;HS3ST5
prerank,cAMP response element binding (GO:0035497),0.7209579011620344,1.5834860979307455,0.03474903474903475,0.38596246848569904,1.0,4/10,9.91%,CREB5;CREB3L2;ATF7;E4F1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.6443068864658325,-1.5826765817389175,0.018789144050104383,0.18406020128964884,0.999,5/12,13.49%,SLC6A6;SLC38A5;SLC1A4;SLC36A1;SLC3A2
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.5524377541859209,-1.5816348433010932,0.024608501118568233,0.1802766446985514,0.999,7/20,14.55%,SLC39A10;SLC39A6;SLC30A1;SLC39A14;SLC39A12;SLC39A13;SLC39A8
prerank,hormone receptor binding (GO:0051427),0.6548185789083791,1.5807893176202845,0.03225806451612903,0.37977056538017306,1.0,5/14,13.11%,GHRH;PTHLH;NCOA6;NPPC;JAK1
prerank,poly(U) RNA binding (GO:0008266),0.5986532780803863,1.5788646969304527,0.030685920577617327,0.3713210546579069,1.0,7/20,8.08%,ATXN1;RBMS1;RBMS3;RBMS2;PABPC5;HNRNPH1;HNRNPC
prerank,phospholipid transfer activity (GO:0120014),-0.544728173174515,-1.5764852896708517,0.021231422505307854,0.18348117712553144,1.0,7/21,8.19%,CERT1;PITPNC1;PITPNA;ABCA3;GLTP;PRELID2;PRELID1
prerank,filamin binding (GO:0031005),0.6943488632303768,1.5752526020790014,0.030592734225621414,0.3683242464511482,1.0,5/11,9.75%,DPYSL3;SYNPO2;NEBL;FBLIM1;RFLNA
prerank,R-SMAD binding (GO:0070412),0.6047051181981576,1.5742962795498807,0.04316546762589928,0.3592801185070476,1.0,6/18,11.51%,SMAD3;PPM1A;LDLRAD4;PMEPA1;SMAD6;SMAD4
prerank,transforming growth factor beta binding (GO:0050431),0.5831933669107809,1.5738325457064362,0.02877697841726619,0.3488567915647239,1.0,7/23,6.94%,TGFBR3;LTBP1;TWSG1;LRRC32;WFIKKN1;TGFBR1;TGFBR2
prerank,SUMO transferase activity (GO:0019789),0.6343739406758834,1.5731808133600247,0.034926470588235295,0.3396494275644819,1.0,7/16,15.52%,RANBP2;HDAC4;PIAS1;NSMCE2;EGR2;CBX4;MUL1
prerank,pentosyltransferase activity (GO:0016763),0.5305558995079863,1.5527083465393616,0.0234375,0.3874775674064507,1.0,13/36,12.48%,PARP14;ZC3HAV1;PARP9;LARGE1;LACC1;PARP3;PARP10;UPP1;PARP11;SIRT4;TIPARP;UMPS;PARP16
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5538518797876212,-1.550029326742907,0.046460176991150445,0.21970492883271786,1.0,4/19,3.76%,NRG3;EFNA5;GRM5;GAS6
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3953217181409428,1.5496690537920919,0.0,0.38507591093688787,1.0,58/232,17.00%,RNF220;PDZRN3;CBLB;RNF152;SMURF2;TRIM56;TRIM10;RNF217;SH3RF1;TRIP12;NEDD4;NHLRC3;RC3H1;DTX4;MYCBP2;TRIM17;RNF19A;RNF216;DTX1;SIAH2;PELI2;TRIM5;DTX3L;BIRC3;MGRN1;ANAPC11;TRIM24;RNF111;PIAS1;RNF145;AMFR;UBR4;WWP2;HUWE1;RFWD3;HECTD1;CUL3;NSMCE2;TRIM21;EGR2;HECW2;TRIM26;TRIM7;CBX4;PRPF19;RNF39;BFAR;RNF43;RNF181;BRAP;RCHY1;MUL1;RNF180;RNF185;KCMF1;RING1;RNF2;RNF135
prerank,endopeptidase inhibitor activity (GO:0004866),0.4504832513818638,1.5454607798935769,0.019667170953101363,0.38625512575402376,1.0,18/82,9.57%,TFPI;COL4A3;TIMP3;ANXA2;SERPING1;CSTB;ITIH2;SERPINB7;SERPINE1;TFPI2;BST2;SPINT2;PZP;TIMP2;SERPINE2;UBE2Z;PROS1;CAST
prerank,peptidase inhibitor activity (GO:0030414),0.5268567181544738,1.5453873671043492,0.030612244897959183,0.3755307442963773,1.0,8/33,9.57%,TFPI;CSTB;ITIH2;SPINT2;PZP;TIMP2;PROS1;CAST
prerank,RNA polymerase II complex binding (GO:0000993),0.5454653359779044,1.5446711829260475,0.02768166089965398,0.36721912426466635,1.0,12/32,19.38%,ELOF1;NCOA3;PCF11;RPRD2;CDC73;WAC;BRD4;PAF1;ERCC5;URI1;UVSSA;RPRD1B
prerank,neurexin family protein binding (GO:0042043),-0.6445147076993103,-1.5388745477999308,0.0498960498960499,0.23294690671652346,1.0,4/10,8.74%,NLGN1;CPE;SYTL2;NLGN3
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.650622854336778,1.5387556529856679,0.05272727272727273,0.372160339527048,1.0,3/14,5.07%,SDR9C7;RDH10;RDH5
prerank,receptor ligand activity (GO:0048018),0.3874512752303455,1.5310531450145077,0.002544529262086514,0.3824488630012792,1.0,31/245,7.74%,SEMA3D;BMP6;WNT4;PTN;DPP4;EPHA7;CXCL10;WNT6;IL16;FGF1;WNT10B;WNT3A;WNT2B;OSM;NBL1;IL11;VEGFD;TGFA;IL34;PTHLH;BMP2;IL17D;IL6;WNT5B;BMP7;FAM3B;SEMA4B;EDA;BMP8B;IL18;NPPC
prerank,protein kinase C activity (GO:0004697),-0.5871959948077992,-1.5237955405002759,0.04184100418410042,0.2523893794294793,1.0,4/14,5.93%,PRKCH;PRKCB;PRKCQ;PKN1
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3960115500773578,1.5231745482689505,0.003968253968253968,0.39294671969444384,1.0,36/181,12.36%,TCF7L2;SMAD3;RBPJ;ARNT2;NCOA3;PARP9;LDB2;DACT1;CRY1;TACC2;MIER3;ARNT;MTDH;PRRX1;CPNE1;BAZ2A;MIER1;TACC1;FOXP3;ANXA4;DTX3L;HDAC4;PPARA;CREBBP;POU1F1;STAT1;GSK3B;MEF2A;PIAS1;MAPK14;WWP2;RERE;ATN1;RBBP8;IFI27;EGR2
prerank,poly-purine tract binding (GO:0070717),0.5361330654398858,1.5220747472740892,0.029801324503311258,0.38646791440529565,1.0,5/27,5.43%,ATXN1;RBMS1;RBMS3;RBMS2;PABPC5
prerank,microtubule motor activity (GO:0003777),-0.4271575493558469,-1.5149726673971076,0.01358695652173913,0.262228463445502,1.0,30/51,38.46%,KIF1B;KIF26B;KIF21A;KIF1C;STARD9;DNAH8;KIF26A;KIF18A;KIF5C;KIF15;KIF3B;DYNC1I2;KIF16B;KIF5A;KIF27;KIF23;KIF22;KIF4A;KIF14;KIFC3;KIF19;DNAH17;KIF20A;KIF20B;DNAH3;KIFC1;DYNLRB1;KIF2C;DNAH1;DYNLRB2
prerank,Tat protein binding (GO:0030957),-0.6339191558573417,-1.512160736719247,0.04781704781704782,0.2611172212517881,1.0,5/10,9.01%,ACTB;CTDP1;GABARAPL1;NPM1;SMARCB1
prerank,MAP-kinase scaffold activity (GO:0005078),0.6514592594785067,1.509231500663456,0.06679389312977099,0.4129863001582114,1.0,3/11,3.27%,AKAP13;KSR1;SH3RF1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.556982202554406,1.5083836739361993,0.04436860068259386,0.40551298451297213,1.0,12/25,18.56%,PARP14;ZC3HAV1;PARP9;PARP3;PARP10;PARP11;SIRT4;TIPARP;PARP16;TNKS2;PARP4;SIRT3
prerank,cholesterol transfer activity (GO:0120020),0.5980919559613141,1.5031866216210414,0.07076350093109869,0.4109946027472355,1.0,2/16,2.03%,GRAMD1C;APOA2
prerank,ubiquitin protein ligase activity (GO:0061630),0.3849150673280061,1.502588438424843,0.003931847968545216,0.40327556793484093,1.0,57/228,17.83%,RNF220;PDZRN3;CBLB;RNF152;SMURF2;TRIM56;TRIM10;RNF217;SH3RF1;TRIP12;NEDD4;NHLRC3;RC3H1;DTX4;MYCBP2;TRIM17;RNF19A;RNF216;DTX1;SIAH2;PELI2;TRIM5;DTX3L;BIRC3;MGRN1;ANAPC11;TRIM24;RNF111;RNF145;AMFR;UBR4;WWP2;HUWE1;RFWD3;HECTD1;CUL3;TRIM21;HECW2;TRIM26;TRIM7;PRPF19;RNF39;BFAR;RNF43;RNF181;BRAP;RCHY1;MUL1;RNF180;RNF185;KCMF1;RING1;RNF2;RNF135;SHPRH;UBE4B;TRIM3
prerank,ligand-gated cation channel activity (GO:0099094),-0.3916510220611332,-1.501088892913099,0.008695652173913044,0.27519765937615837,1.0,17/75,12.30%,GRIA4;GRIK2;GRIN3A;KCNJ3;KCNJ2;GRIK4;PTK2B;GRIA1;GRIN2A;GRIK1;GRIA3;GRIN2B;GRIA2;GRIN1;KCNJ6;KCNJ8;KCNJ15
prerank,poly-pyrimidine tract binding (GO:0008187),0.5562202293054003,1.4967941625374999,0.048824593128390596,0.4112501811166723,1.0,7/23,8.08%,ATXN1;RBMS1;RBMS3;RBMS2;PABPC5;HNRNPH1;HNRNPC
prerank,sterol binding (GO:0032934),0.4632907985418899,1.493120761921029,0.025356576862123614,0.41230684413130686,1.0,16/56,15.36%,RORA;SIDT1;GRAMD1C;APOA2;APOF;OSBPL8;VDAC2;NR1H3;NPC1;INSIG2;SCP2;SOAT1;OSBPL5;STAR;ABCA1;OSBPL9
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.5830631631923566,-1.4858901746816477,0.06363636363636363,0.30086695752057324,1.0,5/13,12.65%,CCDC88A;ARHGDIB;GDI2;RANBP1;ARHGDIA
prerank,telomerase RNA binding (GO:0070034),0.5521761591547717,1.48419616710029,0.07509157509157509,0.4286274179240898,1.0,12/22,21.67%,TERT;DCP2;HNRNPC;XRN1;SMG5;SMG6;SMG7;EXOSC10;DHX36;PARN;TENT4B;TEP1
prerank,sterol transfer activity (GO:0120015),0.5843948230994109,1.477213674306259,0.06954887218045112,0.43968426706740027,1.0,2/17,2.03%,GRAMD1C;APOA2
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.5147440311740641,1.4744388419617653,0.0472972972972973,0.4384576488601626,1.0,11/33,19.38%,ELOF1;NCOA3;PCF11;RPRD2;CDC73;WAC;PAF1;ERCC5;URI1;UVSSA;RPRD1B
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3624829279718218,1.472208053439047,0.001215066828675577,0.4360115252300699,1.0,83/346,17.00%,RNF220;PDZRN3;CBLB;RNF152;RNF213;SMURF2;TRIM56;TRIM10;RNF217;TRAF5;FBXO11;SH3RF1;TRIP12;NEDD4;TTC3;NHLRC3;RC3H1;DTX4;BCOR;MYCBP2;TRIM17;RNF19A;KLHL21;UBE2U;RNF216;DTX1;DZIP3;SIAH2;CUL4A;PELI2;TRIM5;DTX3L;BIRC3;FBXO9;MGRN1;ANAPC11;RNF20;FBXL3;TRIM24;RNF111;RNF145;AMFR;UBE2Z;PJA2;UBR4;UBE2C;FBXO4;WWP2;FBXO24;HUWE1;RFWD3;HECTD1;CUL3;KLHL13;TRIM21;BTRC;HECW2;UBE2E3;UBE2Q2;FBXW11;TRIM26;TRIM7;PRPF19;RNF39;FBXO3;BFAR;RNF43;RNF103-CHMP3;RNF181;BRAP;RCHY1;BIRC6;PML;UBE2R2;RNF146;MUL1;RNF180;RNF185;KCMF1;RING1;TRIM23;RNF2;RNF135
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6139513048764327,1.4717432569778914,0.06542056074766354,0.4288614378922622,1.0,4/15,11.07%,KMT2A;KMT2C;SETD4;SETD1B
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.6206859781388638,-1.470478572540183,0.04925053533190578,0.3266350507729818,1.0,6/10,20.35%,GABRA2;GABRA3;GABRA4;GABRG3;GABRA5;GABRA1
prerank,acylglycerol lipase activity (GO:0047372),-0.6243775733517237,-1.4702622907500476,0.035196687370600416,0.31973648168374336,1.0,6/11,25.62%,MGLL;ABHD2;LIPE;ABHD6;FAAH;ABHD15
prerank,amino acid transmembrane transporter activity (GO:0015171),0.46901233547349697,1.4695794326857257,0.043689320388349516,0.42696076511325093,1.0,6/47,4.20%,SLC7A11;PDPN;SLC7A2;SLC6A13;SLC16A2;SLC7A14
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.6341722892602373,1.467790069868804,0.06844106463878327,0.4235236638159,1.0,5/12,6.94%,TGFBR3;LTBP1;BMPR1A;TGFBR1;TGFBR2
prerank,NAD+ binding (GO:0070403),0.6390131786659143,1.4599725043302094,0.07846715328467153,0.4370804130426083,1.0,3/12,4.43%,ZC3HAV1;PARP9;CRYL1
prerank,C-C chemokine receptor activity (GO:0016493),0.5382014519044516,1.4529713553350936,0.06825938566552901,0.4477476010743935,1.0,6/21,17.30%,ACKR2;CCR9;ACKR3;CCRL2;CXCR4;GPR75
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.6089736511515262,-1.450875910719876,0.06534653465346535,0.35515515243886353,1.0,5/11,23.07%,PPP1R11;PPP1R1A;PPP1R14B;PPP1R14C;PPP1R8
prerank,5'-3' RNA polymerase activity (GO:0034062),0.5157506010519659,1.449169284140685,0.0711743772241993,0.45052999913063996,1.0,10/27,15.90%,POLR2D;TERT;POLR1D;POLR1C;POLR3F;POLR2C;MED20;POLR2F;TENT2;POLR3H
prerank,channel activity (GO:0015267),0.4771083366148432,1.4456010999945719,0.060897435897435896,0.45177163154038175,1.0,7/41,10.22%,PDPN;PANX3;PRF1;BCL2;MPV17;BAX;PANX1
prerank,calcium channel regulator activity (GO:0005246),-0.43656284511546034,-1.4430936682510358,0.03931203931203931,0.364939817565945,1.0,7/37,7.54%,PRKG1;NRXN1;FKBP1A;MCUB;CALM1;CALM2;SLC30A1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3355841071662175,1.4381121348834707,0.0,0.4638722237758405,1.0,177/731,19.21%,TCF7L2;TCF4;CREB5;RORA;ZBTB20;SOX5;ZKSCAN2;EBF1;FOXD1;SMAD3;RBPJ;ZEB2;MXI1;NR2F2;ELF1;KCNIP3;CREB3L2;ARNT2;TEAD1;FOXC1;NFIA;STAT2;NFYC;NFAT5;ZNF697;GATA6;SPIB;MAF;HIF3A;ZBTB4;ZNF395;NR6A1;ZIC2;FOXC2;GLI3;NFATC4;MYB;ZIC4;HIVEP2;IKZF2;PRRX2;HIVEP1;HOXC6;HOXC4;ZIC1;LITAF;STAT5B;RFX3;CREB3L4;ZFP30;HLF;GLI1;ARNT;EN2;TOP1;GLIS3;GZF1;SALL1;PRRX1;MGA;TCF12;KLF5;SP9;CREB3L3;NR1H3;FOXP3;HDAC4;ZKSCAN4;PPARA;TCF7L1;RARB;GLIS2;NSD1;ZBTB37;ZBTB7C;POU1F1;KLF9;HOXA2;STAT1;TRIM24;SKI;ZSCAN21;MEF2A;TEAD2;ATF7;ZNF182;SP8;ZEB1;ZNF394;ELF4;ZBTB3;CREM;E4F1;EBF4;SOX21;PBX1;MAFB;MSC;HEYL;ZNF235;TCF7;SMAD4;STAT4;HIVEP3;EGR3;FOXO3;NR4A1;ZNF219;ZFAT;EGR2;ZKSCAN7;THAP1;HOXA10;BPTF;NFIC;MZF1;BHLHE41;NR3C1;GMEB1;PKNOX1;NFE2L1;NRF1;HIC1;POU2F1;ZNF205;PRDM5;SALL2;DMTF1;RFX2;ZNF569;ZBTB12;RARA;ZNF18;SP3;SNAPC3;ZNF383;HOXB4;TEF;SOX4;IRF9;POU5F1;ELK4;ZNF260;MUC1;JDP2;SMAD2;BCL11B;ZNF483;POU6F1;NFATC2;CCAR1;ZBTB5;DNMT3A;ZFP1;ZNF467;KLF15;STAT5A;ATF2;RFX7;NKX2-1;NRIP1;ZSCAN25;MAFG;DHX36;FOXS1;NFYA;CLOCK;ESRRA;FOXP4;CEBPB;KLF6;PGR;E2F2;MEOX2;NFATC3;SOX30;GLIS1
prerank,histone methyltransferase binding (GO:1990226),-0.5908861032905347,-1.4345927727087473,0.07172995780590717,0.3774174627115804,1.0,8/11,28.90%,LCORL;CTNNB1;HSP90AB1;CBX3;NOP56;WIZ;CBX1;PRDM4
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.5711343767732494,-1.4341407882325912,0.07203389830508475,0.3707688557297366,1.0,7/12,13.74%,PDE4D;PDE4B;PDE8A;PDE3B;PDE3A;PDE2A;PDE4C
prerank,voltage-gated potassium channel activity (GO:0005249),-0.3663663711436165,-1.4338288286719956,0.023054755043227664,0.36412295209861134,1.0,22/80,13.66%,KCNB2;KCND2;KCNQ5;KCNMA1;KCNJ3;KCNH7;KCNJ2;KCNC2;KCNQ3;HCN1;KCNT1;HCN2;KCNH1;KCNH5;KCND3;KCNJ6;KCNB1;KCNJ8;KCNQ1;KCNJ15;KCNE4;KCNC1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.332983415160586,1.4330559895429824,0.0,0.4700025533503936,1.0,171/831,16.65%,TCF7L2;TCF4;CREB5;RORA;ZBTB20;SOX5;ZKSCAN2;EBF1;FOXD1;SMAD3;RBPJ;ZEB2;MXI1;NR2F2;ELF1;KCNIP3;ARNT2;OSR1;TEAD1;FOXC1;NFIA;STAT2;NFYC;NFAT5;ZNF697;GATA6;SPIB;TCF24;MAF;HIF3A;ZBTB4;ZNF395;NR6A1;ZIC2;FOXC2;GLI3;NFATC4;MYB;ZIC4;HIVEP2;IKZF2;PRRX2;HIVEP1;HOXC6;ZBTB8A;HOXC4;ZIC1;LITAF;STAT5B;RFX3;CREB3L4;ZFP30;EPAS1;HLF;GLI1;ARNT;EN2;SIM2;TOP1;AEBP1;GLIS3;GZF1;STOX1;SALL1;OTP;PRRX1;ZNF3;MGA;TCF12;KLF5;SP9;ZNF35;CREB3L3;NR1H3;FOXP3;HDAC4;ZKSCAN4;PPARA;TCF7L1;RARB;GLIS2;NSD1;ZBTB37;ZBTB7C;POU1F1;KLF9;HOXA2;CREBRF;STAT1;SKI;ZSCAN21;MEF2A;NFXL1;ZNF25;TEAD2;ATF7;CUX1;ZNF182;ZFP37;SP8;ZEB1;ZNF394;ELF4;ZBTB3;CREM;E4F1;EBF4;SOX21;PBX1;RFXANK;MAFB;MSC;CUX2;HEYL;ZNF235;RFXAP;TCF7;SMAD4;STAT4;HIVEP3;EGR3;FOXO3;NR4A1;LHX9;ZNF219;ZFAT;EGR2;ZKSCAN7;THAP1;HOXA10;BPTF;NFIC;MZF1;BHLHE41;NR3C1;GMEB1;PKNOX1;NFE2L1;NRF1;HIC1;POU2F1;ZNF205;PRDM5;SALL2;DMTF1;RFX2;ZNF569;ZBTB12;RARA;ZNF18;SP3;SNAPC3;ZNF383;HOXB4;TEF;SOX4;IRF9;VEZF1;POU5F1;ELK4;ZNF260;MUC1;JDP2;DRGX;SMAD2;BCL11B;ZNF483;POU6F1;NFATC2;CCAR1;ZBTB5
prerank,diacylglycerol kinase activity (GO:0004143),-0.5781261458227914,-1.4327054517961748,0.08258928571428571,0.35950452301723035,1.0,4/11,6.91%,DGKB;DGKI;DGKH;DGKZ
prerank,outward rectifier potassium channel activity (GO:0015271),0.6344623974058183,1.4318432191297963,0.11954459203036052,0.4651258709124555,1.0,2/11,0.51%,KCNK2;KCNT2
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.48328230367097563,-1.4285281589301204,0.06578947368421052,0.36236515690408655,1.0,5/23,1.55%,PLCB1;EDNRA;CHRM3;PLCB4;PLCG2
prerank,NAD binding (GO:0051287),0.5190479062797618,1.4253988338439358,0.09044368600682594,0.47530763027319284,1.0,7/26,12.39%,ALDH1A1;ZC3HAV1;PARP9;CRYL1;NNT;ALDH2;NUDT6
prerank,translation elongation factor activity (GO:0003746),-0.5542270116177095,-1.4233637028091768,0.07142857142857142,0.36826985636354537,1.0,7/14,16.50%,EEF1A1;GTPBP1;EEF2;GFM1;EIF5A;EIF5AL1;EIF5A2
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.332223842489312,1.422813327272401,0.0,0.4745469011721938,1.0,176/732,19.21%,TCF7L2;TCF4;CREB5;RORA;ZBTB20;SOX5;ZKSCAN2;EBF1;FOXD1;SMAD3;RBPJ;ZEB2;MXI1;NR2F2;ELF1;KCNIP3;ARNT2;TEAD1;FOXC1;NFIA;STAT2;NFYC;NFAT5;ZNF697;GATA6;SPIB;MAF;HIF3A;ZBTB4;ZNF395;NR6A1;ZIC2;FOXC2;GLI3;NFATC4;MYB;ZIC4;HIVEP2;IKZF2;PRRX2;HIVEP1;HOXC6;HOXC4;ZIC1;LITAF;STAT5B;RFX3;CREB3L4;ZFP30;HLF;GLI1;ARNT;EN2;TOP1;GLIS3;GZF1;SALL1;PRRX1;MGA;TCF12;KLF5;SP9;CREB3L3;NR1H3;FOXP3;HDAC4;ZKSCAN4;PPARA;TCF7L1;RARB;GLIS2;NSD1;ZBTB37;ZBTB7C;POU1F1;KLF9;HOXA2;STAT1;SKI;ZSCAN21;MEF2A;TEAD2;ATF7;ZNF182;SP8;ZEB1;ZNF394;ELF4;ZBTB3;CREM;E4F1;EBF4;SOX21;PBX1;TIPARP;MAFB;MSC;HEYL;ZNF235;TCF7;SMAD4;STAT4;HIVEP3;EGR3;FOXO3;NR4A1;ZNF219;ZFAT;EGR2;ZKSCAN7;THAP1;HOXA10;BPTF;NFIC;MZF1;BHLHE41;NR3C1;GMEB1;PKNOX1;NFE2L1;NRF1;HIC1;POU2F1;ZNF205;PRDM5;SALL2;DMTF1;RFX2;ZNF569;ZBTB12;RARA;ZNF18;SP3;SNAPC3;ZNF383;HOXB4;TEF;SOX4;IRF9;POU5F1;ELK4;ZNF260;MUC1;JDP2;SMAD2;BCL11B;ZNF483;POU6F1;NFATC2;CCAR1;ZBTB5;DNMT3A;ZFP1;ZNF467;KLF15;STAT5A;ATF2;RFX7;NKX2-1;NRIP1;ZSCAN25;MAFG;DHX36;FOXS1;NFYA;CLOCK;ESRRA;FOXP4;CEBPB;KLF6;PGR;E2F2;MEOX2;NFATC3;SOX30;GLIS1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.4403205340084522,-1.4220726561953476,0.061855670103092786,0.35758426833477547,1.0,21/34,35.26%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;NDUFA4;NDUFB2;NDUFA12;NDUFB7;NDUFB10;NDUFC2;NDUFA13;NDUFA9;NDUFA10;NDUFS6;NDUFV3;NDUFS1;NDUFA2;NDUFA6;NDUFS2
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.4403205340084522,-1.4220726561953476,0.061855670103092786,0.35758426833477547,1.0,21/34,35.26%,NDUFV1;NDUFC1;NDUFA8;NDUFS7;NDUFB4;NDUFA1;NDUFA4;NDUFB2;NDUFA12;NDUFB7;NDUFB10;NDUFC2;NDUFA13;NDUFA9;NDUFA10;NDUFS6;NDUFV3;NDUFS1;NDUFA2;NDUFA6;NDUFS2
prerank,sequence-specific DNA binding (GO:0043565),0.3354818930250432,1.4201772151243626,0.0,0.4736058156045985,1.0,131/590,19.21%,TCF7L2;TCF4;CREB5;KMT2A;RORA;ZBTB20;FOXD1;SMAD3;RBPJ;ZEB2;NR2F2;ELF1;ARNT2;OSR1;TEAD1;FOXC1;LBX1;NFAT5;GATA6;SPIB;MAF;ZBTB4;NR6A1;FOXC2;GLI3;NFATC4;ZIC4;MBD2;PRRX2;HIVEP1;HOXC4;ZIC1;RFX3;TERT;CREB3L4;EPAS1;HLF;ARNT;EN2;BCL2;ZNF276;GZF1;TCF12;KLF5;SP9;ZNF35;FOXP3;HDAC4;PPARA;TCF7L1;RARB;GLIS2;ZBTB37;POU1F1;HOXA2;MEF2A;TEAD2;ATF7;CUX1;SP8;ELF4;CREM;PBX1;MAFB;MSC;CUX2;SMG5;ELF2;TCF7;SMAD4;EGR3;SMG6;FOXO3;NR4A1;LHX9;KDM5B;EGR2;THAP1;HOXA10;BPTF;KDM2A;NFIC;BHLHE41;NR3C1;GMEB1;PKNOX1;HIC1;POU2F1;PRDM5;ERH;RFX2;SMG7;ZBTB21;ZBTB12;HDAC2;RARA;SP3;HOXB4;TEF;SOX4;IRF9;KDM2B;POU5F1;ELK4;MBNL2;JDP2;DRGX;BCL11B;POU6F1;NFATC2;UPF3A;ZFP1;LRWD1;SMG1;KLF15;ATF2;TEN1;HMBOX1;RFX7;KDM1A;MAFG;SIRT3;CLOCK;ESRRA;CEBPB;KLF6;E2F2;MEOX2;NFATC3;SOX30;GLIS1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.4963938938722223,-1.418692258319953,0.08390022675736962,0.35826801100634775,1.0,11/22,21.48%,ATP6V0A1;ATP6V1B2;ATP2C1;ATP2A3;ATP6V0C;ATP6V1D;ATP5F1B;ATP2A2;ATP6V0A2;ATP6V0E2;ATP6V0D2
prerank,motor activity (GO:0003774),-0.38549716496037917,-1.4137215744071912,0.03380281690140845,0.36276447259686284,1.0,33/60,38.46%,KIF1B;KIF26B;KIF21A;KIF1C;MYL6;STARD9;DNAH8;KIF26A;KIF18A;KIF5C;KIF15;KIF3B;DYNC1I2;KIF16B;KIF5A;GPR88;KIF27;KIF23;KIF22;KIF4A;KIF14;KIFC3;KIF19;DNAH17;KIF20A;KIF20B;DNAH3;KIFC1;DYNLRB1;PIN1;KIF2C;DNAH1;DYNLRB2
prerank,phospholipase C activity (GO:0004629),-0.4670250158526138,-1.4095216356416016,0.06487695749440715,0.3653777105829984,1.0,5/25,1.55%,PLCB1;EDNRA;CHRM3;PLCB4;PLCG2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.6318163193820743,1.4074291405789863,0.09664694280078895,0.5011254719383003,1.0,3/10,9.40%,CXADR;CD47;DSC2
prerank,pyridoxal phosphate binding (GO:0030170),0.5407659661507653,1.4053953257889142,0.10351201478743069,0.49888960751738487,1.0,5/20,10.09%,SHMT1;PYGB;PDXK;PYGM;ABAT
prerank,bHLH transcription factor binding (GO:0043425),0.5415031706252336,1.404098214208114,0.1009009009009009,0.49532498822976856,1.0,4/19,6.75%,FHL2;SMAD3;TCF12;CREBBP
prerank,phospholipase inhibitor activity (GO:0004859),0.6284389905204962,1.4035606724219716,0.11377245508982035,0.48955920851535367,1.0,7/10,21.39%,ANXA2;ANXA1;ANXA4;ANXA5;ANXA9;ANGPTL3;SNCB
prerank,growth factor receptor binding (GO:0070851),0.39876564375332213,1.4008174484300515,0.03868194842406877,0.4902446481393139,1.0,14/95,6.11%,EFEMP1;PDGFRA;FGF1;IL6ST;IL11;FRS2;FER;ITGA5;VEGFD;TGFA;KL;IL6;ARF4;PDGFRB
prerank,ribosomal large subunit binding (GO:0043023),-0.5718398454537402,-1.399277303486968,0.10483870967741936,0.3818194693843609,1.0,7/11,29.94%,CPEB2;NPM1;RBM3;MALSU1;LTN1;EIF6;CPSF6
prerank,MHC class II protein complex binding (GO:0023026),-0.5816193959705795,-1.398810157115613,0.1006036217303823,0.37650202550811074,1.0,6/11,12.81%,HSPA8;ATP1B1;PKM;HSP90AB1;CD74;HSP90AA1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5962352675433932,-1.3980281905945744,0.10021321961620469,0.3721058245448895,1.0,2/10,3.43%,MECOM;PRDM16
prerank,alkali metal ion binding (GO:0031420),0.5918387763719026,1.3947671115010027,0.11433756805807622,0.5000309405773523,1.0,4/13,11.27%,ATP1A2;HDAC4;PDXK;ACAT1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5436183070687683,1.3919921637356938,0.09851301115241635,0.5007170978278419,1.0,5/18,6.94%,TGFBR3;LTBP1;BMPR1A;TGFBR1;TGFBR2
prerank,peptide hormone receptor binding (GO:0051428),0.6135900994578045,1.3913617847675976,0.11776447105788423,0.49545146286004754,1.0,2/11,3.78%,GHRH;PTHLH
prerank,platelet-derived growth factor binding (GO:0048407),0.6132562324226505,1.3872681937011786,0.13018867924528302,0.500187740367698,1.0,4/11,6.11%,COL3A1;PDGFRA;COL5A1;PDGFRB
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.36435991217869995,1.3826170660559989,0.019151846785225718,0.5064369900271987,1.0,40/188,15.89%,TCF7L2;ZBTB20;SOX5;SMAD3;ARID4A;CREB3L2;TBL1XR1;FOXC1;NFYC;GATA6;FOXC2;CRY2;RFX3;GABPB2;GABPB1;GLI1;BCOR;TCF12;CREB3L3;NR1H3;HDAC4;GLIS2;YAP1;SMAD6;PBX1;TAF7;PSPC1;TCF7;SMAD4;FOXO3;EGR2;MZF1;ARID5B;PRDM5;DMTF1;CARM1;SOX4;PER3;POU5F1;TAF9
prerank,protein phosphatase 1 binding (GO:0008157),-0.486956943960939,-1.3796409551176905,0.07912087912087912,0.4081540799200945,1.0,9/21,23.85%,PPP1R16B;PHACTR4;PPP1R3B;PPP1R11;KCNQ1;PPP1R3C;SH3RF2;PPP1R15A;SMTNL2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.5225619232076315,-1.376823385586277,0.10606060606060606,0.40834485675594534,1.0,5/16,8.67%,SLC26A7;SLC26A2;CLCN7;SLC1A1;SLC12A5
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.4732885695197281,-1.3760486736452702,0.06046511627906977,0.3913637860899524,1.0,8/22,19.46%,CHRM3;HTR2C;CHRM2;HRH1;HTR2B;HTR4;HTR2A;HRH2
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.4732885695197281,-1.3760486736452702,0.06046511627906977,0.3913637860899524,1.0,8/22,19.46%,CHRM3;HTR2C;CHRM2;HRH1;HTR2B;HTR4;HTR2A;HRH2
prerank,serotonin receptor activity (GO:0099589),-0.4732885695197281,-1.3760486736452702,0.06046511627906977,0.3913637860899524,1.0,8/22,19.46%,CHRM3;HTR2C;CHRM2;HRH1;HTR2B;HTR4;HTR2A;HRH2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.4207514677912376,1.3747786191043068,0.06327160493827161,0.5210084039254794,1.0,17/60,9.85%,EFEMP1;EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;EPHA3;EPHA8;NRP1;KIT;ROR1;EPHA1;PDGFRB;EPHA4;MST1R;MUSK
prerank,leak channel activity (GO:0022840),0.5415961328188741,1.3744394019211252,0.11379310344827587,0.5149998385474236,1.0,2/18,2.15%,KCNK2;NALCN
prerank,retinoic acid binding (GO:0001972),0.590121307799724,1.3715471017229768,0.126953125,0.5163346539326122,1.0,1/12,0.95%,NR2F2
prerank,poly(A) binding (GO:0008143),0.513573619422592,1.3712220746249568,0.11052631578947368,0.510504240105949,1.0,4/21,5.43%,RBMS1;RBMS3;RBMS2;PABPC5
prerank,carboxylic acid binding (GO:0031406),-0.4103670905976622,-1.3686827940797992,0.07962529274004684,0.40187309150404427,1.0,15/38,22.81%,GRM7;NOS3;GRIN3A;GLRA3;GRIN2B;SESN3;GRIN1;NOS1;GCLC;EPDR1;UBR1;GLRA2;GLRA1;HIF1AN;SHMT2
prerank,thyroid hormone receptor binding (GO:0046966),0.4801889422006731,1.3588152848848627,0.13344887348353554,0.5395743192958757,1.0,10/28,13.23%,NCOA3;TRIP12;NCOA6;TACC1;NSD1;OASL;TAF7;ZNHIT3;MED12;BRD8
prerank,transcription cis-regulatory region binding (GO:0000976),0.32902988842372144,1.358792973179218,0.009259259259259259,0.532769355011892,1.0,82/406,16.65%,TCF7L2;RORA;ZBTB20;SOX5;SMAD3;MXI1;ARID4A;CREB3L2;OSR1;TBL1XR1;TEAD1;FOXC1;NFYC;GATA6;TCF24;HIF3A;ZBTB4;ZNF395;FOXC2;GLI3;CRY2;ZBTB8A;RFX3;GABPB2;GABPB1;EPAS1;GLI1;BCOR;ARNT;SIM2;AEBP1;STOX1;OTP;ZNF3;TCF12;ZNF35;CREB3L3;NR1H3;HDAC4;GLIS2;CREBRF;MEF2A;NFXL1;ZNF25;CUX1;ZFP37;YAP1;CREM;SMAD6;E4F1;PBX1;TIPARP;RFXANK;TAF7;MSC;PSPC1;CUX2;RFXAP;TCF7;SMAD4;FOXO3;LHX9;EGR2;MZF1;NR3C1;ARID5B;PRDM5;SALL2;DMTF1;CARM1;RARA;SP3;SNAPC3;SOX4;PER3;VEZF1;POU5F1;TAF9;DRGX;SMAD2;TBL1X;ZBTB5
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.4084608647905613,1.3579032540766292,0.0783132530120482,0.5286121909114619,1.0,20/69,16.77%,PLA2G4A;CERS5;CERS6;LIPT1;ZDHHC3;PLA2G4C;MOGAT3;CREBBP;SCP2;KAT6B;NAA16;ESCO1;SOAT1;NAA15;DGAT2;PORCN;KAT6A;ZDHHC17;KAT2B;LPGAT1
prerank,chemokine binding (GO:0019956),0.46939591937683717,1.356682484541231,0.10016420361247948,0.5250715612096156,1.0,4/30,7.77%,PDPN;ACKR2;CCR9;ACKR3
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.5717831264220121,-1.3565628015291886,0.11982570806100218,0.42340397541447533,1.0,4/10,17.85%,CACNB2;CACNB4;CACNA1D;CACNA1A
prerank,ion channel activity (GO:0005216),-0.3501506976532487,-1.3491517135028597,0.04242424242424243,0.43496381522662503,1.0,18/80,9.21%,GRID2;PIEZO2;GRIA4;GRIK2;GRIN3A;ABCC9;GRIK4;GRIA1;UNC80;MCUB;GRIN2A;GRIK1;GRIA3;GRIN2B;TRPC6;GRIA2;GRIN1;GABRB1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5577466224301042,-1.3490550360910174,0.13417190775681342,0.4289959308214886,1.0,4/11,15.91%,SGMS1;SGMS2;PTDSS1;PIGO
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.4014043387761516,-1.3457515180993647,0.09900990099009901,0.4309108547716667,1.0,17/37,33.70%,LARS2;KARS1;CARS1;EARS2;TARS3;IARS1;RARS2;VARS2;HARS1;YARS2;FARSB;YARS1;TARS1;WARS2;NARS1;PARS2;QARS1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.49227238524431,-1.3450901952365675,0.10887096774193548,0.4201452818085678,1.0,9/16,22.94%,ANO1;ANO3;ANO4;TTYH2;TTYH3;ANO2;TTYH1;ANO5;NMUR2
prerank,intracellular chloride channel activity (GO:0061778),-0.49227238524431,-1.3450901952365675,0.10887096774193548,0.4201452818085678,1.0,9/16,22.94%,ANO1;ANO3;ANO4;TTYH2;TTYH3;ANO2;TTYH1;ANO5;NMUR2
prerank,sodium:proton antiporter activity (GO:0015385),-0.5533819694570403,-1.344314067793278,0.12219959266802444,0.41636943543637256,1.0,3/11,6.32%,SLC9A2;SLC9B2;SLC9A8
prerank,RNA polymerase core enzyme binding (GO:0043175),0.468231434381133,1.3437436218167738,0.12116040955631399,0.5547093717313805,1.0,12/33,19.46%,ELOF1;NCOA3;PCF11;RPRD2;CDC73;WAC;PAF1;ERCC5;URI1;UVSSA;RPRD1B;ERBB2
prerank,cholesterol binding (GO:0015485),0.43042542699952746,1.3423588502277595,0.09646302250803858,0.5523844480618734,1.0,13/47,14.75%,SIDT1;GRAMD1C;APOA2;APOF;OSBPL8;VDAC2;NR1H3;NPC1;SCP2;SOAT1;OSBPL5;STAR;ABCA1
prerank,titin binding (GO:0031432),-0.5261661316701024,-1.3420433326393069,0.11879049676025918,0.4159881647914102,1.0,4/13,7.24%,CALM1;CALM2;CALM3;CAMK2D
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.5497572200200833,1.339690545692076,0.1559633027522936,0.5534774401073039,1.0,2/15,6.30%,PLA2G4A;PLA2G4C
prerank,nuclear localization sequence binding (GO:0008139),0.522366016026774,1.3379724067860468,0.141804788213628,0.551303331402234,1.0,6/18,14.30%,TNPO1;KPNA6;KPNA7;KPNA4;POM121;BRAP
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.6100568774304229,1.3358509726259404,0.15730337078651685,0.5506663890105961,1.0,6/10,26.96%,NSD3;NSD1;SETD5;SETD2;ASH1L;SMYD2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3150392855020405,1.3288762922913055,0.00778642936596218,0.564021599528233,1.0,133/597,19.21%,TCF7L2;TCF4;CREB5;ZBTB20;SOX5;SMAD3;ARID4A;ELF1;CREB3L2;ARNT2;OSR1;TBL1XR1;TEAD1;FOXC1;LBX1;NFYC;NFAT5;GATA6;SPIB;MAF;NR6A1;FOXC2;ORC5;GLI3;NFATC4;ZIC4;MBD2;PRRX2;HIVEP1;CRY2;HOXC4;ZIC1;RFX3;GABPB2;GABPB1;CREB3L4;HLF;GLI1;BCOR;ARNT;EN2;ZNF276;TCF12;KLF5;SP9;CREB3L3;NR1H3;FOXP3;HDAC4;TCF7L1;RARB;GLIS2;ZBTB37;POU1F1;HOXA2;TEAD2;ATF7;CUX1;SP8;YAP1;ELF4;CREM;SMAD6;PBX1;TAF7;MSC;MCM4;PSPC1;CUX2;ELF2;TCF7;SMAD4;EGR3;FOXO3;NR4A1;TSPYL2;LHX9;KDM5B;EGR2;HOXA10;NFIC;MZF1;BHLHE41;NR3C1;GMEB1;MCM6;PKNOX1;HIC1;ARID5B;PRDM5;DMTF1;RFX2;ORC3;CARM1;ZBTB12;RARA;SP3;HOXB4;ORC4;TEF;SOX4;IRF9;PER3;POU5F1;ELK4;TAF9;MBNL2;JDP2;DRGX;BCL11B;POU6F1;NFATC2;TBL1X;CENPC;ZFP1;KLF15;ATF2;HMBOX1;RFX7;NKX2-1;MAFG;DHX36;NFYA;CLOCK;ESRRA;CEBPB;BRD7;KLF6;E2F2;MEOX2;NFATC3;SOX30;GLIS1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5346439827741208,-1.328233063610917,0.15478615071283094,0.44300677318719384,1.0,4/12,6.75%,INSR;PIK3R1;GNAS;YWHAH
prerank,monocarboxylic acid binding (GO:0033293),0.5201836207682116,1.3258939533890768,0.15700934579439252,0.565968788845998,1.0,3/18,16.06%,NR2F2;RARA;NAPEPLD
prerank,leucine zipper domain binding (GO:0043522),0.5982907982644464,1.32576039203114,0.16533864541832669,0.5598768439188965,1.0,1/10,0.55%,PAWR
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5109166721245954,1.3230495781745135,0.145985401459854,0.560384257131857,1.0,6/18,11.18%,TGFBR3;SMAD3;TGFBR1;TGFBR2;SMAD6;TGFBRAP1
prerank,rRNA binding (GO:0019843),-0.3955098639709959,-1.3221743921435525,0.07614213197969544,0.45044178269330404,1.0,14/42,17.35%,RPS9;RPL5;RPS3;RPL11;RPLP0;RPS13;MRPS18A;RPL23;RPS5;PPAN;FASTKD2;RPS14;RPL12;ERI1
prerank,nuclear import signal receptor activity (GO:0061608),0.5357672997229542,1.321370081628649,0.15653775322283608,0.5588221413579404,1.0,4/15,7.24%,TNPO1;KPNA6;KPNA7;KPNA4
prerank,endopeptidase regulator activity (GO:0061135),0.42900337752131124,1.3187309325052032,0.12086092715231789,0.5600302008113667,1.0,7/40,9.57%,TFPI;CSTB;ITIH2;SPINT2;PZP;PROS1;CAST
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.5430900923675432,-1.31653313444643,0.13948497854077252,0.45785489511499805,1.0,2/11,6.59%,HCN1;HCN2
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.5264485677117242,-1.3128157615734113,0.15618661257606492,0.46013335238179254,1.0,3/12,6.32%,SLC9A2;SLC9B2;SLC9A8
prerank,FAD binding (GO:0071949),0.4825830796332995,1.3118495289282368,0.1408199643493761,0.5731264390011734,1.0,5/24,4.60%,MICAL3;DDO;CRY2;CRY1;SQOR
prerank,metal ion:proton antiporter activity (GO:0051139),-0.5139088786070616,-1.31094742414688,0.1733615221987315,0.45860872731055286,1.0,3/13,6.32%,SLC9A2;SLC9B2;SLC9A8
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.5837133860054465,1.3088716745784779,0.18058252427184465,0.5758540933777226,1.0,2/10,1.15%,CXCL10;PRKAG2
prerank,store-operated calcium channel activity (GO:0015279),-0.5601990544643723,-1.308837975271279,0.14137214137214138,0.4577217266271432,1.0,4/10,6.77%,TRPC3;TRPC5;TRPC4;TRPC6
prerank,phosphoric diester hydrolase activity (GO:0008081),0.44142313183441506,1.3070134138862244,0.13523131672597866,0.5752277102298836,1.0,6/35,6.22%,ENPP3;MPPED2;SMPD3;ENPP1;PLCE1;PLCB3
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.531647114061877,1.3041726567406908,0.16728624535315986,0.5768029905984923,1.0,2/15,2.40%,ACKR2;CCR9
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.43406920517566905,-1.3011961461881207,0.14508928571428573,0.4703270849216528,1.0,9/27,14.55%,SLC26A7;SLC26A2;ANO1;XPR1;SLC5A5;SLC39A14;SLC22A6;SLC25A30;SLC39A8
prerank,potassium ion leak channel activity (GO:0022841),0.5366851487250957,1.301061942240084,0.1684027777777778,0.5792755580644795,1.0,1/15,0.04%,KCNK2
prerank,protease binding (GO:0002020),0.36960728999649867,1.3007458652208987,0.10086455331412104,0.5742140719226874,1.0,20/99,9.34%,DPP4;COL3A1;FN1;ECM1;TIMP3;ANXA2;CSTB;ADAMTSL4;CFLAR;BCL2;SERPINE1;BDKRB2;POLG;GSK3B;RIPK2;PZP;TIMP2;AMFR;INSL3;SUMO1
prerank,calcium channel inhibitor activity (GO:0019855),-0.5465230884889136,-1.3000971662590433,0.15811088295687886,0.46741732624574334,1.0,5/11,7.54%,FKBP1A;MCUB;CALM1;CALM2;SLC30A1
prerank,chemokine activity (GO:0008009),0.45247936331119853,1.2999015819050688,0.13747954173486088,0.5708365463901425,1.0,4/31,7.71%,CXCL10;CXCL16;CKLF;CCL2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.5005080600856924,-1.296411671066164,0.13901345291479822,0.4648167762450067,1.0,8/16,21.48%,ATP6V0A1;ATP6V1B2;ATP6V0C;ATP6V1D;ATP5F1B;ATP6V0A2;ATP6V0E2;ATP6V0D2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.5005080600856924,-1.296411671066164,0.13901345291479822,0.4648167762450067,1.0,8/16,21.48%,ATP6V0A1;ATP6V1B2;ATP6V0C;ATP6V1D;ATP5F1B;ATP6V0A2;ATP6V0E2;ATP6V0D2
prerank,DNA-binding transcription factor binding (GO:0140297),0.3367235194194825,1.295571085762172,0.06577181208053691,0.5773976328568412,1.0,38/189,14.82%,TCF7L2;FHL2;SMAD3;RBPJ;TLE1;LDB2;DACT1;TLE3;MIER3;BCL2;MTDH;PRRX1;TCF12;MIER1;HDAC4;PPARA;CREBBP;POU1F1;STAT1;GSK3B;SKI;MEF2A;PIAS1;YAP1;CRTC1;CREM;WWP2;RERE;ATN1;CRTC3;RBBP8;IFI27;EGR2;BHLHE41;PRDM5;TLE6;RUNX1T1;HDAC2
prerank,DNA binding (GO:0003677),0.30251322964393,1.2950898708473646,0.007743362831858407,0.5728681466117278,1.0,162/694,19.11%,TCF7L2;TCF4;RORA;TSHZ2;FOXD1;SMAD3;RBPJ;ZEB2;ARID4A;RBMS1;NR2F2;TEAD1;NUPR1;FOXC1;NFYC;DDX60;PDS5B;ZBTB4;ZNF395;DENND4A;SSBP2;NR6A1;ZIC2;FOXC2;ZIC4;NHEJ1;POLR2D;HIVEP2;CRY2;NUCKS1;RFX3;TERT;CRY1;WRN;EPAS1;HLF;GLI1;ARNT;SIM2;BCL2;TOP1;GZF1;OTP;ZBP1;ZNF3;RAD50;APLP2;HDGFL3;ZNF35;NR1H3;FOXP3;HDAC4;PPARA;TCF7L1;TSHZ3;CREBBP;RARB;RFC1;OASL;POLG;STAT1;FBH1;QRICH1;MEF2A;ZMYND11;NTHL1;CRLF3;SYCP2;CUX1;XRCC4;ACR;RLF;GLYR1;NABP1;CREM;HDGFL2;FUBP1;RPA3;SOX21;PBX1;MAFB;MCM4;CUX2;HUWE1;DCLRE1A;ZNF292;CENPX;POLR3F;XRN1;SMAD4;RTF1;ZMYM6;FOXO3;NR4A1;RBBP8;ZNF219;MTERF2;SPO11;ILF3;KDM5B;EGR2;OGG1;THAP1;TRIM26;BPTF;SUPV3L1;RBM5;MCM6;RAD51B;HIC1;ARID5B;RBM6;POU2F1;KAT6A;MND1;GTF2H4;ERCC5;ERCC6;PRDM5;RFX2;ZBTB21;HDAC2;DNASE1L1;SURF6;SNAPC3;ERCC1;SMARCA4;KDM2B;LIN9;POU5F1;ZMYM3;ELK4;APP;TAF9;SMAD2;TRIM16;POU6F1;NFATC2;DNMT3A;CENPC;CHD8;NUFIP1;JRKL;HMBOX1;C1D;PARP4;TSHZ1;NKX2-1;PCBP2;DHX36;FOXS1;SIRT3;NFYA;CHD4;CLOCK;ESRRA;CEBPB;PGR;E2F2;XPC;MEOX2;TDP2
prerank,cadherin binding (GO:0045296),-0.2777303164768169,-1.2923865970104509,0.01694915254237288,0.46848879744771055,1.0,81/315,14.88%,PTPRB;DOCK9;CTNND2;COBLL1;CTNNA2;BSG;ITGA6;PTPRJ;CDH2;CDH11;PROM1;FNBP1L;HSPA8;LRRFIP1;CDH12;CTNNA3;MRTFB;BMPR2;KDR;RPL24;FXYD5;NOTCH3;CDH1;CSNK1D;EPN2;PTPRM;ANK3;MACF1;DIAPH3;TRPC4;EEF1G;DAB2IP;CDH10;RPL6;CTNNB1;CLINT1;CDH8;MRE11;PUF60;PKM;CDH22;HSP90AB1;CDH4;EFHD2;TES;EEF2;RPS2;CDH7;CDH20;HNRNPK;RPL14;SHTN1;PCBP1;STXBP6;BZW2;RPS26;PTPRT;VASP;RACK1;CDC42EP1;CBL;DBNL;ARHGAP1;CD46;PPP1CA;PTPRO;ANLN;RPL29;EGFR;GPRC5A;RANBP1;ACVR1;SLC3A2;F11R;NOP56;EHD4;TJP2;MPP7;PARK7;GLOD4;PAK4
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.4039941964896767,1.2919289258237834,0.13636363636363635,0.575889651182074,1.0,4/53,2.88%,SLC7A11;SLC7A2;SLC1A3;SLC6A9
prerank,fibroblast growth factor receptor binding (GO:0005104),0.49484089438237744,1.291467292031168,0.16725352112676056,0.5715878432841698,1.0,3/21,3.39%,FGF1;FRS2;KL
prerank,glycine binding (GO:0016594),-0.535820746757555,-1.290559365363581,0.1859504132231405,0.4673515671906942,1.0,8/11,28.98%,GRIN3A;GLRA3;GRIN2B;GRIN1;GLRA2;GLRA1;GLDC;GNMT
prerank,C-C chemokine binding (GO:0019957),0.4795318732538611,1.2897897879132065,0.14462081128747795,0.5704182099399377,1.0,5/22,15.74%,ACKR2;CCR9;ACKR3;CCRL2;CXCR4
prerank,histone acetyltransferase binding (GO:0035035),0.48565417591307747,1.2856236552973566,0.1781818181818182,0.5761422769781046,1.0,12/21,24.07%,GLI3;EPAS1;FOXP3;STAT1;MEF2A;TAF7;KANSL1;CITED2;SIRT2;HIF1A;ECD;EGR1
prerank,insulin-like growth factor I binding (GO:0031994),0.535389341450121,1.2842506428347165,0.2036697247706422,0.5742505167536925,1.0,3/13,3.96%,IGFBP3;IGFBP5;IGFBP6
prerank,flavin adenine dinucleotide binding (GO:0050660),0.39977325995018614,1.2837861358570546,0.13114754098360656,0.5701155807771847,1.0,10/53,6.79%,MICAL3;DDO;AOX1;CRY2;POR;CRY1;SQOR;ACOXL;NOS2;DPYD
prerank,inward rectifier potassium channel activity (GO:0005242),-0.42561208132305556,-1.2809136003924884,0.14549653579676675,0.4843840180554177,1.0,10/24,26.78%,ABCC9;KCNJ3;KCNJ2;KCNJ6;KCNJ8;KCNJ15;KCNJ10;KCNN3;KCNK1;KCNJ16
prerank,insulin-like growth factor binding (GO:0005520),0.5172759448693843,1.2777210056621355,0.1960431654676259,0.5818684616881317,1.0,3/15,3.96%,IGFBP3;IGFBP5;IGFBP6
prerank,amino acid binding (GO:0016597),-0.40397685805071143,-1.2768436118372872,0.12669683257918551,0.4890775281093671,1.0,7/31,10.30%,GRM7;NOS3;GRIN3A;GLRA3;GRIN2B;GRIN1;NOS1
prerank,fatty acid synthase activity (GO:0004312),-0.536946400076584,-1.2762441907012316,0.1834319526627219,0.4850720341186872,1.0,2/10,3.52%,ELOVL5;ELOVL7
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5114818069967044,1.2747315907533996,0.18484288354898337,0.5846860920967881,1.0,4/17,9.97%,ACOT11;PLA2G6;ACOT9;ACOT1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.5543136317138195,1.2746848803940207,0.20074349442379183,0.5794698710298755,1.0,7/11,24.17%,ANAPC11;AMFR;PRPF19;UBE4B;UBR5;UBE2K;PPIL2
prerank,adenylate cyclase binding (GO:0008179),-0.5345704397659163,-1.26857240976652,0.17995910020449898,0.4980549521039457,1.0,6/10,10.76%,AKAP6;CAP2;CALM1;CALM2;CALM3;ADCY2
prerank,manganese ion binding (GO:0030145),0.3972176351556727,1.2667922850791686,0.15483870967741936,0.5956601144668557,1.0,9/48,7.95%,MPPED2;FAM20C;WRN;LARGE1;GALNT2;GALNT1;GYG1;B4GALT1;NEK4
prerank,potassium channel regulator activity (GO:0015459),-0.352144697002727,-1.2662373054911777,0.128,0.4981658492020958,1.0,11/49,13.29%,DPP10;KCNAB1;KCNMB2;ABCC9;KCNIP4;KCNIP1;DPP6;AKT1;NEDD4L;ADRB2;KCNE4
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3680228116954009,-1.265110628391577,0.11822660098522167,0.4953784934678738,1.0,13/42,11.40%,LRRC4C;BSG;ESAM;CNTN4;CNTN6;ROBO4;NPTN;JAM3;STXBP6;CNTN2;EMB;CDC42EP1;PPP1CA
prerank,syntaxin-1 binding (GO:0017075),-0.42639123470938906,-1.2619828408812235,0.163855421686747,0.4973142452232694,1.0,7/22,9.75%,SYT1;SYNPR;NSF;SNAP25;STXBP1;CPLX1;SNPH
prerank,GTPase inhibitor activity (GO:0005095),-0.5067706590792942,-1.259384756069133,0.1943231441048035,0.498207436727774,1.0,7/13,21.74%,SLIT2;CPEB2;TNK2;RHOH;PDE6D;GPS1;ARL2
prerank,calcium-activated potassium channel activity (GO:0015269),-0.5106621837915319,-1.2592555904171705,0.18803418803418803,0.4933341712753478,1.0,2/11,1.65%,KCNMB2;KCNMA1
prerank,solute:anion antiporter activity (GO:0140323),0.5256455174918804,1.2577909923286383,0.2076923076923077,0.614499062333114,1.0,2/14,3.50%,SLC7A11;SLC26A9
prerank,lysine N-methyltransferase activity (GO:0016278),0.48314982849766686,1.2575308993874617,0.20207253886010362,0.6096837255033634,1.0,10/20,26.96%,METTL21C;ETFBKMT;SETD4;SETD7;ATPSCKMT;SETD2;EHMT2;SETD6;EEF1AKMT4;SMYD2
prerank,nucleotide diphosphatase activity (GO:0004551),0.5259101697429831,1.2513856173563047,0.2099236641221374,0.6207317527540084,1.0,6/14,18.67%,ENPP1;FHIT;NUDT13;NUDT6;NUDT4;CILP2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4975390900207026,1.2511848221296071,0.19963031423290203,0.6159631996120819,1.0,4/16,13.40%,PIR;HGD;ALOXE3;BCO2
prerank,retinoid X receptor binding (GO:0046965),0.5474699644850167,1.2501104626430926,0.2174757281553398,0.6137374515588739,1.0,5/11,20.35%,NCOA6;TACC1;NSD1;NRIP1;ARID5A
prerank,semaphorin receptor binding (GO:0030215),-0.4307071376723496,-1.2495776325134618,0.16964285714285715,0.5113679449556994,1.0,10/23,12.74%,SEMA6D;RIT2;SEMA4D;SEMA3C;SEMA6A;SEMA7A;SEMA3E;SEMA3G;SEMA6B;SEMA3A
prerank,kinesin binding (GO:0019894),-0.4098722115851485,-1.2478233441156783,0.1767337807606264,0.5104270532262418,1.0,10/27,17.13%,KIF1B;ACTB;SNCA;AP1AR;MAPK8IP1;NEFH;CLSTN1;MAPK8IP3;TOR1B;PRC1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.37120859284019503,1.2473288570897936,0.14375987361769352,0.6159968613873904,1.0,19/71,12.72%,PTPN13;EYA2;EYA1;TPTE;PTPN14;PTPN4;PTPN3;PTPN22;PTPRA;MTMR3;PTPN2;PTPN9;PTPN21;PTPN6;EYA4;CDC14A;PTPRU;PTPN1;PTPN18
prerank,methyl-CpG binding (GO:0008327),0.4625258637771629,1.2460955533220874,0.21490467937608318,0.6142704922156493,1.0,10/22,25.58%,ZBTB4;MBD2;ERH;ZBTB21;LRWD1;TET1;PRMT1;ZCWPW1;MECP2;ZBTB33
prerank,translation initiation factor activity (GO:0003743),-0.38422759247051785,-1.2457180143525912,0.13910761154855644,0.5107221729263649,1.0,11/36,19.87%,EIF2B2;EIF3F;EIF5B;EIF4A1;EIF1B;EIF3A;COPS5;EIF1;EIF3H;EIF4A2;EIF3G
prerank,calcium activated cation channel activity (GO:0005227),-0.457258519583985,-1.2441391682274647,0.202991452991453,0.5092800748946794,1.0,4/17,7.08%,KCNMB2;KCNMA1;ANO1;TMEM63C
prerank,voltage-gated ion channel activity (GO:0005244),-0.48817416544589964,-1.243213385562035,0.19829424307036247,0.5064631162757406,1.0,3/14,3.19%,KCND2;CACNA1E;HCN1
prerank,regulatory RNA binding (GO:0061980),0.4077208561949823,1.2414891125574374,0.17252931323283083,0.6215427414647475,1.0,16/38,25.27%,TUT4;PIWIL4;RC3H1;TARBP2;ZC3H7B;POU5F1;DDX21;HNRNPA2B1;PUM2;TUT7;ELAVL1;ZC3H12A;PNPT1;DHX9;ZC3H10;MATR3
prerank,semaphorin receptor activity (GO:0017154),0.5373835524467387,1.2388527350467868,0.22612085769980506,0.6238623182106087,1.0,2/11,2.97%,PLXNA2;NRP1
prerank,chemokine receptor binding (GO:0042379),0.4173056188570112,1.237497849191519,0.19273301737756715,0.6222529891050816,1.0,6/35,15.02%,CXCL10;CXCL16;CKLF;CCL2;CCL25;CCRL2
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.38740608500208273,-1.2374512546943541,0.1780821917808219,0.5156524508869098,1.0,8/32,13.49%,SLC6A6;SLC7A5;SLC38A5;SLC1A1;SLC1A4;SLC43A2;SLC36A1;SLC3A2
prerank,actinin binding (GO:0042805),0.4622340320560825,1.233219358464714,0.20170940170940171,0.6286229764729189,1.0,7/21,15.77%,CSRP3;DAG1;SYNPO2;CSRP1;CACNA1C;RARA;PKD2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.49742246721674566,-1.2311201251226263,0.23651452282157676,0.5254399027257886,1.0,6/12,19.24%,PIK3R6;PIK3C2B;PIK3R3;ATM;PIK3CD;PIK3C3
prerank,sulfuric ester hydrolase activity (GO:0008484),0.525769281988432,1.230000125982001,0.23709369024856597,0.6325527166895013,1.0,3/12,12.59%,SULF1;ARSI;ARSB
prerank,Hsp90 protein binding (GO:0051879),-0.3844775370683002,-1.2263703822574843,0.1792452830188679,0.5315928588670046,1.0,10/33,19.43%,SLC12A2;KDR;RPS3;HDAC6;UNC45B;NPAS2;MAPT;NOD2;PACRG;AHSA1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.4413498766326155,1.225900867909499,0.21543985637342908,0.6393203527598575,1.0,8/27,15.90%,POLR2D;POLR1D;POLR1C;POLR3F;POLR2C;MED20;POLR2F;POLR3H
prerank,amino acid:sodium symporter activity (GO:0005283),0.5416954191742082,1.2251250687737465,0.24399260628465805,0.6362513593064991,1.0,3/11,3.95%,SLC1A3;SLC6A13;SLC6A12
prerank,transcription coactivator binding (GO:0001223),0.4705168498853822,1.2240610697862597,0.2127659574468085,0.6340884346137765,1.0,6/20,12.21%,RORA;SMAD3;TERT;TEAD2;SMAD4;VGLL4
prerank,mRNA 3'-UTR binding (GO:0003730),0.35230463181388433,1.220122417211645,0.16442451420029897,0.6397476684966907,1.0,11/79,8.08%,CELF2;RBMS1;RBMS3;RC3H1;RBMS2;IGF2BP1;PABPC5;SECISBP2L;CPEB1;RNF20;HNRNPC
prerank,actin binding (GO:0003779),-0.28050503655042813,-1.2163735119240398,0.07251908396946564,0.550761734696826,1.0,49/170,18.47%,SYNE1;MYRIP;SSH2;PARVB;DMD;NOS3;FMN2;TMSB4X;KCNMA1;KLHL2;CAP2;EPS8;FXYD5;PHACTR4;UTRN;SNCA;MACF1;KLHL1;TMSB10;TLN2;MOBP;SPTB;CCDC88A;MSRB2;MAP1B;CEACAM1;MSRB1;CORO7;ARPC1A;KIF18A;DBNL;PDLIM3;MLPH;ANLN;ACTN4;PHACTR3;MAPT;NOD2;TWF1;FHL3;ADD1;ADCY8;SSH3;LDB3;GAS2L3;LCP1;HPCA;PACRG;MAEA
prerank,exonuclease activity (GO:0004527),0.3899730800302672,1.2144619978049582,0.19269102990033224,0.6505370820862157,1.0,8/46,10.74%,ENPP3;ENPP1;REXO5;WRN;RAD50;POLG;EXD1;ENPP2
prerank,MAP kinase kinase activity (GO:0004708),0.49345301897311816,1.2134569180755093,0.23118279569892472,0.6484443221114646,1.0,8/15,18.80%,MAP2K6;LRRK2;MAPK14;MAP2K5;MAP2K1;MAPKAPK5;MAPKAPK3;MAP2K4
prerank,protein tyrosine kinase activity (GO:0004713),0.33767122696245416,1.2130874681443733,0.15529753265602322,0.64455408995679,1.0,29/108,15.94%,TEC;STYK1;EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;EPHA3;EPHA8;FER;KIT;ROR1;EPHA1;PDGFRB;EPHA4;BAZ1B;MST1R;MUSK;HIPK3;PTK2;EPHA2;JAK1;ALK;FRK;NTRK3;RYK;TXK;IGF1R
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.39112641641476426,-1.2110309667387162,0.20518867924528303,0.5585273329924867,1.0,14/28,32.13%,PRORP;RPP30;DBR1;NUDT16L1;DICER1;ENDOV;EXO1;EDC3;POP7;NUDT16;MRPL44;APEX1;FEN1;ELAC1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.5019425878105404,1.2106872331897858,0.2633390705679862,0.6459736543145808,1.0,1/13,0.34%,SLC7A2
prerank,ephrin receptor activity (GO:0005003),0.4733196480273146,1.210551436480056,0.2559852670349908,0.6365950893577913,1.0,6/17,12.29%,EPHA7;EPHA3;EPHA8;EPHA1;EPHA4;EPHA2
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.4733196480273146,1.210551436480056,0.2559852670349908,0.6365950893577913,1.0,6/17,12.29%,EPHA7;EPHA3;EPHA8;EPHA1;EPHA4;EPHA2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5552798487286943,1.2105208688442726,0.2718631178707224,0.6319035481196336,1.0,3/10,5.51%,CASP12;CFLAR;CASP4
prerank,symporter activity (GO:0015293),-0.5161940717010625,-1.2096760196469714,0.24750499001996007,0.5565151679386481,1.0,3/10,13.08%,SLC5A5;SLC5A6;MFSD2A
prerank,GTPase activator activity (GO:0005096),0.29903742819882806,1.2095729901657564,0.08711656441717791,0.6296013501299211,1.0,61/313,13.39%,ARHGAP29;RANBP3L;ALDH1A1;RASGRF1;RIN2;RAPGEF4;AKAP13;ARHGAP10;ARHGAP42;DOCK5;DOCK11;ARHGAP20;ARHGAP18;SBF2;ASAP1;DLC1;DENND2A;DENND4A;ARHGAP28;ARFGAP3;ARHGAP32;FGD4;RCBTB2;NRP1;TBC1D16;PCP2;ERRFI1;SEC23A;MYCBP2;RANBP2;PLCE1;ASAP3;GRTP1;RASA1;TAGAP;RALBP1;DENND1A;ARHGEF10L;ARHGEF11;ACAP2;ARHGAP26;SYDE1;GMIP;EIF2B3;LRRK2;HPS1;IQGAP2;NGEF;DNM1L;FNIP1;IQSEC2;NUCB2;ARHGAP9;RAB3IP;SIPA1L2;RAP1GAP;ARRB1;GNB5;SMAP2;LLGL2;NPRL3
prerank,voltage-gated sodium channel activity (GO:0005248),-0.41596098895757383,-1.2092669915168237,0.23076923076923078,0.5524122135345936,1.0,12/22,27.38%,SCN1A;HCN1;HCN2;SCN2A;CACNA1G;SCN8A;SCN9A;SCN3A;SCN2B;SCN1B;CACNA1I;HCN4
prerank,RNA stem-loop binding (GO:0035613),0.5176985583588513,1.2089428244185918,0.24390243902439024,0.6267500253867739,1.0,6/12,23.45%,RC3H1;METTL16;CPEB3;EPRS1;ZC3H12A;DHX9
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.46782554073001803,-1.2076976954778271,0.24008810572687225,0.5513290513197467,1.0,7/14,20.73%,NOD1;MAL;ATP2A3;RACK1;PYCARD;CASP1;BAD
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.47755394710628174,1.2063976291343381,0.2527881040892193,0.628649718890305,1.0,8/17,28.36%,CMPK2;AK5;AK8;NME6;CLP1;DTYMK;AK1;NOL9
prerank,active ion transmembrane transporter activity (GO:0022853),-0.3618076559075774,-1.2049830827368742,0.19602977667493796,0.5524101681505332,1.0,17/37,24.50%,SLCO1C1;SLCO2A1;COX4I1;UQCRH;SLC16A7;UQCR11;SLC22A6;COX8A;NDUFA4;COX6A1;SLCO4A1;NDUFA4L2;SLCO4C1;CYB5A;SLCO1B1;UQCR10;UQCRQ
prerank,tubulin binding (GO:0015631),-0.2584672396861917,-1.204769126725036,0.05405405405405406,0.5479442931775589,1.0,73/295,18.18%,DNM3;MTUS1;SGIP1;UNC5C;AGBL4;SYBU;NAV3;TTLL7;DIP2B;MID1;KIF1B;EML6;REEP1;PAK1;KIF26B;SNCA;KIF21A;RPS3;KIF1C;FMN1;RP1;STARD9;TTLL5;ARHGEF2;GABARAP;CRIPT;MID2;STMN2;CCDC88A;EFHC2;DIXDC1;RCC2;MTCL1;MAP1B;PHF6;TERF1;HDAC6;GABARAPL1;ARL8A;SNPH;KIF26A;KIF18A;NEFH;FGF13;TRIM36;ARHGEF7;KIF5C;PRUNE1;WASHC1;KIF15;KIF3B;NDE1;CLASP2;RAE1;KIF16B;BRCA2;RAB11FIP5;KIF5A;MAPT;CLIP2;KRIT1;MAP2;SKA2;STMN4;CCDC69;GAS2L3;BRCA1;PRC1;CCT5;KIF27;TPPP;STMN1;PACRG
prerank,I-SMAD binding (GO:0070411),0.5115276307879154,1.2046214795460632,0.24558303886925795,0.6285900114312745,1.0,5/13,11.51%,SMAD3;TGFB1I1;TGFBR1;SMAD6;SMAD4
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.280022681705755,-1.2030016224059803,0.0944055944055944,0.547146993191618,1.0,36/147,13.37%,RAPGEF5;DOCK9;DOCK4;FGD5;ARHGEF28;CYTH3;PREX2;RASGRF2;ELMO1;ABR;DOCK10;SPATA13;CYTH1;TIAM1;DOCK2;ARHGEF6;ARHGEF15;RAB3GAP1;ARHGEF2;EIF2B2;FGD6;PREX1;RAPGEF2;CCDC88A;HERC2;SMCR8;SH3BP5L;BCR;DOCK8;ALS2;ARHGEF7;VAV1;RGP1;DOCK1;RAPGEF6;RABGEF1
prerank,double-stranded DNA binding (GO:0003690),0.28719169880805756,1.202566846398919,0.0681044267877412,0.629950033688818,1.0,98/531,16.48%,TCF4;CREB5;ZBTB20;RBMS1;ELF1;ARNT2;OSR1;TEAD1;LBX1;NFAT5;DDX60;GATA6;SPIB;MAF;NR6A1;FOXC2;GLI3;NFATC4;ZIC4;PRRX2;HIVEP1;NUCKS1;HOXC4;ZIC1;RFX3;CRY1;CREB3L4;HLF;ARNT;EN2;ZNF276;TOP1;ZBP1;TCF12;RAD50;KLF5;HDGFL3;SP9;FOXP3;TCF7L1;RARB;GLIS2;ZBTB37;POU1F1;HOXA2;STAT1;FBH1;ZMYND11;NTHL1;TEAD2;ATF7;CUX1;SP8;ELF4;CREM;HDGFL2;PBX1;MSC;CUX2;CENPX;POLR3F;ELF2;TCF7;EGR3;FOXO3;NR4A1;RBBP8;LHX9;KDM5B;EGR2;HOXA10;NFIC;BHLHE41;NR3C1;GMEB1;RAD51B;PKNOX1;HIC1;MND1;GTF2H4;ERCC5;RFX2;ZBTB12;RARA;SP3;HOXB4;TEF;SOX4;IRF9;POU5F1;ELK4;MBNL2;JDP2;DRGX;SMAD2;BCL11B;POU6F1;NFATC2
prerank,transition metal ion binding (GO:0046914),0.289443374210764,1.2011343360071276,0.07882352941176471,0.6295137793564253,1.0,74/397,14.53%,KMT2A;AGMO;ENPP3;MPPED2;CBLB;SMAD3;MOXD1;FAM20C;ENPP1;PAPPA;KDM7A;SHMT1;AOX1;RC3H1;LITAF;LOXL3;WRN;UBA5;LARGE1;ANPEP;SEC23A;LACC1;MYCBP2;PAM;ZNF3;CSRP1;GALNT2;HDAC4;CUTA;NPEPPS;GALNT1;NSD1;SEC24D;GLO1;GYG1;B4GALT1;TRIM24;SKI;NEK4;ZMYND11;TIMP2;BAZ1B;ZFP37;ZEB1;ACR;PDXK;SLU7;MNAT1;QPCTL;ERAP1;CUTC;ENPP2;SCD5;ESCO1;ENDOU;SEC24C;ZCCHC4;FNTB;KDM5B;NQO2;EEA1;THAP1;PTPN1;KDM2A;TET2;PPM1M;TIMM9;RNPEP;ZNF205;KAT6A;LNPEP;MDM4;IFIH1;RCHY1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.49794326852423376,1.199640085217974,0.25,0.6289642222676133,1.0,2/14,9.45%,CMPK2;AK5
prerank,sodium channel activity (GO:0005272),-0.36950767102826165,-1.1976461818260067,0.19047619047619047,0.5552519939925925,1.0,10/37,11.70%,GRIK2;GRIK4;SCN1A;HCN1;GRIK1;HCN2;SCN2A;CACNA1G;SCN8A;SCN9A
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.38988082842031735,-1.1966185065062387,0.22037914691943128,0.5528237125119798,1.0,8/27,18.12%,SLC9A2;SLC9B2;SLC8A1;SLC9A8;CNNM4;SLC3A2;SLC9A5;SLC8B1
prerank,protein heterodimerization activity (GO:0046982),0.3137063107514073,1.196283896128598,0.12231182795698925,0.6337686022492461,1.0,28/178,11.85%,TCF4;BMP6;ATP1A2;ZHX2;MICU1;ARNT2;APOA2;DGKD;EPAS1;TLR4;ARNT;BCL2;TPM1;MCL1;CREB3L3;TOP2B;BDKRB2;VAPA;MEF2A;PHB2;BAX;TPM4;TAF7;PAFAH1B3;BCL2L1;IRAK3;ATP1B2;NR4A1
prerank,histone acetyltransferase activity (GO:0004402),0.41463966304471966,1.1961625241050264,0.21428571428571427,0.6296485292920918,1.0,14/30,20.13%,NCOA3;CREBBP;KAT6B;EPC1;BAZ1A;SRCAP;ARRB1;KAT6A;KAT2B;TAF9;ATF2;CLOCK;EPC2;NAA40
prerank,voltage-gated chloride channel activity (GO:0005247),-0.5129466050567776,-1.195695953698179,0.24151696606786427,0.5501735406806401,1.0,4/10,16.90%,ANO1;CLCN3;CLCN1;CLCN5
prerank,pre-mRNA binding (GO:0036002),0.42367070757405245,1.1953390172186094,0.2110912343470483,0.6274989960961596,1.0,5/28,10.38%,CELF2;RBM41;ZRSR2;SLU7;RNPC3
prerank,chemokine receptor activity (GO:0004950),0.43708278475517315,1.193711831243909,0.2332761578044597,0.6275936414236778,1.0,6/24,17.30%,ACKR2;CCR9;ACKR3;CCRL2;CXCR4;GPR75
prerank,telomeric DNA binding (GO:0042162),0.4147553105613339,1.1930707770258853,0.2322695035460993,0.6249717287862119,1.0,14/32,20.10%,TERT;WRN;RAD50;SMG5;SMG6;SMG7;HNRNPA2B1;UPF3A;SMG1;TEN1;HMBOX1;KDM1A;UPF2;CTC1
prerank,protein serine/threonine kinase activity (GO:0004674),0.29472829839722764,1.1908519380356972,0.08523409363745499,0.6264576417633461,1.0,75/334,15.81%,PDPK1;ROCK2;CAMK1D;NRK;STK32B;GRK3;FAM20C;MAPK4;STK39;PRKAA2;OXSR1;EIF2AK2;TSSK3;BMPR1A;BMP2K;CASK;FAM20A;CDK8;DAPK1;TAOK3;NEK8;IKBKE;PRKCZ;TOP1;ARAF;LATS2;MAP3K1;AAK1;TGFBR1;MAPK6;TGFBR2;MAP4K1;CLK4;GSK3B;NEK4;WNK4;RIPK2;STK24;STK3;SIK3;LRRK2;TLK2;CDK7;CDK12;BRD4;CDK16;MAPK14;AKT3;HIPK3;GRK5;IRAK3;MAP3K7;RPS6KA3;MASTL;DAPK2;MAP2K1;MAP3K13;SRPK1;MAPK9;ACVR1C;WNK1;MAPKAPK5;TBK1;NUAK2;CSNK2A2;MAP3K2;EIF2AK3;ILK;LIMK1;CDKL3;STK4;ACVR2B;PKN2;PRKD2;ERN2
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.44861264691248764,1.1874288507211777,0.2549019607843137,0.6312783821713391,1.0,3/21,1.53%,PDE1A;PDE8B;PDE5A
prerank,glucuronosyltransferase activity (GO:0015020),-0.42781653219739924,-1.1854834592130494,0.24604966139954854,0.5703407982907179,1.0,3/19,5.29%,CSGALNACT1;EXT1;B3GAT2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.436479958672514,1.184688482759407,0.25668449197860965,0.6339990619580306,1.0,3/23,1.53%,PDE1A;PDE8B;PDE5A
prerank,iron ion binding (GO:0005506),0.37153456623536013,1.1795940043633437,0.21508828250401285,0.6425109601460525,1.0,9/48,15.10%,AGMO;KDM7A;AOX1;FECH;FTO;SCD5;TET2;PHYH;ALKBH1
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.37248287652459156,1.1793592153858004,0.23140495867768596,0.6388597516657045,1.0,11/48,11.89%,TRPM3;TRPM6;NALCN;P2RX1;SLC4A11;CALHM2;TMEM165;PKD1L3;TRPC1;GRIN3B;SLC41A1
prerank,nuclear receptor binding (GO:0016922),0.32551949993233803,1.1761568042019057,0.21652421652421652,0.642513568226133,1.0,21/111,13.23%,TCF7L2;SMAD3;NCOA3;TRIP12;TGFB1I1;STAT5B;CRY1;TACC2;NCOA6;BAZ2A;TACC1;NSD1;OASL;STAT1;PHB2;TAF7;PPID;ZNHIT3;NR4A1;MED12;BRD8
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.5095764818394004,-1.1756406348255615,0.2736220472440945,0.5892373868241139,1.0,9/10,33.78%,MGME1;EXD2;DCLRE1C;POLD1;EXO1;APEX1;DCLRE1B;FEN1;TATDN1
prerank,chemorepellent activity (GO:0045499),0.42138705230006224,1.174540400808266,0.26217228464419473,0.642641159594776,1.0,3/25,1.02%,SEMA3D;DPP4;EPHA7
prerank,O-acyltransferase activity (GO:0008374),0.41805343099394887,1.174327300238483,0.2504317789291883,0.6390087489231792,1.0,6/30,12.05%,PLA2G4A;MBOAT2;PLA2G4C;MOGAT3;SOAT1;DGAT2
prerank,cytokine receptor binding (GO:0005126),0.3383339854249527,1.1731892422573982,0.20478325859491778,0.6381150832362148,1.0,20/83,16.33%,TGFBR3;SMAD3;IL6ST;OSM;IL11;VEGFD;IL34;IL6;IL18;IL13RA1;ERAP1;TGFBRAP1;SH2B3;CSF1;JAK1;IL22;CCL25;CCRL2;IL23R;SMAD2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.5190007810583437,1.1707278660110345,0.29259259259259257,0.6404411476698764,1.0,3/11,5.51%,CASP12;CFLAR;CASP4
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3591140908840955,1.168015674751337,0.2096,0.6432047094474596,1.0,16/60,9.85%,EPHA7;PDGFRA;FGFR1;AXL;DDR2;INSRR;EPHA3;EPHA8;KIT;ROR1;EPHA1;PDGFRB;TGFBR2;EPHA4;MST1R;MUSK
prerank,acid-thiol ligase activity (GO:0016878),0.4886430679559492,1.1663555558533756,0.29389312977099236,0.6430729848965595,1.0,4/13,17.44%,ACSL1;SLC27A2;ACSS1;ACSS3
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.34856039195698196,1.1647892149769496,0.2161339421613394,0.6430925127949411,1.0,13/73,11.10%,LGR4;FPR2;GCGR;GP1BA;GLP2R;MC2R;SORCS2;RXFP2;BDKRB2;OPRD1;NMUR1;MAS1;NLRP6
prerank,kinase binding (GO:0019900),-0.2392562922480342,-1.1607604023251095,0.05185185185185185,0.6204609278559841,1.0,109/434,16.72%,FRMD5;DLG2;UNC5C;SLC12A7;SLC12A2;PTPRJ;PTPRK;PLCG2;PDE8A;BCAR3;TFRC;ACSL3;CSPG4;CIT;ACTB;RPS19;TIAM1;NSF;NBEA;CADPS;ACVRL1;UTRN;CALM1;CALM2;LRBA;EMP2;RPS6;RPS3;ESR1;RPS7;EEF1A1;DAB2IP;CTNNB1;ACTA2;HDAC7;HSP90AB1;CEP68;CALM3;RCC2;EEF2;WWC1;HNRNPA0;CEACAM1;CNTLN;RAD23A;SMCR8;RHOB;PIK3IP1;SIK1;NPM1;RFFL;SYN1;CCND1;FAS;TRIM68;TRIP6;TTC28;SNAP91;CNKSR2;INKA2;SPRED2;DVL1;RHOG;SMAD1;BORA;CAV2;POLA1;NEFH;BARD1;NBEAL2;ANKRA2;TBC1D14;BCAR1;ARHGEF7;EGFR;ATF4;JTB;USF1;SRCIN1;CEP43;CAV1;WDCP;CASP9;RAC1;USP37;RGCC;PRKRIP1;PPP1CC;RHOH;PGAM1;PARK7;PTPRC;SHC4;VDAC1;CDKN1A;NEK9;NR4A3;CYLD;MAPT;IRGM;LYST;NOD2;PLCG1;MYOM1;SPRED3;IBTK;VRK1;AP1B1;BTG1
prerank,GTPase regulator activity (GO:0030695),0.2971397067640977,1.1607472341639238,0.17300131061598953,0.6498448813323564,1.0,44/212,13.91%,ARHGAP29;RANBP3L;ALDH1A1;RIN2;ARHGAP10;ARHGAP42;ARHGAP20;ARHGAP18;ASAP1;DLC1;ARHGAP28;ARFGAP3;ARHGAP32;NRP1;TBC1D16;ERRFI1;SEC23A;RANBP2;ASAP3;GRTP1;RASA1;TAGAP;RALBP1;ARHGEF10L;ACAP2;ARHGAP26;SYDE1;GMIP;LRRK2;IQGAP2;RALGDS;DNM1L;IPO7;ARHGAP9;SIPA1L2;RAP1GAP;ARRB1;GNB5;SMAP2;LLGL2;NPRL3;WASL;TBC1D7;CDC42SE1
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.32855876615244795,-1.1607098481116407,0.2,0.6153745921315423,1.0,12/46,15.97%,MGAT5;HEXB;EXT1;POMGNT1;LFNG;MFNG;B3GNT2;PIGQ;MGAT4A;GCNT1;B3GNT9;POMGNT2
prerank,cAMP binding (GO:0030552),-0.4815117453987221,-1.1603097892554686,0.255859375,0.6113770565697544,1.0,6/11,9.24%,PDE4D;PDE4B;HCN1;PDE10A;RAPGEF2;PDE2A
prerank,protein phosphatase regulator activity (GO:0019888),0.3625151199541887,1.1593788492604877,0.25210084033613445,0.6493419592567135,1.0,11/53,12.86%,RCAN2;PTN;PPP2R2B;EIF2AK2;RCAN1;PPP4R2;PPP4R1;PPP6R3;PPP1R16A;PPP1R7;SHOC2
prerank,nuclease activity (GO:0004518),0.36182837800408435,1.158507943202174,0.24615384615384617,0.6478297047901738,1.0,18/52,22.02%,ENPP1;REXO5;WRN;NTHL1;SND1;OGG1;ERCC5;DNASE1L1;DIS3;ERN2;RNASEH1;RNASE3;DFFB;DNA2;RNASEL;PARN;STK31;ZC3H12A
prerank,actin monomer binding (GO:0003785),-0.3895459635492984,-1.1580903456513951,0.27312775330396477,0.6120979149929915,1.0,8/22,24.78%,NOS3;TMSB4X;TMSB10;TWF1;PFN2;ABITRAM;PRKCE;PFN1
prerank,growth factor activity (GO:0008083),0.34114629425156257,1.1551042555066047,0.23652694610778444,0.652568196951114,1.0,19/74,19.81%,PTN;FGF1;OSM;IL11;VEGFD;TGFA;IL6;IGF2;FGF18;ENDOU;CSF1;BDNF;INHA;OSGIN2;OSGIN1;GDNF;IL7;HBEGF;ANGPTL3
prerank,copper ion binding (GO:0005507),0.3790014534381171,1.1527668450743813,0.2561174551386623,0.6540641823971861,1.0,7/42,10.62%,MOXD1;LOXL3;LACC1;PAM;CUTA;ACR;CUTC
prerank,nucleotidyltransferase activity (GO:0016779),0.44905549454236976,1.1526691342682187,0.3029197080291971,0.6503704489849375,1.0,9/19,22.62%,TUT4;TERT;REV1;TENT2;CRPPA;TUT7;PAPSS1;TENT4B;PNPT1
prerank,hexose transmembrane transporter activity (GO:0015149),-0.4816120096843711,-1.1489174444955765,0.2857142857142857,0.6309898335702212,1.0,8/12,43.32%,SLC2A1;SLC2A4;SLC2A2;SLC5A3;SLC2A3;PPBP;SLC2A5;SLC2A6
prerank,metalloendopeptidase activity (GO:0004222),0.338029843591229,1.1474808040876845,0.23845007451564829,0.6595872230710494,1.0,13/76,12.02%,ADAMTSL5;ADAMTS12;ADAMTS10;ADAMTS1;ADAMTSL4;ADAMTS6;NRDC;THSD4;MMP14;PMPCB;NLN;ADAM19;PAPLN
prerank,miRNA binding (GO:0035198),0.39849885705636695,1.14630288385764,0.28061224489795916,0.6587235667886027,1.0,13/30,25.27%,TUT4;RC3H1;ZC3H7B;POU5F1;DDX21;HNRNPA2B1;PUM2;TUT7;ELAVL1;ZC3H12A;PNPT1;ZC3H10;MATR3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3946271457349306,1.1439574409850548,0.27241379310344827,0.6607785119040227,1.0,15/32,23.26%,KDM7A;P4HTM;FTO;TMLHE;KDM2A;TET2;KDM8;PHYH;ALKBH1;KDM2B;ALKBH4;EGLN1;TET1;PHF8;HSPBAP1
prerank,PDZ domain binding (GO:0030165),0.34698831046998935,1.142689108273865,0.2530487804878049,0.6603285299048459,1.0,6/61,3.42%,ARHGAP29;TGFBR3;PLEKHA2;CXADR;SDC2;FZD2
prerank,sulfotransferase activity (GO:0008146),0.38693306355689405,1.1421034560119785,0.2703639514731369,0.6579483395588765,1.0,3/33,4.64%,UST;CHST15;TPST1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.49062745003328634,1.1396219693308687,0.2820037105751391,0.6604933825142719,1.0,3/12,9.81%,SLC19A1;SLC17A9;SLC25A24
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.48983349769449835,-1.1375166237817602,0.30833333333333335,0.6553201001922122,1.0,6/10,23.41%,SLCO1C1;SLCO2A1;SLC22A6;SLCO4A1;SLCO4C1;SLCO1B1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4805712237818579,1.1354054985671957,0.32397003745318353,0.6670134479309665,1.0,3/12,11.18%,TRAF5;STAT1;TRAP1
prerank,glucose transmembrane transporter activity (GO:0005355),-0.4281624476348588,-1.133120392005662,0.3006396588486141,0.6619725509210559,1.0,10/17,43.32%,SLC2A1;SLC2A4;SLC2A2;SLC5A11;SLC2A10;SLC5A3;SLC2A3;PPBP;SLC2A5;SLC2A6
prerank,calcium ion binding (GO:0005509),0.2800920711491499,1.1317458961740896,0.1801470588235294,0.6726274709010268,1.0,50/323,11.81%,ENPP3;TNNC1;FBN1;MAN1C1;ITPR1;SELP;GJB2;PLA2G4A;ENPP1;MICU1;CLEC3B;CEMIP2;PRF1;S100A6;ANXA2;CDH5;FBLN1;AMY1A;AMY1C;AMY1B;RCN1;ANXA3;S100A10;ANXA1;ADGRV1;PAM;ANXA11;CPNE1;ANXA4;PLA2G4C;CRP;THBS3;GLCE;ESYT1;ANXA5;DCHS1;PCDHB8;ANXA7;DSC3;DSC2;PLSCR4;SLC25A24;TPM4;STIM2;ENPP2;CDH13;PLSCR2;IHH;NUCB2;PPP3CB
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.39911490426878304,1.1239013468464314,0.30985915492957744,0.6890217815371057,1.0,6/26,4.55%,SLC6A13;SLC16A11;SLC16A2;SLC16A12;SLC6A12;SLC16A5
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.4699382895118365,-1.123433540866584,0.32919254658385094,0.6811865258924084,1.0,5/10,19.24%,PIK3C2B;PIK3R3;ATM;PIK3CD;PIK3C3
prerank,E-box binding (GO:0070888),0.37498309862825435,1.1230751460648027,0.30743243243243246,0.6872365528632994,1.0,1/34,0.06%,TCF4
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.34935754054166,-1.1217090064827022,0.2761394101876676,0.6805292271147579,1.0,6/34,7.21%,MYO10;CYTH3;ARAP2;ARAP3;HIP1R;AKT1
prerank,CoA hydrolase activity (GO:0016289),0.453917433380761,1.1185698158259072,0.32833020637898686,0.695506198988607,1.0,3/16,9.97%,ACOT11;ACOT9;ACOT1
prerank,CXCR chemokine receptor binding (GO:0045236),0.51021522231225,1.118421802422227,0.36257309941520466,0.6919967305327029,1.0,1/11,1.07%,CXCL10
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4985802701068565,1.1181284801327087,0.3244274809160305,0.6888551951796987,1.0,3/11,9.81%,SLC19A1;SLC17A9;SLC25A24
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3794725077924533,1.1180911985941364,0.31118314424635335,0.6851286496729562,1.0,15/34,26.96%,NSD3;METTL21C;ETFBKMT;SETD4;SETD7;ATPSCKMT;SETD2;SETDB1;KMT5B;SMYD3;EHMT2;SUV39H1;SETD6;EEF1AKMT4;SMYD2
prerank,lipase activity (GO:0016298),0.36616363258341544,1.1180170919422763,0.30629139072847683,0.6814600280679095,1.0,2/43,1.31%,PLA1A;SMPD3
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3016959300103524,1.1168101146655882,0.26203966005665724,0.6808380081733565,1.0,15/134,5.94%,PDPN;SLC7A2;SLC1A3;SLC13A3;SLC6A13;SLC16A11;GJA1;SLC19A1;SLC6A9;SLC26A9;SLC16A12;SLCO3A1;SLC17A9;SLC35D1;SLC4A11
prerank,adrenergic receptor binding (GO:0031690),-0.41697930215241163,-1.1157370176897436,0.3068432671081678,0.6912745050260822,1.0,7/16,24.13%,PDE4D;GNAS;RAPGEF2;AKAP5;C1QBP;ADRB1;APLP1
prerank,protein kinase inhibitor activity (GO:0004860),-0.3275177084629391,-1.1146490519191743,0.30864197530864196,0.6887214810769579,1.0,15/42,19.56%,CIT;SNCA;SMCR8;NPM1;SH3BP5L;MAPK8IP1;INKA2;SPRED2;RACK1;CEP43;PRKRIP1;CDKN1A;IBTK;CDKN1C;SPRED1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.3700657798977308,1.1144827469433116,0.3130148270181219,0.6831306896508899,1.0,3/35,2.99%,TEC;STYK1;FER
prerank,ion channel inhibitor activity (GO:0008200),-0.3334370290828831,-1.1137862974457886,0.288135593220339,0.6856193963887723,1.0,9/35,10.37%,KCNMB2;FKBP1A;MCUB;CALM1;CALM2;CAMK2D;SLC30A1;NEDD4L;RACK1
prerank,cation channel activity (GO:0005261),0.31276462737913546,1.1127531625292597,0.2571001494768311,0.684131044113608,1.0,18/94,11.64%,TRPM3;MCU;TRPM6;NALCN;ANXA2;KCNQ4;SLC24A3;P2RX1;TMEM38A;SLC4A11;ANO10;CALHM2;OTOP1;PKD1L3;PANX1;TRPC1;ANO6;GRIN3B
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.47756247973343147,1.112649459382697,0.33458646616541354,0.6806391632112756,1.0,4/13,6.11%,PDGFRA;ITGA5;VEGFD;PDGFRB
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.5004234976588998,1.1119756843582544,0.3487903225806452,0.6788403878486965,1.0,3/10,10.66%,SLC6A13;SLC6A12;SLC10A1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.3794864139873671,-1.1108241927330142,0.3341288782816229,0.6884762746831712,1.0,5/21,20.27%,GRM5;GRIA1;CHRNA4;CHRFAM7A;CHRNA7
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.4001804424269245,-1.1088247787208783,0.3228511530398323,0.6885071896483568,1.0,4/18,6.99%,PIK3R1;PIK3R6;PIK3R3;WDR81
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.4779082359870725,1.1081560757499913,0.35119047619047616,0.6849202492379078,1.0,2/11,8.12%,SASH1;PPEF2
prerank,CoA-ligase activity (GO:0016405),0.4602527881982387,1.1055442047034043,0.36590038314176243,0.6878187783492561,1.0,4/14,17.44%,ACSL1;SLC27A2;ACSS1;ACSS3
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.33832611834376275,1.0997613199971015,0.3107890499194847,0.6991422006118286,1.0,16/60,17.03%,LRRK1;CTDSPL;PPM1E;PPM1A;MTMR3;PPEF2;CTDSP2;LRRK2;PPM1B;PPP1CB;CDC14A;PPP3CB;PPM1M;CTDSP1;PPP2CA;CDKN3
prerank,metal ion binding (GO:0046872),0.26298232703944374,1.0980675149386838,0.23556581986143188,0.6998740117929378,1.0,76/477,13.28%,EYA2;IGFBP3;ENPP3;TNNC1;FBN1;MAN1C1;ITPR1;SELP;GJB2;PLA2G4A;ENPP1;MICU1;OXSR1;CLEC3B;TSSK3;CEMIP2;PRF1;DCTPP1;S100A6;CLYBL;ANXA2;CDH5;FBLN1;AMY1A;AMY1C;AMY1B;RCN1;ANXA3;S100A10;ANXA1;ADGRV1;WRN;PAM;ANXA11;PIR;CPNE1;IDH1;TESMIN;ANXA4;PLA2G4C;CRP;THBS3;PAPOLG;GLCE;ESYT1;ANXA5;DCHS1;PCDHB8;ANXA7;STK3;SIK3;PDXK;LRRK2;DSC3;DSC2;PLSCR4;SLC25A24;TPM4;STIM2;GEM;ENPP2;HACL1;CDH13;PLSCR2;IRAK3;ADPRS;IHH;NUCB2;PPP3CB;CRNN;TRIM26;OPA1;SRPK1;IDH2;SMOC2;BAIAP3
prerank,metallopeptidase activity (GO:0008237),0.3038891523791016,1.0937833447219114,0.2976878612716763,0.7067479725282232,1.0,22/113,14.02%,ADAMTSL5;PAPPA;ADAMTS12;ADAMTS10;ADAMTS1;ADAMTSL4;ADAMTS6;NRDC;ANPEP;BMP1;THSD4;MMP14;ADAM12;ERAP1;MYSM1;PMPCB;NLN;ADAM19;PAPLN;RNPEP;ADAMTS7;LNPEP
prerank,potassium:proton antiporter activity (GO:0015386),-0.46607330072051545,-1.092119002439063,0.35876288659793815,0.7282845619559616,1.0,3/10,14.68%,SLC9A2;SLC9A8;SLC9A5
prerank,RNA binding (GO:0003723),-0.212769118833326,-1.0913265774229446,0.03125,0.7251001065883099,1.0,364/1321,22.83%,SORBS2;SYNE1;RIMS1;STRBP;NOL4;RPS24;ACTN1;TMSB4X;RALYL;QKI;HSPA8;LRRFIP1;TCF20;RPS9;RPL18A;TFRC;RPL19;TPT1;RFTN1;CMSS1;NOVA2;FAU;RPS12;ADARB1;RPL26;RPL41;RPS15;RPL24;RPS23;MBNL1;CELF4;RPL5;KHDRBS2;RPS27;RPS19;RPL38;RBFOX3;LIN28B;RBFOX1;SCG3;PUS7;RPS8;SETX;RPL10A;RPL27A;RPL13;LUC7L3;CSTF2;RPS18;MACF1;RPL27;RPS16;RPL35A;RPS6;RPL21;RPS3;R3HDM1;ELAVL2;RPL39;RPS17;ATXN2;RPS7;RPL37A;KIF1C;RPL4;RPS25;EEF1A1;PTBP1;CPEB2;RPS15A;ELP1;CEBPZ;RPL6;ADARB2;RPL11;RPLP0;RPS21;RPS28;RPL28;TAF15;RPL32;RPL8;HMGB1;PUF60;KHDRBS3;STXBP1;SCAF4;PKM;RPL13A;RPL30;DHX15;SRP14;SRSF2;HSP90AB1;YBX1;ATP5F1A;RPS20;RPS4X;ZFR2;GTPBP1;MRPL4;RPL18;KPNB1;RPS13;TES;CPSF2;NOL11;RCC2;EEF2;MTCL1;UNK;RPS2;RRP7A;SRSF1;APOBEC1;ZCRB1;HNRNPA0;PHF6;CNBP;MYEF2;DDX54;HNRNPK;RPL14;DDX49;RPL22;PCBP1;TIAL1;DDX11;PUM3;HNRNPH2;SSRP1;ZC3H11A;PPIL4;NPM1;YTHDF2;SREK1;DDX47;DYNC1H1;WDR36;DDX17;TRA2A;THOC2;SART3;FAM32A;YY1;DNTTIP2;BUD13;GFM1;KCTD12;MAP3K20;HSPE1;RPS26;TRIP6;CALR;NKAP;BYSL;KARS1;GNL3L;RO60;CCAR2;DHX30;YTHDC2;CARS1;RACK1;GDI2;PSMD4;NELFCD;MAK16;MANF;RPS10;NOL12;IGHMBP2;EXOSC2;NIP7;EIF5B;RALY;NVL;EIF4A1;BARD1;FTSJ3;RPL23;RPL17;PSMA6;PTCD2;PABPC4;EIF1B;EIF5A;WBP11;FKBP3;RPL29;MRPL1;PABPC4L;H1-0;THUMPD1;RPP30;S100A16;HSP90AA1;MRPS30;GSPT2;EIF3A;MRPS23;RPL22L1;RPS5;ELP5;PPAN;GRN;FASTKD2;RPS14;SLC3A2;NOP56;SNRNP35;DCP1A;PRKRIP1;LSM14B;ACTN4;PPP1CC;RAE1;SART1;TUBB4B;PPRC1;SNRPB;DBR1;ANP32A;VIRMA;MSI2;FAM120C;PPIA;PARK7;HNRNPF;XPOT;AKAP1;MRM1;CCDC47;CPEB4;RARS2;TUBA1B;ZC3H13;MAPT;HMGN2;ZGRF1;SRBD1;MTPAP;SRP9;ZMAT3;ENO1;MRPL28;RPL12;ZCCHC3;NOL7;NUDT16L1;MYO18A;CSTF2T;ADD1;RBM33;RPL9;SMNDC1;ESF1;FRG1;DDX51;UBE2O;RBM3;XRN2;BRCA1;RPS19BP1;RPL37;IMP3;RBM19;GNL3;ERI1;LUC7L;RPS11;CS;EIF1;PPIB;DUSP11;HSD17B10;MEX3A;DICER1;RNPS1;PABPC1;LGALS1;LLPH;N4BP1;SNRPF;CCDC9;TRIM28;SRSF9;SNU13;RAVER2;YRDC;POLDIP3;FKBP4;MRPS5;RIDA;ZCCHC8;NOC2L;NONO;RPL7;RPL31;RPL7A;C1QBP;MKRN1;EWSR1;UTP6;EIF3H;TYW5;RBM15B;RBM47;EIF4A2;WRAP53;EIF3G;PPP1R10;SAFB2;TRMT6;BMS1;YARS2;RTCA;UPF1;PURB;LSM4;FAM98A;MKI67;ALKBH5;RPL3;BAG4;SNRPD1;SNRPD2;NANOS3;MEX3D;HNRNPLL;HEATR1;DHX35;UTP11;TFB2M;TRMT9B;MRPL23;MRPL9;FAM50A;FBRSL1;MDH2;ZC3H8;SRSF6;CAPRIN1;SF3B5;CELF6;GSPT1;CHTOP;NKRF;FASN;MCAT;TFB1M;CPSF3;MRPS31;HEXIM2;TOE1;WDR46;FLYWCH2;HDGF;SRF;MRPS12;RPL23A;SYF2;YWHAZ;TUFM
prerank,protein kinase binding (GO:0019901),-0.2253245029520173,-1.0912597125734995,0.1349206349206349,0.7198853602171698,1.0,117/479,16.53%,FRMD5;UNC5C;SLC12A7;SLC12A2;PTPRJ;PTPRK;PRKCB;PLCG2;GRM5;PDE3B;BMPR2;TFRC;ACSL3;RYR2;CSPG4;CIT;ACTB;RPS19;NSF;NBEA;CADPS;ACVRL1;UTRN;CALM1;CALM2;LRBA;EMP2;RPS6;RPS3;ESR1;RPS7;EEF1A1;DAB2IP;NELL2;PKN1;HINT1;PRKAR1A;ACTA2;HDAC7;HDAC9;CEP68;CCDC88A;CALM3;TCF3;RCC2;EEF2;MAP3K11;ACE;HNRNPA0;CEACAM1;CNTLN;SMCR8;RHOB;SIK1;PINK1;NPM1;RFFL;SYN1;CCND1;TRIM68;DUSP22;SNAP91;CNKSR2;INKA2;SPRED2;DVL1;DUSP8;GCH1;RHOG;RACK1;SMAD1;BORA;CAV2;POLA1;NEFH;NBEAL2;ANKRA2;TBC1D14;BCAR1;PRKAR2B;ARHGEF7;KCNQ1;ATF4;JTB;USF1;SRCIN1;ACVR1;HSP90AA1;CEP43;CAV1;CAVIN2;MAPK8IP3;CASP9;RAC1;USP37;RGCC;PRKRIP1;PPP1CC;RHOH;TJP2;PGAM1;PTPRC;SHC4;VDAC1;CDKN1A;NEK9;NR4A3;CYLD;MAPT;IRGM;LYST;NOD2;PLCG1;SPRED3;IBTK;VRK1;AP1B1
prerank,microtubule binding (GO:0008017),-0.23976746580830374,-1.0871922160684726,0.18303571428571427,0.7257724894326201,1.0,50/222,17.80%,DNM3;MTUS1;SGIP1;SYBU;NAV3;MID1;KIF1B;EML6;REEP1;KIF26B;MACF1;KIF21A;RPS3;KIF1C;FMN1;RP1;STARD9;ARHGEF2;CRIPT;MID2;CCDC88A;RCC2;MTCL1;MAP1B;TERF1;HDAC6;SNPH;KIF26A;KIF18A;NEFH;FGF13;KIF5C;KIF15;KIF3B;NDE1;CLASP2;RAE1;KIF16B;KIF5A;MAPT;CLIP2;KRIT1;MAP2;SKA2;CEP290;CCDC69;GAS2L3;PRC1;KIF27;TPPP
prerank,aminopeptidase activity (GO:0004177),0.39157106512426226,1.0869106332102856,0.3466204506065858,0.7205289584345121,1.0,9/26,14.11%,ANPEP;MMP14;NPEPPS;CTSH;ERAP1;BLMH;RNPEP;LNPEP;KDM8
prerank,voltage-gated calcium channel activity (GO:0005245),-0.3305795538613389,-1.0836365543228819,0.29658792650918636,0.730173459096022,1.0,6/37,9.86%,CACNA1E;CACNB2;CACNB4;OPRM1;CACNA1G;CACNA1D
prerank,epidermal growth factor receptor binding (GO:0005154),0.4013791884334828,1.0818823716652808,0.35071942446043164,0.7296807663408637,1.0,4/25,6.06%,EFEMP1;FER;TGFA;ARF4
prerank,"DNA binding, bending (GO:0008301)",0.44810439173737715,1.0793643490744136,0.3769230769230769,0.7328580703154606,1.0,2/14,1.80%,FOXD1;FOXC1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.44855475916658777,1.0793477462948344,0.3684210526315789,0.7291162116695771,1.0,4/14,8.35%,COL4A3;TIMP3;BST2;TIMP2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.42092904918781177,1.0781986322075816,0.3574007220216607,0.7281623162043933,1.0,7/20,20.04%,AGPAT4;MOGAT3;AGPAT3;DGAT2;LPGAT1;ABHD5;DGAT1
prerank,cytokine receptor activity (GO:0004896),0.30710891382926697,1.0773262929323264,0.3443609022556391,0.726474851543469,1.0,6/83,2.40%,LEPR;GHR;IL31RA;IL6ST;ACKR2;CCR9
prerank,solute:sodium symporter activity (GO:0015370),-0.35079307596123377,-1.0702251139086167,0.33710407239819007,0.7617358851483309,1.0,9/27,32.61%,SLC4A10;SLC5A6;SLC4A7;SLC20A2;SLC5A11;SLC13A5;SLC5A3;SLC4A5;SLC4A4
prerank,methylated histone binding (GO:0035064),0.32261077419644174,1.065149887485135,0.3469079939668175,0.7541945360438622,1.0,25/62,24.69%,KDM7A;SUZ12;MORC3;DPF2;TRIM24;ZMYND11;GLYR1;TAF7;RRP8;BPTF;MORC4;KDM8;PYGO1;LRWD1;CHD8;MBTD1;MPHOSPH8;PHF1;PHF13;PHF8;ZCWPW1;TAF1;WDR5;ING5;ATRX
prerank,cytochrome-c oxidase activity (GO:0004129),-0.4038361360052267,-1.0648364308399525,0.3760869565217391,0.7711462519117515,1.0,8/15,30.33%,COX4I1;COX8A;NDUFA4;COX6A1;NDUFA4L2;CYB5A;COX4I2;COX5B
prerank,acetyltransferase activity (GO:0016407),0.3762653428465046,1.0641305620758497,0.3704318936877076,0.7529232136815441,1.0,10/31,16.97%,CREBBP;KAT6B;NAA16;PAFAH1B3;ESCO1;ACAT1;NAA15;KAT6A;KAT2B;PAFAH2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.43185072975175914,-1.0633970710104077,0.3790849673202614,0.769859531317059,1.0,6/12,20.73%,NOD1;ATP2A3;RACK1;PYCARD;CASP1;BAD
prerank,zinc ion binding (GO:0008270),0.26286105074833094,1.0632041709544386,0.32298136645962733,0.7515152608257947,1.0,55/293,14.53%,KMT2A;ENPP3;CBLB;SMAD3;ENPP1;PAPPA;KDM7A;SHMT1;RC3H1;LITAF;UBA5;ANPEP;SEC23A;MYCBP2;PAM;ZNF3;CSRP1;HDAC4;NPEPPS;NSD1;SEC24D;GLO1;TRIM24;SKI;ZMYND11;TIMP2;BAZ1B;ZFP37;ZEB1;ACR;PDXK;SLU7;MNAT1;QPCTL;ERAP1;ENPP2;ESCO1;SEC24C;ZCCHC4;FNTB;KDM5B;NQO2;EEA1;THAP1;PTPN1;KDM2A;TET2;TIMM9;RNPEP;ZNF205;KAT6A;LNPEP;MDM4;IFIH1;RCHY1
prerank,tau-protein kinase activity (GO:0050321),0.4080957726583302,1.062544951229452,0.38361266294227186,0.7494474596058074,1.0,3/20,8.65%,ROCK2;GSK3B;SIK3
prerank,protein homodimerization activity (GO:0042803),0.24981628745083642,1.0565562254932015,0.2930648769574944,0.7616598140459292,1.0,110/589,15.77%,KMT2A;TNNC1;DPP4;SMAD3;NADK2;ZHX2;NR2F2;PDGFRA;FGFR1;MTUS2;MAPK4;ENPP1;GHR;CPQ;GBP2;APOA2;SHMT1;ZBTB4;BMPR1A;NR6A1;S100A6;SNX6;GLIPR2;HSD17B1;DGKD;S100A10;AOX1;KIT;TERT;WRN;IL17D;UBA5;CRYL1;EFEMP2;FECH;TPST1;ARNT;BCL2;TPM1;RDH5;MCL1;APPL2;TPR;IDH1;ZDHHC3;CREB3L3;FOXP3;TRIM5;GBP5;BST2;NOS2;DPYD;GBP4;GYG1;SPPL3;GLCE;STAT1;GOLGA5;RIPK2;SNX9;EXD1;PHB2;BAX;PDXK;LRRK2;APPL1;TPM4;FBXO4;PLEK;PAFAH1B3;DNM1L;BCL2L1;IRAK3;SMAD4;CSF1;DGAT2;TRIM21;NQO2;EEA1;ABCD3;THAP1;NOG;RAP1GAP;MAP3K13;PGRMC1;SUPV3L1;PON3;MZF1;BHLHE41;CCDC66;NPR3;NRF1;SDCBP2;PIP4K2B;ADRA2C;TIMM9;CIB2;ERCC5;TARBP2;RCHY1;PML;GDF15;CHMP4A;CHMP4B;ADRA2A;CUBN;STK4;HSPB6;FLRT3;PKD2
prerank,vinculin binding (GO:0017166),-0.452554067287693,-1.0536805920271908,0.39227642276422764,0.7918489623966298,1.0,3/11,3.65%,ACTN1;DMD;UTRN
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2657213175093491,1.051569046292621,0.36180904522613067,0.770758417636868,1.0,39/254,13.50%,TCF4;SMAD3;RBPJ;ELF1;FOXC1;NFIA;NFYC;NFAT5;SPIB;ZNF395;FOXC2;MYB;HOXC4;LITAF;HLF;PRRX1;TCF12;KLF5;CREB3L3;PPARA;GLIS2;CREBRF;ZSCAN21;MEF2A;RLF;ELF4;E4F1;RFXANK;RFXAP;SMAD4;FOXO3;NR4A1;EGR2;HOXA10;NFIC;MZF1;NR3C1;GMEB1;NRF1
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3523288165393939,-1.0462632879454414,0.3634361233480176,0.8075809468584921,1.0,8/24,17.26%,RPL26;RPL41;RPL5;RPS7;RPS13;RPS14;GNL3;CCT5
prerank,phosphoric ester hydrolase activity (GO:0042578),0.33126187410453006,1.0462627829306428,0.3883333333333333,0.7809097959744776,1.0,6/49,6.54%,MPPED2;ATP1A2;DUSP10;DUSP28;PTPN22;DUSP16
prerank,transferrin receptor binding (GO:1990459),0.4802254644985006,1.0450094643029395,0.43232323232323233,0.7803270766198406,1.0,2/10,12.58%,RGMA;HFE
prerank,endopeptidase activator activity (GO:0061133),-0.4482565480802847,-1.044636621738844,0.42592592592592593,0.8066566211296663,1.0,4/10,26.69%,PSMD14;PSENEN;PSME1;NLRC4
prerank,protein phosphatase binding (GO:0019903),-0.25810949514444453,-1.0417027546446802,0.34415584415584416,0.8095614376781486,1.0,24/117,16.20%,PPP1R16B;GRIN3A;FOXO1;PIK3R1;PHACTR4;MAP3K5;PPP1R3B;MET;DAB2IP;CTNNB1;SNX3;FBXL2;CEACAM1;MFHAS1;PPP1R11;PTPRT;RACK1;EGFR;KCNQ1;SOD1;MYO16;MAPT;PPP1R3C;ADCY8
prerank,protein kinase C binding (GO:0005080),0.338176874166632,1.0406778135625592,0.4084033613445378,0.7878671508830365,1.0,12/43,15.77%,PRKCSH;NELL1;PARD6G;DACT1;PARD6A;TOP2B;PLEK;GRK5;DACT2;CAVIN3;ADCY6;PRKD2
prerank,cGMP binding (GO:0030553),-0.4230396907353956,-1.040646522306443,0.40476190476190477,0.806941723540777,1.0,4/11,9.24%,PDE11A;PDE10A;RAPGEF2;PDE2A
prerank,phospholipase A2 activity (GO:0004623),0.37736636690202335,1.0406012463317191,0.4056761268781302,0.7842734820955846,1.0,3/26,8.09%,PLA2G4A;PLA2G4C;PLA2G6
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.4459927832393671,1.0405620102444901,0.4377431906614786,0.7806044158089611,1.0,3/12,3.32%,CDH5;ITGA5;VEGFD
prerank,phosphatase activator activity (GO:0019211),-0.4004256850330281,-1.0352031250625386,0.42358078602620086,0.8174922597472783,1.0,9/14,24.29%,PHACTR4;CALM1;CALM2;CALM3;PPP2R5B;PPP2R5D;PPP1R15A;PPP2R5A;B3GAT3
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.25921859377261947,-1.033153936283791,0.39090909090909093,0.8178360291950556,1.0,23/91,15.71%,PLCB1;HIP1;KCNJ2;SYTL2;HIP1R;SNX3;CLVS1;KCNH1;SDCBP;SYT7;STXBP6;PLEKHA5;LDLRAP1;RAB35;SNAP91;MARK1;KCNQ1;AMER2;KIF16B;SNX18;MAPT;KRIT1;TWF1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4084875803443729,-1.0331046155974593,0.4311740890688259,0.8124102691474467,1.0,2/14,1.62%,SLC26A7;SLC26A2
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.40642293799698154,-1.0330504018512412,0.43121149897330596,0.8070578301815624,1.0,4/13,12.24%,RYR2;PRKAR1A;PRKAR2B;KCNQ1
prerank,cyclic nucleotide binding (GO:0030551),0.3911599733504947,1.032944370391102,0.4086629001883239,0.7967300957155836,1.0,5/21,6.53%,RAPGEF4;PDE5A;SLC19A1;POPDC2;CNBD2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.43600034147062716,1.032910187682226,0.4301675977653631,0.792998603378762,1.0,2/14,10.33%,RSAD2;ACO1
prerank,histone methyltransferase activity (GO:0042054),0.3609906686805871,1.0323964582670966,0.425,0.7906240763049716,1.0,11/32,23.85%,SUZ12;KMT2C;NSD3;SETD7;CARM1;SETD2;SETDB1;KMT5B;SMYD3;PRMT1;EHMT2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.30444403112737295,1.0322742643853833,0.4018264840182648,0.7871400756784672,1.0,13/74,10.05%,NADK2;FAM20C;FAM20A;DGKD;HYKK;PI4KA;PANK2;PIK3C2A;FAM20B;GALK2;PDXK;GK5;TRPT1
prerank,snoRNA binding (GO:0030515),-0.32316850135168174,-1.0304489249770545,0.40481927710843374,0.8090819339740477,1.0,15/30,35.67%,BYSL;NOP56;NUDT16L1;IMP3;SNU13;UTP6;BMS1;HEATR1;IMP4;NUDT16;NOP10;PRKDC;NHP2;NUDT1;DHX37
prerank,endoribonuclease activity (GO:0004521),0.3527833662059715,1.0287398934312681,0.4230118443316413,0.7926085768576361,1.0,12/32,23.42%,PIWIL4;NYNRIN;SND1;SMG6;ENDOU;SLFN14;ZC3H12B;ERN2;RNASEL;YBEY;ZC3H12A;KHNYN
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.45721603602296823,1.0262991427554582,0.412109375,0.7913419517979909,1.0,3/10,12.11%,DUSP10;DUSP16;DUSP5
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.45721603602296823,1.0262991427554582,0.412109375,0.7913419517979909,1.0,3/10,12.11%,DUSP10;DUSP16;DUSP5
prerank,dynactin binding (GO:0034452),0.45121269208652887,1.0255333369115682,0.4524714828897338,0.78968952871733,1.0,2/12,7.66%,SNX6;GSK3B
prerank,potassium ion antiporter activity (GO:0022821),-0.3933196585230053,-1.0254981470238087,0.4353448275862069,0.8181528059499661,1.0,3/15,6.32%,SLC9A2;SLC24A2;SLC9A8
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.34545545542193234,-1.025285756967307,0.41189931350114417,0.8132173402675666,1.0,5/23,8.81%,HIP1;HIP1R;SNX3;CLVS1;PLEKHA5
prerank,peptidoglycan binding (GO:0042834),-0.43346634168562864,-1.0246517058254379,0.41282565130260523,0.8098588516331657,1.0,4/10,15.57%,NOD1;PGLYRP1;RNASE7;NOD2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.40563366528319345,-1.0237056048644975,0.4243027888446215,0.8071332151036243,1.0,6/12,31.59%,B3GNT2;B3GNT9;B3GNT3;B4GAT1;B3GNT6;B3GALT1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3753819236720204,1.0222472732567398,0.4160958904109589,0.794567776273647,1.0,4/25,6.27%,PLEKHA2;GAB2;ADAP2;PLEKHA4
prerank,pyrophosphatase activity (GO:0016462),0.31935308346778896,1.0215479561690866,0.4115702479338843,0.79252294289186,1.0,5/50,7.46%,ENPP3;ENPP1;DCTPP1;ENTPD7;DCP2
prerank,protein phosphatase activator activity (GO:0072542),0.42708557957017135,1.0215128631155976,0.45149253731343286,0.7889557094678549,1.0,1/13,0.16%,IGFBP3
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2648784165336878,1.0214649770641377,0.4117647058823529,0.7854346298253096,1.0,34/173,16.65%,ZBTB20;ZEB2;MXI1;KCNIP3;ZBTB4;NFATC4;AEBP1;GZF1;OTP;ZNF3;FOXP3;PPARA;ZBTB37;SKI;ZNF25;ZFP37;ZEB1;CREM;E4F1;HEYL;FOXO3;ZNF219;THAP1;MZF1;BHLHE41;NR3C1;HIC1;PRDM5;ZBTB21;ZBTB12;POU5F1;JDP2;POU6F1;ZBTB5
prerank,U6 snRNA binding (GO:0017070),-0.39450865259766366,-1.0207957403384171,0.4327731092436975,0.8103336825446359,1.0,7/14,30.82%,SART3;EIF5A;LSM4;LSM2;LSM3;LSM8;PRPF8
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3370101494875509,1.0202988211790311,0.43690851735015773,0.7849503053485966,1.0,7/44,11.07%,KMT2A;KMT2C;NSD3;NSD1;SETD4;SETD7;SETD1B
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3205827801741172,1.0195152370731628,0.43423137876386686,0.7834523865787221,1.0,9/49,7.88%,PLA2G4A;ANXA2;ANXA3;ANXA1;CPNE1;ANXA4;PLA2G4C;ESYT1;ANXA5
prerank,phosphate ion binding (GO:0042301),-0.4348038769457558,-1.0194195537915745,0.4610526315789474,0.8091294556098586,1.0,5/10,29.64%,PDE2A;PNP;ADSS2;ADSS1;RELA
prerank,phosphotyrosine residue binding (GO:0001784),-0.3097100804528094,-1.0170579171026877,0.4227053140096618,0.8104588499345871,1.0,14/37,24.78%,PLCG2;BCAR3;PIK3R1;SHE;PIK3R3;LDLRAP1;VAV1;SYK;PTPN5;SHD;IRS1;SAMSN1;SHC3;PFN1
prerank,NF-kappaB binding (GO:0051059),0.3751749940979533,1.0156753694845344,0.43636363636363634,0.7895393835196863,1.0,5/24,7.66%,MTDH;CPNE1;FOXP3;ANXA4;GSK3B
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.42640818051750345,-1.0138732776817163,0.46320346320346323,0.8139832553677335,1.0,2/11,4.80%,LEF1;GATA2
prerank,myosin II binding (GO:0045159),-0.4419286596175578,-1.0137506893540498,0.44685466377440347,0.8091326389423803,1.0,3/10,10.73%,SHROOM4;STXBP5L;SHROOM1
prerank,lysophospholipase activity (GO:0004622),0.39276567712088256,1.0137470983832961,0.4459203036053131,0.7909897544166524,1.0,4/20,10.74%,PLA2G4A;PLA2G4C;PLA2G6;ENPP2
prerank,guanyl ribonucleotide binding (GO:0032561),0.26338275596847,1.0132014055948588,0.4444444444444444,0.7887549056744372,1.0,50/196,19.74%,MPPED2;GBP6;PDE5A;GBP2;RRAS2;SLC19A1;RAB10;RAB22A;ARL3;RHOBTB2;ARF4;GBP5;RHOF;GTPBP10;GBP4;RRAD;RHOQ;LRRK2;ARF3;RAP2C;GEM;RABL6;GBP7;TUBA1C;TUBE1;RHOC;TUBB6;PIP4K2B;RHOU;ARL4A;MIEF1;TUBB2B;ATL1;GBP3;RAB5A;RIT1;TUBD1;TRIM23;ARF1;RAN;RAP2B;LSG1;GNAI3;RHOT1;RANBP17;ARL6;DIRAS1;RHOT2;ARFIP2;NRAS
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.4367010089062499,1.012757448901645,0.4288389513108614,0.7864606366199282,1.0,3/12,11.59%,GAB2;FRS2;SH2B3
prerank,mitogen-activated protein kinase binding (GO:0051019),0.35288477933580575,1.0110882857584247,0.4503424657534247,0.7871554968557414,1.0,14/29,23.43%,DUSP10;TPR;DUSP16;ATF7;MAPK14;DUSP5;MAPKAPK5;MAPKAPK3;DIRAS1;TNIP1;MAPK7;CDK5RAP3;PRMT1;DUSP4
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.36197373833245794,1.010742243336869,0.43103448275862066,0.7845173818114891,1.0,5/25,6.49%,MICAL3;CYP27A1;POR;FMO5;NOS2
prerank,protein phosphatase 2A binding (GO:0051721),-0.3503317852551897,-1.0094718280767563,0.4413793103448276,0.8153973726020112,1.0,6/23,16.20%,GRIN3A;FOXO1;DAB2IP;MFHAS1;MAPT;ADCY8
prerank,beta-tubulin binding (GO:0048487),0.35564560304119247,1.0084410091641145,0.44858156028368795,0.7869968578844746,1.0,6/31,9.78%,GJB6;DLEC1;UXT;EML4;PDCD5;APPL1
prerank,metalloaminopeptidase activity (GO:0070006),0.40834561305139466,1.008367474546197,0.45269016697588127,0.7837246474848134,1.0,6/16,14.02%,ANPEP;MMP14;NPEPPS;ERAP1;RNPEP;LNPEP
prerank,tau protein binding (GO:0048156),-0.2978770906371206,-1.0072168894415967,0.44768856447688565,0.8166290459596748,1.0,11/40,15.98%,ACTB;SNCA;S100B;HSP90AB1;LGMN;HDAC6;MARK1;TTBK1;HSP90AA1;BRSK2;MAP2
prerank,ligand-gated calcium channel activity (GO:0099604),-0.35736872528964336,-1.0070835307201742,0.4794816414686825,0.8119907294790442,1.0,5/19,9.11%,RYR2;GRIN2A;RYR3;GRIN2B;GRIN1
prerank,alpha-actinin binding (GO:0051393),0.3698781883595826,1.0063254356096476,0.4619377162629758,0.7853069731853729,1.0,7/24,17.91%,DAG1;SYNPO2;PRICKLE4;CACNA1C;RARA;PKD2;PDLIM2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.4300638802227268,1.0060045371719446,0.4484848484848485,0.7827911876248294,1.0,4/12,15.93%,TENT5A;PAPOLG;TENT2;PAPOLB
prerank,estrogen receptor binding (GO:0030331),-0.3142006398688977,-1.0052389429647555,0.46115288220551376,0.8118095245433538,1.0,5/32,7.65%,LEF1;RERG;ESR1;CTNNB1;DDX54
prerank,mechanosensitive ion channel activity (GO:0008381),-0.4080150202732117,-1.0042089077122598,0.4804928131416838,0.8097049958397162,1.0,1/12,0.51%,PIEZO2
prerank,retinoic acid receptor binding (GO:0042974),0.3991022898353814,1.002544472676799,0.4342105263157895,0.7879992449843709,1.0,3/17,6.89%,NCOA6;TACC1;NSD1
prerank,steroid hydroxylase activity (GO:0008395),0.40064734163809645,1.0012027096998484,0.45640074211502785,0.7877606261140507,1.0,2/16,3.22%,CYP7B1;CYP27A1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.2989537514392234,1.0003725377012629,0.4762611275964392,0.7864567401037055,1.0,11/75,8.95%,SDR9C7;RDH10;LDHAL6B;PHGDH;PGD;CRYL1;RDH5;ME2;PTGR1;DHDH;GLYR1
prerank,SH3 domain binding (GO:0017124),-0.2707732033615238,-0.9958900963182294,0.44692737430167595,0.8275544087942049,1.0,11/62,10.74%,AFAP1L1;SGIP1;SHANK3;ENAH;ELMO1;ADAM15;DAB2IP;ARHGAP27;ABI3;VASP;CBL
prerank,MAP kinase phosphatase activity (GO:0033549),0.42698236414796104,0.9946491810843149,0.4627450980392157,0.7968501474344762,1.0,3/12,12.11%,DUSP10;DUSP16;DUSP5
prerank,ribosomal small subunit binding (GO:0043024),-0.37202966044323893,-0.992221153020679,0.47058823529411764,0.8325285832790903,1.0,9/17,37.26%,CPEB2;NPM1;EIF1B;EIF1;PIM1;ERAL1;DHX29;MTIF2;UNG
prerank,cardiolipin binding (GO:1901612),0.44855374640847684,0.9913768161448842,0.46904315196998125,0.8012594458703399,1.0,4/10,25.30%,GSDME;OPA1;GSDMD;STOML2
prerank,sodium channel regulator activity (GO:0017080),-0.29636299340905237,-0.9868135846284564,0.47549019607843135,0.8424990543126372,1.0,18/37,29.85%,FGF14;FGF12;FXYD5;YWHAH;CAMK2D;NEDD4L;NOS1;FGF13;FXYD1;SCN2B;SCN1B;SGK1;SGK2;SGK3;PKP2;RANGRF;FGF11;FXYD6
prerank,DNA secondary structure binding (GO:0000217),0.3443614704044129,0.9864441908919619,0.4947916666666667,0.8099429004963212,1.0,6/31,14.03%,KMT2A;WRN;FANCM;RBBP8;RAD51B;ERCC5
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.3043106841103245,-0.9862580849200755,0.4441860465116279,0.838866750817292,1.0,9/30,16.83%,CST3;GAS6;SNCA;SERPINB9;PTTG1;SPOCK1;RPS6KA1;CD27;UBE2O
prerank,TBP-class protein binding (GO:0017025),-0.34537536361358934,-0.9842145676531642,0.49504950495049505,0.8390503268799415,1.0,11/21,38.55%,ESR1;HHEX;TAF11;PSMC5;GTF2A2;TAF1B;RUVBL2;THRA;GTF2B;PSMC1;YEATS2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4019119702999461,-0.9809938360564741,0.4989648033126294,0.843215690788215,1.0,4/11,6.77%,TRPC3;TRPC5;TRPC4;TRPC6
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4359526926521373,0.9788396933277662,0.5065420560747663,0.8255366837056362,1.0,3/10,11.36%,NAA16;NAA30;NAA15
prerank,ion gated channel activity (GO:0022839),-0.32922263574276317,-0.9773930645640534,0.49891540130151846,0.8481479781801939,1.0,9/24,15.35%,ANO1;ANO3;KCNT1;TMEM63C;ANO4;TTYH2;TTYH3;ANO2;TTYH1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.3427383343726117,-0.9768539093032983,0.5032537960954447,0.844579447903173,1.0,5/18,16.09%,GAS6;SNCA;SERPINB9;RPS6KA1;CD27
prerank,mannosyltransferase activity (GO:0000030),0.36508839699043794,0.976528624623874,0.4723809523809524,0.827688945372752,1.0,4/21,7.26%,TMTC4;TMTC1;ALG9;POMT2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.3442690746091309,0.9713256495757805,0.48704663212435234,0.8368516126628498,1.0,5/28,11.18%,TRAF5;EDA;STAT1;CASP8AP2;TRAP1
prerank,methylation-dependent protein binding (GO:0140034),0.2994791049123393,0.9703296578896474,0.4976671850699845,0.835628641346938,1.0,22/57,24.69%,KDM7A;SUZ12;MORC3;TRIM24;ZMYND11;GLYR1;RRP8;BPTF;MORC4;KDM8;PYGO1;LRWD1;CHD8;MBTD1;MPHOSPH8;PHF1;PHF13;PHF8;ZCWPW1;WDR5;ING5;ATRX
prerank,single-stranded DNA binding (GO:0003697),0.2754810246376055,0.9691805746578755,0.5261584454409567,0.8349154077796329,1.0,25/93,20.15%,RBMS1;SSBP2;POLR2D;CRY2;NUCKS1;TOP1;FBH1;NABP1;FUBP1;RPA3;MCM4;RTF1;RBBP8;MCM6;RAD51B;ERCC5;ERCC1;PCBP2;DHX36;XPC;TDP2;LONP1;SMC6;CTC1;NABP2
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.4096509610515127,0.9680819159526903,0.49612403100775193,0.8339592572200197,1.0,4/12,10.02%,CDK8;CDK7;CDK12;BRD4
prerank,phosphatase inhibitor activity (GO:0019212),0.3757167067301909,0.9674790210821568,0.5157116451016636,0.8320361205857328,1.0,8/20,24.31%,PTN;ANP32E;BOD1L1;URI1;STYX;STYXL1;PPP1R2;CABIN1
prerank,endonuclease activity (GO:0004519),0.3067286078564539,0.9660433589079765,0.5152,0.8319004742447655,1.0,12/49,15.81%,PIWIL4;NTHL1;NYNRIN;SND1;SMG6;ENDOU;OGG1;SLFN14;ERCC5;ZC3H12B;DIS3;ERN2
prerank,lipoprotein particle receptor binding (GO:0070325),0.34094876774092975,0.9650041335180348,0.5034129692832765,0.8311455045150682,1.0,4/27,6.65%,APOA2;HSPG2;APBB1;CRP
prerank,cysteine-type endopeptidase activity (GO:0004197),0.28519775923353263,0.9649543683566808,0.5131782945736434,0.827868816437974,1.0,21/78,18.30%,USP18;CASP12;CFLAR;CASP4;CTSH;USP24;USP9X;ESPL1;USP8;USP47;CTSW;CAPN15;USP40;USP35;USP34;USP36;CTSF;USP12;CASP3;USP15;USP10
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.21111478617302437,-0.9645114019841939,0.6185567010309279,0.874157666685616,1.0,71/248,22.39%,DNM3;GNAO1;RAB27A;RIT2;RERG;VWA8;ABCA3;GNAS;KIF1C;EEF1A1;NKIRAS1;MYL6;RAB6B;GTPBP1;RAB27B;RAB38;EEF2;RAB3C;ARL1;RHOB;ARHGDIB;RAB35;GFM1;RRAGB;ATAD1;ARL8A;MFN2;GCH1;RHOG;KIF26A;MFN1;HSP90AA1;GSPT2;ABCD2;KIF15;HRAS;RAC1;KRAS;RAB5C;GNA12;RHOH;GPN3;KIF5A;GNAQ;TOR1B;GNA14;IRGM;HBS1L;MYO18A;RAP1A;DNAJC27;RRAGC;RABL3;GNAL;GNA13;RHOBTB1;GPR88;TPPP;RAB1B;RAC3;SAR1B;IFT22;ATL2;BMS1;RND2;RAB32;GNG3;ARL2;GSPT1;RAB18;CHD1L
prerank,kinase activity (GO:0016301),-0.23563152013364938,-0.9628025474009744,0.5333333333333333,0.8736637513900701,1.0,30/109,19.24%,DGKB;DGKI;DGKH;ITPKB;PGK1;PIK3C2B;DGKZ;AKT1;PGM2L1;CAMK2A;RFK;PINK1;FN3K;IP6K2;LYN;ETNK1;BCKDK;PIK3CD;CERK;SEPHS1;DGKG;PPIP5K2;PRKD1;PPIP5K1;PANK1;CKB;FN3KRP;IRAK1;NADK;PIK3C3
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.3614235448774546,0.9625236345078397,0.5026269702276708,0.8302093094436936,1.0,3/20,8.89%,CMPK2;CASK;DLG1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.3747773615209663,-0.960848469691644,0.512396694214876,0.8739203152017029,1.0,2/15,1.62%,SLC26A7;SLC26A2
prerank,phosphatase binding (GO:0019902),0.2722942550581489,0.960203018563921,0.5515759312320917,0.8322563693340657,1.0,23/105,16.48%,SMAD3;CDH5;CRY2;CRY1;IKBKE;DZIP3;MTMR3;MVP;DLG1;MAPK14;PPP6R3;PTK2;SHOC2;JAK1;CDC27;CNST;WNK1;TBK1;EIF2AK3;SH3YL1;IQGAP1;SMAD2;NFATC2
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.37516193799413255,-0.9592309484534501,0.5086206896551724,0.8731961948351401,1.0,3/13,12.62%,PIP5K1B;PIK3C2B;PIK3CD
prerank,endopeptidase activity (GO:0004175),0.24109502705672248,0.9579019925266345,0.568944099378882,0.8343940883518176,1.0,39/257,14.28%,DPP4;USP18;ADAMTSL5;ADAMTS12;ADAMTS10;ADAMTS1;ADAMTSL4;ADAMTS6;NRDC;THSD4;CASP4;CPNE1;MMP14;CORIN;CTSH;USP24;USP9X;ESPL1;PSMB10;ACR;PLAU;PSMA3;USP8;USP47;CTSW;PSMA5;PMPCB;NLN;ADAM19;PAPLN;CELA1;PLAT;USP40;SENP1;ADAMTS7;KDM8;USP35;USP34;USP36
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.3621966058388067,-0.9568465374571765,0.559748427672956,0.8747468443208809,1.0,3/15,6.29%,PIK3R1;PIK3R6;PIK3R3
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.4328590661862093,0.956350067503118,0.5209923664122137,0.8348248209858068,1.0,3/10,10.41%,USP27X;STAMBP;STAMBPL1
prerank,carbohydrate kinase activity (GO:0019200),0.42070389550790444,0.9547919244508372,0.5123809523809524,0.8350554941483791,1.0,5/11,18.10%,GALK2;XYLB;KHK;HK1;NAGK
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.39848194257665814,-0.9547428614591259,0.5213178294573644,0.8756564768803914,1.0,7/10,41.55%,NCF2;CYBB;NOX4;NCF1;NOX3;NCF4;DUOX1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.3594923899827457,-0.9535341042767094,0.5256673511293635,0.87403041408101,1.0,9/14,41.55%,NCF2;CYBB;KMO;NOX4;CYB5R4;NCF1;NOX3;NCF4;DUOX1
prerank,G protein-coupled receptor binding (GO:0001664),0.25892986231643217,0.9534458524026844,0.5465753424657535,0.8350179691465058,1.0,19/132,15.18%,WNT4;WNT6;GRK3;WNT10B;WNT3A;WNT2B;WNT5B;ARHGEF11;WNT5A;ADM;INSL3;ARHGEF12;HOMER3;DVL3;ARRB1;RNF43;CCL25;CCRL2;RYK
prerank,chloride channel inhibitor activity (GO:0019869),0.4263042898453861,0.9532199343537748,0.5207547169811321,0.8323079709361894,1.0,3/10,14.09%,WNK4;STX8;WNK1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.3334772139839001,-0.9524156166957282,0.5254988913525499,0.8673113619158244,1.0,8/21,19.65%,CDK14;CDK6;CDK15;CDK19;CDKL2;CDK2;CDK4;CCNK
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.3334772139839001,-0.9524156166957282,0.5254988913525499,0.8673113619158244,1.0,8/21,19.65%,CDK14;CDK6;CDK15;CDK19;CDKL2;CDK2;CDK4;CCNK
prerank,nuclear receptor coactivator activity (GO:0030374),0.29726145609155624,0.9522386750703018,0.5384615384615384,0.8313021040704313,1.0,16/52,18.40%,ZMIZ1;NCOA3;NCOA6;TACC1;SFR1;SS18;MED12;BRD8;NCOA2;CARM1;RBM14;CNOT9;CCAR1;TMF1;PPARGC1B;KDM1A
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.3521001245420363,-0.9496674929274916,0.5213483146067416,0.8696348108538666,1.0,4/16,11.28%,MACROD2;RPS3;CD38;SMUG1
prerank,magnesium ion binding (GO:0000287),0.25529883436124956,0.9486047215418658,0.5583684950773559,0.8365834558458253,1.0,32/135,19.45%,EYA2;OXSR1;TSSK3;DCTPP1;CLYBL;WRN;IDH1;STK3;SIK3;PDXK;LRRK2;GEM;HACL1;IRAK3;ADPRS;OPA1;SRPK1;IDH2;CIB2;NUAK2;FIGNL1;STK4;ERN2;YDJC;EPHX2;RAN;ABL2;DHX36;PGM1;TDP2;SRR;MVK
prerank,neuropeptide hormone activity (GO:0005184),0.3586716506847038,0.9471582669010586,0.5595854922279793,0.8367642352147061,1.0,2/22,5.28%,GHRH;UCN
prerank,exopeptidase activity (GO:0008238),0.29229824295876183,0.9466524215845278,0.5309446254071661,0.8346656877460961,1.0,12/50,14.11%,DPP4;DPEP2;ANPEP;DPP8;NPEPPS;CTSH;ERAP1;BLMH;DPP7;RNPEP;LNPEP;KDM8
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.4016656362288106,-0.9463243289513312,0.5321285140562249,0.873612751908898,1.0,4/10,6.26%,DPP10;DPP6;FAP;PRCP
prerank,transcription corepressor binding (GO:0001222),0.33557239643584547,0.9459547592296006,0.5316901408450704,0.8330119162742519,1.0,2/27,3.79%,RORA;SUZ12
prerank,deoxyribonuclease activity (GO:0004536),-0.361410796094141,-0.9456127478653957,0.535632183908046,0.8706757336824175,1.0,2/14,5.90%,RPS3;MRE11
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.33369916362662866,0.9436872672784012,0.533003300330033,0.8350416385239223,1.0,9/28,18.80%,PRKAA2;MAP2K6;LRRK2;MAPK14;MAP2K5;MAP2K1;MAPKAPK5;MAPKAPK3;MAP2K4
prerank,GTPase activity (GO:0003924),-0.2125334522444193,-0.9436664587322958,0.658008658008658,0.8709621056741614,1.0,57/192,22.27%,DNM3;GNAO1;RAB27A;RIT2;RERG;GNAS;EEF1A1;NKIRAS1;RAB6B;GTPBP1;RAB27B;RAB38;EEF2;RAB3C;ARL1;RHOB;ARHGDIB;RAB35;GFM1;RRAGB;ARL8A;MFN2;GCH1;RHOG;MFN1;GSPT2;HRAS;RAC1;KRAS;RAB5C;GNA12;RHOH;GPN3;GNAQ;GNA14;IRGM;HBS1L;RAP1A;DNAJC27;RRAGC;RABL3;GNAL;GNA13;RHOBTB1;TPPP;RAB1B;RAC3;SAR1B;IFT22;ATL2;BMS1;RND2;RAB32;GNG3;ARL2;GSPT1;RAB18
prerank,general transcription initiation factor binding (GO:0140296),-0.3196343726041657,-0.9435282320489353,0.5415617128463476,0.8666372973066686,1.0,12/25,38.55%,ESR1;HHEX;TAF11;PSMC5;RELA;GTF2A2;TAF1B;RUVBL2;THRA;GTF2B;PSMC1;YEATS2
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.23482547596724448,-0.9428832795651332,0.5986394557823129,0.8636000785186155,1.0,12/100,7.21%,MYO10;CYTH3;ARAP2;HIP1;CERT1;ARAP3;HIP1R;DAB2IP;SNX3;CLVS1;KCNH1;AKT1
prerank,galactosyltransferase activity (GO:0008378),0.4089004736132149,0.9421293151738246,0.5228519195612431,0.8355824919170216,1.0,2/11,7.26%,A4GALT;B4GALT1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.36439484794199756,-0.9406973351765798,0.5396145610278372,0.8644232194643839,1.0,3/14,14.45%,CAPN1;CAPN10;CAPNS1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.28710279974824854,0.9392426578462274,0.555921052631579,0.8391680821813524,1.0,11/55,13.14%,MCU;ITPR1;ANXA2;SLC24A3;ATP2B4;TMEM165;PKD1L3;PANX1;TRPC1;GRIN3B;ATP2B1
prerank,gated channel activity (GO:0022836),-0.3611546202766778,-0.9341036543870841,0.5452631578947369,0.8760946762586744,1.0,1/14,0.51%,PIEZO2
prerank,phosphatidylglycerol binding (GO:1901611),-0.37307022066016604,-0.9312296241210641,0.5404255319148936,0.8788893557881613,1.0,2/13,3.78%,PITPNC1;PITPNA
prerank,clathrin adaptor activity (GO:0035615),-0.3453152129717668,-0.9305944490227196,0.5185995623632386,0.87585692269369,1.0,7/15,27.43%,HIP1;HIP1R;LDLRAP1;AP2B1;AP2A2;AP2A1;AP2M1
prerank,ubiquitin protein ligase binding (GO:0031625),-0.20256139408229595,-0.9297414668142265,0.702020202020202,0.8735029482881612,1.0,67/253,22.01%,HSPA8;FOXO1;MID1;PRR5L;SMAD7;RPL5;ACTG1;RPL11;PRKAR1A;GABARAP;HSP90AB1;ATP6V0C;HERC2;SLF1;BAG1;MFHAS1;TNFRSF1B;HDAC6;GABARAPL1;UBB;PINK1;RFFL;ELOB;HSPBP1;SPOP;BAG6;CALR;MFN2;USP13;CD40;TNK2;ANKRA2;RPL23;NLK;GPI;PRKAR2B;TPI1;EGFR;HSP90AA1;UBOX5;WASHC1;KDM4A;FZD4;UBA52;CAMLG;TUBA1B;CDKN1A;HSPA5;GPR37;YOD1;BRCA1;LTBR;UBE2D1;CKB;TRIM37;PACRG;TRIM28;SMAD5;PATZ1;WRAP53;UBE2J1;FZD5;USP2;BAG4;NKD2;TRAF1;ATXN3
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.291505295240496,-0.9292353687830784,0.5767441860465117,0.8700555642239214,1.0,11/33,18.10%,RNF144B;RNF144A;RPS3;DCUN1D2;UBE3D;DCUN1D5;DCUN1D1;RNF125;PARK7;FOXL2;TOLLIP
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.23616414757669804,-0.9278558940710032,0.6392961876832844,0.8690045742920708,1.0,25/85,30.27%,NDST3;MGLL;ABHD2;GDPD1;CA2;LIPE;BCHE;AOAH;GDE1;ABHD6;PLAAT3;LPL;PNPLA6;PNPLA3;PLA2G7;PLA2G4F;PAFAH1B2;FAAH;PTRH2;ABHD15;PLAAT1;LIPC;PLA2G4B;PGLS;PGAP1
prerank,GTPase binding (GO:0051020),0.23997187348248208,0.9269699054411967,0.6437994722955145,0.8641795005094562,1.0,41/194,16.55%,RAPGEF4;AKAP13;RNF152;AFDN;SPTBN1;RADIL;FGD4;AMBRA1;PARD6A;MYCBP2;UNC13B;RANBP2;PLCE1;OPTN;RASA1;EXOC2;RALBP1;NGFR;GOLGA5;CHM;STRN3;MICALL1;LRRK2;IQGAP2;DOCK7;TRIOBP;CDC42EP4;DNM1L;RAB34;DVL3;RAP1GAP;IFT20;WASF1;TBC1D7;MYO1C;ABCA1;GOLGA4;IQGAP1;NDRG1;MYO5A;NOX1
prerank,double-stranded RNA binding (GO:0003725),0.2728625736961373,0.9238287186377189,0.596244131455399,0.8682227458454188,1.0,14/70,14.41%,SIDT1;EIF2AK2;DDX60;VIM;RC3H1;MTDH;ZBP1;OASL;OAS2;ADAR;ILF3;SUPV3L1;TARBP2;IFIH1
prerank,GTP binding (GO:0005525),0.24423310006253673,0.9236649831761907,0.6433378196500673,0.8653540814344299,1.0,45/172,19.74%,GBP6;GBP2;RRAS2;RAB10;RAB22A;ARL3;RHOBTB2;ARF4;GBP5;RHOF;GTPBP10;GBP4;RRAD;RHOQ;LRRK2;ARF3;RAP2C;GEM;RABL6;GBP7;TUBA1C;TUBE1;RHOC;TUBB6;PIP4K2B;RHOU;ARL4A;TUBB2B;ATL1;GBP3;RAB5A;RIT1;TUBD1;TRIM23;ARF1;RAN;RAP2B;LSG1;RHOT1;RANBP17;ARL6;DIRAS1;RHOT2;ARFIP2;NRAS
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.3435016151693787,-0.922592564393371,0.5615212527964206,0.8771914209274365,1.0,5/15,12.62%,PIK3C2B;PIK3R3;ATM;PI4K2A;PIK3CD
prerank,calcium:sodium antiporter activity (GO:0005432),-0.40140954883393787,-0.9209704368589191,0.5870020964360587,0.876628636990628,1.0,5/10,21.78%,SLC24A2;SLC8A1;SLC3A2;SLC8B1;SLC24A5
prerank,ephrin receptor binding (GO:0046875),0.3504240217719533,0.9200161596224918,0.5689655172413793,0.8705883083495821,1.0,4/21,12.76%,EFNB2;PTPN1;EFNA1;EFNB1
prerank,single-stranded DNA helicase activity (GO:0017116),-0.3245929544233007,-0.9199227388464659,0.57847533632287,0.8746613764869343,1.0,9/19,31.34%,HELQ;RAD51;RFC4;POLQ;WRNIP1;RFC5;RFC2;CHTF18;PIF1
prerank,WW domain binding (GO:0050699),0.33112319388218614,0.9192592384302928,0.5541284403669725,0.8690536995176378,1.0,6/26,12.55%,TCEAL7;PMEPA1;LITAF;SCNN1A;TCEAL3;TCEAL6
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.41235372702665823,0.9151073264724521,0.5589430894308943,0.8751225862515439,1.0,4/10,15.61%,KDM7A;KDM2A;KDM8;KDM2B
prerank,3'-5' DNA helicase activity (GO:0043138),0.36642631346466736,0.9144161339636305,0.5825602968460112,0.8734388443079609,1.0,5/16,13.28%,WRN;ASCC3;FBH1;FANCM;MCM6
prerank,calcium channel activity (GO:0005262),-0.23381581977066068,-0.9138391435149474,0.6466876971608833,0.8851463374130975,1.0,9/84,4.60%,CACNA1E;CACNB2;TRPC3;SLC24A2;RYR2;CACNB4;TRPC5;TRPC4;OPRM1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.3049571458221576,0.9128392989201901,0.5683690280065898,0.8739993183113441,1.0,13/38,20.00%,PLA2G4A;SNX12;PLEKHA4;DENND1A;SNX27;WDR45B;ATG2A;SH3PXD2B;WIPI2;SNX21;PLEKHF1;RUBCNL;SESTD1
prerank,NADPH binding (GO:0070402),-0.3619967429561597,-0.9121806526445781,0.563265306122449,0.8846797406635135,1.0,4/13,25.65%,KCNAB1;MTRR;NDOR1;CRYZ
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.2411096345182146,-0.9095783909305635,0.5935672514619883,0.8864208353011395,1.0,17/72,15.71%,PLCB1;HIP1;KCNJ2;SYTL2;HIP1R;SDCBP;SYT7;STXBP6;LDLRAP1;RAB35;SNAP91;MARK1;KCNQ1;AMER2;SNX18;KRIT1;TWF1
prerank,hormone activity (GO:0005179),0.286496646821346,0.9094063414603488,0.6111111111111112,0.8784321676225121,1.0,7/54,16.13%,GHRH;PTHLH;UCN;NPPC;AGRP;CCL25;INHA
prerank,signal sequence binding (GO:0005048),0.31343374386591505,0.9091724718313647,0.5796610169491525,0.8756981728097789,1.0,5/35,7.24%,TNPO1;KDELR3;KPNA6;KPNA7;KPNA4
prerank,hexosyltransferase activity (GO:0016758),-0.22736716091574766,-0.9091379699452434,0.6588628762541806,0.8830771311176991,1.0,20/101,15.97%,TMTC2;CSGALNACT1;FUT9;HEXB;EXT1;POMGNT1;DPY19L1;LFNG;ALG5;MFNG;B3GNT2;B4GALT4;PIGM;MGAT4A;GCNT1;CHSY3;B3GNT9;TMTC3;B3GALNT2;POMGNT2
prerank,gamma-tubulin binding (GO:0043015),-0.315539341448947,-0.908226778261303,0.5924276169265034,0.8807187170542806,1.0,8/21,24.37%,PAK1;DIXDC1;ARHGEF7;BRCA2;RAB11FIP5;CDK5RAP2;RACGAP1;TUBGCP3
prerank,receptor tyrosine kinase binding (GO:0030971),0.2796663743244277,0.9070354438530724,0.6161290322580645,0.8770682887077775,1.0,12/56,14.53%,CBLB;GAB2;FRS2;PTPN14;ANGPT1;LRP4;PTPN2;SH2B3;MAP3K7;PTPN1;SHC2;NCK1
prerank,voltage-gated anion channel activity (GO:0008308),-0.34425681009763787,-0.9066310108977269,0.6029106029106029,0.8800276563777457,1.0,5/15,16.90%,ANO1;CLCN3;CLCN1;VDAC1;CLCN5
prerank,small GTPase binding (GO:0031267),0.23712715124568218,0.9049169835154921,0.6775956284153005,0.8784175526237041,1.0,37/169,16.55%,RAPGEF4;AKAP13;RNF152;AFDN;FGD4;PARD6A;MYCBP2;UNC13B;RANBP2;PLCE1;OPTN;EXOC2;RALBP1;NGFR;GOLGA5;CHM;STRN3;MICALL1;LRRK2;IQGAP2;DOCK7;TRIOBP;CDC42EP4;DNM1L;RAB34;DVL3;RAP1GAP;IFT20;WASF1;TBC1D7;MYO1C;ABCA1;GOLGA4;IQGAP1;NDRG1;MYO5A;NOX1
prerank,neuropeptide receptor binding (GO:0071855),0.3758370749780064,0.9042223773132657,0.5777385159010601,0.8767297340322838,1.0,1/14,2.01%,GHRH
prerank,ankyrin binding (GO:0030506),-0.3208962315116278,-0.9039319574905096,0.5991091314031181,0.8823359118945605,1.0,6/19,14.81%,CDH1;SLC8A1;NRCAM;SPTB;CACNA1D;PTPRC
prerank,RNA polymerase binding (GO:0070063),-0.3256144029619567,-0.9029657412755326,0.6258205689277899,0.8803036715457668,1.0,6/18,17.82%,TCERG1L;STOM;YTHDC2;ANP32B;BRCA1;PPIB
prerank,transcription coregulator binding (GO:0001221),0.28422753084047236,0.9019667394912353,0.6332288401253918,0.8785983000501637,1.0,4/50,4.00%,RORA;SMAD3;SUZ12;TERT
prerank,carboxy-lyase activity (GO:0016831),0.3361944894816516,0.901514527481812,0.6094032549728752,0.8764926707659152,1.0,5/23,17.32%,AZIN2;BCKDHA;UMPS;FAHD1;PCK2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.3920048245320795,0.9003022846417613,0.6011904761904762,0.8759886155830239,1.0,1/12,3.49%,AOX1
prerank,receptor antagonist activity (GO:0048019),0.35842733368531077,0.8955763426521407,0.5741811175337187,0.8828448291173379,1.0,4/17,17.49%,WFIKKN1;DKK3;LRPAP1;IL18BP
prerank,proton transmembrane transporter activity (GO:0015078),-0.26881629859788553,-0.8950100239447158,0.6563307493540051,0.8944660054183629,1.0,15/39,26.39%,CLCN3;ATP6V1B2;COX4I1;UQCRH;UQCR11;COX8A;NDUFA4;COX6A1;CLCN5;ATP6V1F;NDUFA4L2;CYB5A;UQCR10;UQCRQ;COX4I2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.31621661031202175,0.8949560165691877,0.5932504440497336,0.8809448080577256,1.0,3/29,3.50%,SLC13A3;SLC19A1;SLC26A9
prerank,triglyceride lipase activity (GO:0004806),-0.31066468892792454,-0.8945802463349597,0.6457399103139013,0.8911118281448536,1.0,5/20,28.37%,LIPE;LPL;PNPLA3;LIPH;LIPC
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.39253147560433443,0.8942739644831834,0.624765478424015,0.8793827888548134,1.0,3/11,11.36%,NAA16;NAA30;NAA15
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.251732117595295,-0.8894647643216691,0.6640625,0.8985896862194008,1.0,13/51,17.03%,SLCO1C1;SLCO2A1;SLC7A5;SLC16A10;CLCN3;SLC5A5;SLC5A6;SLC22A6;SLC25A30;MFSD2A;SLC35E3;SLCO4A1;SLC20A2
prerank,protein tyrosine kinase binding (GO:1990782),-0.235589205379649,-0.8887638964695638,0.6528925619834711,0.8958271821276971,1.0,14/71,14.92%,DOCK4;NRG3;GRB14;GRM5;BMPR2;GAS6;CEACAM1;DUSP22;RACK1;CBL;ACVR1;HSP90AA1;TJP2;SHC4
prerank,alpha-tubulin binding (GO:0043014),-0.2826601535355334,-0.8886423285386276,0.6465116279069767,0.8918606534919122,1.0,8/31,13.20%,TTLL7;DIP2B;SNCA;EFHC2;HDAC6;ARL8A;TRIM36;WASHC1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.3409787081439385,-0.88786471301872,0.6029723991507431,0.8893975650973623,1.0,4/15,15.39%,EPB41;SCARB1;SNAP91;WDFY1
prerank,fibroblast growth factor binding (GO:0017134),0.3397284528884457,0.8867321078290304,0.6234887737478411,0.8928560537977954,1.0,3/21,5.56%,FGFR1;KL;GLG1
prerank,anion:anion antiporter activity (GO:0015301),-0.33214354140030056,-0.8845251088202676,0.6418219461697723,0.8924759982814451,1.0,2/17,1.62%,SLC26A7;SLC26A2
prerank,carbohydrate:cation symporter activity (GO:0005402),-0.3721390907082306,-0.884315869216371,0.6211812627291242,0.8886721470364166,1.0,6/11,31.96%,SLC2A9;SLC5A11;SLC23A1;SLC23A2;SLC2A10;SLC5A3
prerank,NADP binding (GO:0050661),0.30602802340044755,0.8840840837889209,0.6194690265486725,0.8951747358797786,1.0,6/32,7.82%,HSD17B1;GMDS;PGD;NOS2;DPYD;NNT
prerank,phosphatase activity (GO:0016791),0.26003291661461625,0.8833779860711685,0.6548536209553159,0.893512807492379,1.0,12/73,12.11%,ATP1A2;PLPP3;DUSP10;DUSP28;PTPN22;DUSP16;MDP1;PLPPR3;NT5C;NOCT;PPP1CB;DUSP5
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.23575511206183875,-0.8824382232713078,0.7055393586005831,0.8885070575554247,1.0,13/70,15.97%,CSGALNACT1;HEXB;EXT1;POMGNT1;LFNG;MFNG;B3GNT2;MGAT4A;GCNT1;CHSY3;B3GNT9;B3GALNT2;POMGNT2
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.38230274717849255,0.8820006994878703,0.6296296296296297,0.8933126342850755,1.0,1/11,0.88%,ITPR1
prerank,damaged DNA binding (GO:0003684),0.2794289735444966,0.8817237555105883,0.639261744966443,0.89086489337486,1.0,10/44,15.40%,CRY2;CREBBP;NTHL1;RPA3;XRCC1;DCLRE1A;RBBP8;OGG1;ERCC5;ERCC1
prerank,protein kinase activator activity (GO:0030295),-0.24219899642186382,-0.8816887153719941,0.7168141592920354,0.8860299808793676,1.0,13/60,15.47%,GRM5;RPLP1;CALM1;GAS6;CALM2;CALM3;STK11;FGF13;ALS2;GPRC5A;RGCC;CDKN1A;IRGM
prerank,acetylcholine receptor activity (GO:0015464),-0.2999911482324602,-0.8804362313491758,0.6277372262773723,0.8845884118868694,1.0,5/22,20.27%,CHRM3;CHRM2;CHRNA4;CHRFAM7A;CHRNA7
prerank,anion transmembrane transporter activity (GO:0008509),-0.3641360237353496,-0.8766642921658567,0.6129666011787819,0.8884381338742394,1.0,4/12,16.43%,ABCG2;SLC22A6;SLC39A8;ABCC5
prerank,MAP kinase activity (GO:0004707),0.37030154205050325,0.8762028705637437,0.6093457943925233,0.899429221220018,1.0,4/14,13.33%,MAPK4;MAPK6;MAPK14;MAPK9
prerank,androgen receptor binding (GO:0050681),-0.2903483085422842,-0.8750808897430343,0.6346153846153846,0.8880065531246581,1.0,6/25,14.75%,PRKCB;PKN1;TRIM68;CALR;KDM4C;PARK7
prerank,myosin binding (GO:0017022),0.2671795007490811,0.8691926281656668,0.6666666666666666,0.91128581970301,1.0,5/55,3.84%,CALD1;KIRREL1;SPATA6;TRAK1;RAB10
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2094075410574742,0.8629091465698158,0.8368794326241135,0.9211399523102523,1.0,84/431,17.71%,ATP1A2;GBP6;PRKAG2;ENPP1;OXSR1;GBP2;KSR1;TSSK3;RRAS2;BMPR1A;MYO1B;RAB10;DAPK1;RAB22A;ARL3;RRM1;TOP1;LATS2;TGFBR1;RHOBTB2;ARF4;GBP5;RHOF;GTPBP10;GBP4;MAP4K1;WNK4;RRAD;STK3;RHOQ;SIK3;PDXK;LRRK2;ARF3;TLK2;RAP2C;PFKM;AKT3;GEM;HACL1;RABL6;GBP7;OAS2;TUBA1C;IRAK3;TUBE1;RHOC;CLPX;ABCD3;TUBB6;DAPK2;SRPK1;MCM6;PIP4K2B;RHOU;ERCC6;WNK1;ABCF1;TRIB1;TRNT1;P2RY1;NUAK2;ARL4A;ABCA1;STK4;ERN2;TUBB2B;HSPA9;ATL1;GBP3;RAB5A;RIT1;TUBD1;TRIM23;P2RX4;MKNK2;ARF1;RAN;RAP2B;LSG1;CHD8;RHOT1;TAP2;DMPK
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.25564502168188574,-0.8614910287570877,0.7360774818401937,0.9131320650162417,1.0,8/42,12.61%,PLCG2;BCAR3;PIK3R1;SHE;PIK3R3;LDLRAP1;VAV1;SYK
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.35533226545662033,0.8602727887343068,0.631578947368421,0.9235375244480742,1.0,3/14,9.52%,MTHFD1;ALDH4A1;PYCR3
prerank,histone deacetylase binding (GO:0042826),0.24869407254683948,0.8600968154051635,0.7380239520958084,0.9207521103746661,1.0,24/88,18.62%,GLI3;ZMYND15;DACT1;MIER3;BCOR;MIER1;FOXP3;HDAC4;TOP2B;MEF2A;GMNN;CIR1;SMG5;HOXA10;BHLHE41;HIC1;RAD9A;HDAC2;KAT2B;PKN2;NIPBL;YWHAE;DHX36;CHD4
prerank,lipoprotein particle binding (GO:0071813),0.3190903488078007,0.8563537340764824,0.6666666666666666,0.9253644974801319,1.0,4/20,11.03%,COLEC12;APOA2;CRP;CDH13
prerank,adenyl ribonucleotide binding (GO:0032559),0.21153693114625838,0.8544123055465871,0.8159509202453987,0.9262551009201525,1.0,43/291,14.75%,MPPED2;ATP1A2;RAPGEF4;PRKAG2;ENPP1;OXSR1;KSR1;TSSK3;BMPR1A;SLC19A1;MYO1B;DAPK1;RRM1;TOP1;LATS2;TGFBR1;POPDC2;CNBD2;MAP4K1;WNK4;STK3;SIK3;PDXK;TLK2;PFKM;AKT3;HACL1;OAS2;IRAK3;CLPX;ABCD3;DAPK2;SRPK1;MCM6;PIP4K2B;ERCC6;WNK1;ABCF1;TRIB1;TRNT1;P2RY1;NUAK2;ABCA1
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.27728963168074117,-0.8538605310260772,0.6767441860465117,0.9244869772253139,1.0,4/27,6.71%,SLC12A2;SLC9B2;CNNM4;ATP2A3
prerank,metalloexopeptidase activity (GO:0008235),0.2665830912049983,0.8532544201849795,0.7131147540983607,0.9253833611587682,1.0,12/51,14.02%,CPQ;ANPEP;AEBP1;MMP14;PEPD;NPEPPS;CPB2;ERAP1;RNPEP;CPXM2;AGBL2;LNPEP
prerank,aspartic-type peptidase activity (GO:0070001),-0.37823632317928496,-0.8527391570831974,0.6613861386138614,0.9227699053256863,1.0,1/10,6.54%,CTSD
prerank,mRNA binding (GO:0003729),0.21485189736210414,0.85117585479922,0.8081683168316832,0.9262880200293814,1.0,59/249,20.84%,CELF2;RBMS1;RBMS3;SAMD4A;SHMT1;PTBP3;RBFOX2;PCF11;RC3H1;RBMS2;IGF2BP1;PABPC5;TPR;SECISBP2L;NANOS2;CPEB1;SRRM2;NOVA1;RNF20;SNIP1;HNRNPC;NYNRIN;NOCT;FUBP1;ACO1;TDRD7;IGF2BP2;SRSF4;EIF4ENIF1;DDX6;SF3B6;PTBP2;RBM5;THOC5;ZC3H12B;GEMIN5;RBM15;RBM14;SRSF5;CSTF3;HNRNPR;CPEB3;SSB;HNRNPA2B1;PUM2;FXR2;SHFL;SLBP;PCBP2;DHX36;GRSF1;NANOS1;DDX5;KHDRBS1;IREB2;KHSRP;RBM25;ELAVL1;PARN
prerank,mannose binding (GO:0005537),0.3636838980273615,0.8490780769744692,0.6598890942698706,0.927210003816457,1.0,3/12,13.88%,CLN5;ACR;LMAN1L
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.34496838164842736,0.848726733011012,0.6823308270676691,0.924832221668993,1.0,1/16,0.90%,SLC13A3
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.2945019517011559,-0.8481652594879584,0.6904231625835189,0.9279861205737501,1.0,9/21,24.48%,REV3L;POLA1;POLE;POLD1;POLB;POLE3;POLQ;POLK;CHRAC1
prerank,phosphatidic acid binding (GO:0070300),0.3304811474112734,0.8479456656084685,0.6768402154398564,0.9232818782777603,1.0,7/19,20.00%,SMPD3;PACSIN2;MICALL1;OPA1;MAPKAP1;PITPNM1;SESTD1
prerank,low-density lipoprotein particle binding (GO:0030169),-0.3194042592628808,-0.8468033697888996,0.657563025210084,0.926501349219402,1.0,4/16,7.10%,THBS1;SORL1;STAB1;SCARB1
prerank,phospholipase activity (GO:0004620),0.2538981483364072,0.8442933776862642,0.7275541795665634,0.9273767536784043,1.0,7/67,10.74%,SMPD3;PLA2G4A;PLCE1;PLCB3;PLA2G4C;PLA2G6;ENPP2
prerank,calcium-release channel activity (GO:0015278),0.3304425980105564,0.8425002402449139,0.678030303030303,0.9279392441535539,1.0,6/17,20.85%,ITPR1;TPCN1;PKD2;TRPA1;ITPR2;ITPR3
prerank,peptidase activator activity (GO:0016504),-0.2884455672330026,-0.8419693790730612,0.6818181818181818,0.9317947956065457,1.0,6/22,17.42%,MAL;PSMD14;PINK1;CAV1;PSENEN;PSME1
prerank,single-stranded RNA binding (GO:0003727),-0.24357844346103358,-0.8411198913427148,0.7800511508951407,0.9292938130159225,1.0,6/43,8.16%,STRBP;PTBP1;ADARB2;ZFR2;CNBP;DDX11
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.3492000736591644,0.8377531859280438,0.664804469273743,0.9340756493411783,1.0,1/15,0.80%,SLC1A3
prerank,phosphatidylinositol binding (GO:0035091),-0.2132398707493629,-0.8375926965650016,0.8414239482200647,0.9319223853801271,1.0,18/91,15.43%,EPB41;MCF2L;HIP1;PITPNC1;PITPNA;HIP1R;MPPE1;CCDC88A;SCARB1;SNAP91;PIGU;PIGK;FES;GAP43;SNX8;PASK;WDFY1;MAPT
prerank,neuropeptide receptor activity (GO:0008188),-0.2684024818934985,-0.8363153021690616,0.7259953161592506,0.9303523974474809,1.0,8/29,25.90%,SORCS1;SORCS3;OPRM1;TACR3;GPR37;NMUR2;GRPR;KISS1R
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.2692635792936262,-0.8352562459665531,0.7240566037735849,0.9281941151802023,1.0,10/29,22.24%,CIT;PRKAR1A;INKA2;SPRED2;PRKAR2B;PKIG;CDKN1A;PKIB;SPRED1;HEXIM2
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2809871618555041,-0.8343991677265034,0.724373576309795,0.9257616832080374,1.0,5/26,10.48%,AGBL4;CPE;CPD;CPA6;ACE2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.35958593215435675,-0.8342596106027999,0.6889763779527559,0.9220373854119658,1.0,2/10,7.38%,ADARB2;APOBEC1
prerank,DNA polymerase activity (GO:0034061),0.31571880892316184,0.833123334438003,0.6758747697974218,0.9402403315773687,1.0,4/22,8.90%,POLH;TERT;POLG;REV1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.2966224981299126,0.8317845361337872,0.6834782608695652,0.940051563993444,1.0,2/24,3.86%,CAMK1D;DAPK1
prerank,cysteine-type peptidase activity (GO:0008234),0.24610424030090575,0.8307332160141571,0.7669753086419753,0.9388827481712392,1.0,19/73,18.30%,USP18;CASP4;CTSH;USP24;USP9X;ESPL1;USP8;USP47;CTSW;BLMH;USP40;USP35;USP34;USP36;CTSF;USP12;CASP3;USP15;USP10
prerank,myosin V binding (GO:0031489),-0.31161369958737295,-0.8293360578233504,0.6895161290322581,0.9274664628470078,1.0,3/15,7.38%,RAB6B;RAB27B;RAB3C
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.3367730976672927,-0.8251661999169515,0.6659836065573771,0.931367092827539,1.0,6/12,17.19%,JMJD1C;KDM4D;KDM4C;KDM4A;PHF2;HR
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.2866724374546282,-0.823579571708577,0.7386609071274298,0.9305296251858468,1.0,5/21,18.69%,AKAP6;RYR2;KCNQ1;AKAP1;AKAP5
prerank,solute:proton symporter activity (GO:0015295),-0.29759346609004833,-0.8235548331213488,0.7306122448979592,0.9265967706208328,1.0,12/16,44.76%,SLC15A2;SLC2A9;SLC36A1;SLC39A8;SLC36A2;SLC2A10;SLC15A1;MFSD3;SLC15A4;SLC11A2;SLC25A3;SLC2A13
prerank,organic cation transmembrane transporter activity (GO:0015101),0.33076615318553704,0.8216633251675283,0.6947565543071161,0.9528183613723997,1.0,6/16,21.36%,SLC5A7;SLC22A2;SLC22A4;SLC44A2;SLC7A8;SLC22A3
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.33419545009048063,-0.8208436463119535,0.6955602536997886,0.9275608241437545,1.0,2/12,11.18%,ENTPD1;SLC25A42
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.30801902522798735,0.8167080767087497,0.71939736346516,0.9586695528445485,1.0,4/22,12.11%,DUSP10;MTMR3;DUSP16;DUSP5
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.3076415498323949,0.8150719419845794,0.733102253032929,0.9584974643126496,1.0,9/22,22.79%,RBMS3;CPEB1;ILF3;CPEB3;DHX36;KHSRP;ELAVL1;ZC3H12A;ZFP36L2
prerank,SH2 domain binding (GO:0042169),0.2803029558055969,0.8144555646249803,0.7229129662522202,0.9565792489406792,1.0,3/31,3.64%,DLC1;DAG1;AFAP1
prerank,syntaxin binding (GO:0019905),-0.22051024364553626,-0.8133617889783292,0.830028328611898,0.9370041464297215,1.0,22/61,26.68%,SYT1;SYNPR;NSF;SNAP25;STXBP5L;STXBP1;STX16;CPLX1;SNPH;NAPA;SYT9;SYT2;CACNA1A;SYPL1;SYT6;VPS18;SYT10;SYT5;VAMP1;STX7;SNAP29;SYT17
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3004705893821624,0.8128686281200033,0.7201492537313433,0.9565048447227736,1.0,1/26,0.48%,PTN
prerank,pseudouridine synthase activity (GO:0009982),-0.31774955140523803,-0.8094724078370591,0.7393939393939394,0.9398378986236104,1.0,7/13,28.32%,PUS7;PUS3;TRUB1;PUSL1;RPUSD2;RPUSD3;RPUSD1
prerank,Toll-like receptor binding (GO:0035325),-0.3333202969304394,-0.8093306951081108,0.7269076305220884,0.9361500181743077,1.0,7/11,33.66%,DAB2IP;TOLLIP;MYD88;TLR6;TLR1;S100A9;TIRAP
prerank,death domain binding (GO:0070513),0.3533441262687531,0.8075176826185679,0.6982248520710059,0.9630103493905866,1.0,4/11,10.73%,BCL2;MCL1;BAX;BCL2L1
prerank,kinase activator activity (GO:0019209),-0.25389124576561795,-0.807017468335402,0.7535885167464115,0.9363302860021627,1.0,6/30,13.86%,RPLP1;STK11;MALT1;FGF13;GPRC5A;RGCC
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2803193056892626,0.803662560495481,0.7666098807495741,0.9668067320013821,1.0,7/31,15.01%,UBE2U;UBE2Z;UBE2C;UBE2E3;UBE2Q2;BIRC6;UBE2R2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.2328207862341071,0.8032217344215116,0.8126843657817109,0.9644481187908827,1.0,30/83,24.12%,USP18;USP27X;STAMBP;USP24;USP9X;USP8;USP47;STAMBPL1;MYSM1;USP40;USP35;USP34;USP36;USP45;USP12;USP15;USP32;USP10;JOSD1;USP39;BRCC3;USP4;USP7;PAN2;USP26;ZC3H12A;OTUD5;USP19;USP25;OTUD7B
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.3116003711431866,-0.8030885741709423,0.7290322580645161,0.9393769904145285,1.0,7/13,51.25%,MIF;ECI1;IDI1;DCT;HSD3B2;EHHADH;IDI2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.32076400669127314,0.8023725706045075,0.7410071942446043,0.9628265064896278,1.0,2/18,5.07%,HSD17B1;RDH5
prerank,CCR chemokine receptor binding (GO:0048020),0.2898994644907086,0.8005519347869122,0.765625,0.9629764245223446,1.0,5/28,15.02%,MSMP;CCL2;NES;CCL25;CCRL2
prerank,palmitoyltransferase activity (GO:0016409),-0.26326165596611467,-0.79797201392417,0.7557077625570776,0.9444738590986056,1.0,13/28,33.47%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;YKT6;ZDHHC5;ZDHHC4;GOLGA7B;ZDHHC13;GOLGA7
prerank,MHC protein binding (GO:0042287),-0.27576623798467365,-0.797864923159559,0.7539863325740319,0.9407481310320226,1.0,4/20,14.24%,ATP5F1A;CD74;ATP5F1B;TUBB4B
prerank,P-type ion transporter activity (GO:0015662),-0.3238648766182399,-0.7951146758501301,0.7263157894736842,0.9414293862754125,1.0,6/12,27.62%,ATP2C1;ATP2A3;ATP2A2;ATP2B3;ATP2B2;ATP2C2
prerank,histone demethylase activity (GO:0032452),0.28365800059630153,0.7937966570062789,0.7626811594202898,0.9717020827382357,1.0,9/27,20.38%,KDM7A;KDM3B;JARID2;KDM5B;KDM2A;KDM8;KDM2B;KDM1A;JMJD6
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.2851438569789467,0.7934320831775362,0.7592267135325131,0.9692167003275115,1.0,4/27,6.37%,RNF217;RNF19A;SIAH2;PPARA
prerank,Notch binding (GO:0005112),0.2952201069958447,0.7913352707402501,0.7225130890052356,0.9697702323369568,1.0,3/22,5.80%,SNED1;AAK1;DTX1
prerank,kinase inhibitor activity (GO:0019210),-0.24584738067229794,-0.7894902377947247,0.7995169082125604,0.9468382047051319,1.0,9/33,15.23%,SNCA;SMCR8;NPM1;LRP6;SH3BP5L;MAPK8IP1;PRKRIP1;RHOH;CDKN1A
prerank,ferrous iron binding (GO:0008198),-0.27395056896546355,-0.7888470234272074,0.7535211267605634,0.94400753039399,1.0,3/21,4.96%,FTH1;SNCA;FTL
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.23909569729461638,-0.7876275883374733,0.8414322250639387,0.9422620188659018,1.0,12/38,23.13%,SHANK3;PIK3R1;SHANK2;GRIP1;LDLRAP1;MAPK8IP3;MMS19;SHANK1;DEDD2;CARD10;NUP62;IRS1
prerank,ADP binding (GO:0043531),-0.25819356807878,-0.7862301744222316,0.7912844036697247,0.9405430456239342,1.0,6/25,15.94%,ME1;PGK1;ATP5F1A;GCLC;ATP5F1D;MYO18A
prerank,nucleosomal DNA binding (GO:0031492),0.301394401160211,0.7856905872402843,0.750445632798574,0.9765347309330719,1.0,8/21,18.62%,MBD2;HNRNPC;GATAD2B;ACTL6A;HDAC2;SMARCA4;SMARCC1;CHD4
prerank,N-methyltransferase activity (GO:0008170),0.29990065397080834,0.7841474235092794,0.7530864197530864,0.9760179658914204,1.0,7/20,23.12%,HNMT;ZCCHC4;FDXACB1;PEMT;METTL15;METTL5;PRMT1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.26937495068217915,-0.7831416787188121,0.7825112107623319,0.9414490854242519,1.0,10/24,28.89%,ZDHHC14;ZDHHC20;ZDHHC2;ZDHHC24;ZDHHC7;ZDHHC23;ZDHHC9;YKT6;ZDHHC4;GOLGA7B
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.3183097190820311,0.782411655899451,0.7370304114490162,0.9758822762329388,1.0,5/15,20.00%,PLA2G4A;SH3PXD2B;PLEKHF1;RUBCNL;SESTD1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.24579834366066533,0.7823763278696749,0.7886435331230284,0.9729038934677634,1.0,18/54,20.86%,MIER3;MIER1;HDAC4;ACY3;ASPA;NTAN1;HINT3;NAAA;ACR;SIRT4;AMDHD2;HDAC2;PDF;AGA;NIT1;PIGL;SIRT2;NADSYN1
prerank,disordered domain specific binding (GO:0097718),0.29181802153855574,0.7822509450497814,0.7712418300653595,0.9700763578890643,1.0,3/23,8.30%,FN1;NCOA3;TEAD2
prerank,neuropeptide binding (GO:0042923),-0.2797902625290643,-0.7808211575854201,0.7929515418502202,0.9412863630949087,1.0,2/18,4.64%,OPRM1;SORL1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.2726849132426415,0.7799756349746906,0.7732656514382402,0.97087775409969,1.0,11/29,19.09%,LCT;ABHD10;MGAM;ADPRS;CTBS;GANAB;GANC;NEU3;GBA2;PGGHG;IDUA
prerank,SUMO binding (GO:0032183),0.32956543654885706,0.7794902427559768,0.7161904761904762,0.9686826389722601,1.0,4/13,15.00%,RNF111;CASP8AP2;CBX4;PML
prerank,hexosaminidase activity (GO:0015929),0.3402060196405327,0.7793269794375097,0.7212121212121212,0.9660314173338925,1.0,1/12,2.28%,CEMIP2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.3299006624204487,-0.7770387802610567,0.757700205338809,0.9435930856102415,1.0,5/10,30.97%,ANKRD13A;ANKRD13B;FAN1;LAPTM5;FAAP20
prerank,hyaluronic acid binding (GO:0005540),-0.3299993918270443,-0.7756597187498692,0.778,0.9417990950226245,1.0,2/10,4.97%,LAYN;CEMIP
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.28727876208284586,0.7750269171267578,0.7793594306049823,0.9696286522169024,1.0,8/24,20.00%,PLA2G4A;OSBPL8;OSBPL5;PLEKHA8;PLEKHF1;ARFIP2;RUBCNL;SESTD1
prerank,GDP binding (GO:0019003),0.23652536075289718,0.7750189723700924,0.8226837060702875,0.9666755501664602,1.0,19/63,23.16%,RRAS2;RAB10;RAB22A;ARL3;RAP2C;GEM;MIEF1;RAB5A;RIT1;TRIM23;RAN;RAP2B;GNAI3;DIRAS1;NRAS;RAB14;RRAGD;RAP2A;RAB11B
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.26271926337881024,0.7749177486251042,0.8092868988391376,0.9639096619825226,1.0,9/34,17.02%,FAM20A;STK3;IGF2;PARP16;MAP2K1;MTCP1;IQGAP1;STK4;RICTOR
prerank,Wnt-activated receptor activity (GO:0042813),0.31642372445643785,0.773691221607096,0.7280701754385965,0.9628023305190555,1.0,2/15,4.47%,FZD2;ROR1
prerank,heme binding (GO:0020037),-0.20674523177891874,-0.7721999810913773,0.9047619047619048,0.9432544470615312,1.0,20/65,28.12%,NOS3;SDHC;GUCY1B1;NOS1;HMOX2;CYP2A6;PTGIS;CYBB;HEBP1;EIF2AK1;CYP2S1;SDHD;CYP46A1;CYB5A;NOX4;CYP2R1;HMOX1;ABCB6;STEAP4;CYP26B1
prerank,chemoattractant activity (GO:0042056),0.27469702689624653,0.7721479658015193,0.8137082601054482,0.9623594205320257,1.0,2/26,3.32%,CXCL10;VEGFD
prerank,cation transmembrane transporter activity (GO:0008324),0.2422825955853684,0.7707953783830523,0.8092948717948718,0.9615419212571433,1.0,7/48,12.14%,SLC7A2;SLC6A9;SLC38A6;PKD1L3;SLC41A1;SLC38A1;SLC38A9
prerank,muscle alpha-actinin binding (GO:0051371),0.3066335679674851,0.7640714058494712,0.7509363295880149,0.9689623956150738,1.0,7/15,26.77%,SYNPO2;PRICKLE4;PKD2;PDLIM2;PDLIM7;PDLIM1;PDLIM5
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.283702188859576,0.7607644815210682,0.7892857142857143,0.9711508077831554,1.0,3/22,6.65%,HSPG2;APBB1;CRP
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.32990208385638986,0.7559234211244621,0.7769230769230769,0.9754239803407133,1.0,11/11,67.03%,DDAH2;PADI2;ALLC;PADI6;PADI3;AGMAT;PADI4;PADI1;ARG1;ARG2;DDAH1
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.2355879093773732,-0.7557178849943552,0.8598130841121495,0.9627820005101952,1.0,10/34,22.27%,DIS3L2;EXOSC2;EXD2;ANGEL2;XRN2;CNOT2;ERI1;EXOSC4;CNOT8;TOE1
prerank,CARD domain binding (GO:0050700),-0.28581291320545976,-0.7553828636072059,0.8204081632653061,0.9594567586630378,1.0,5/14,20.03%,NOD1;IRGM;NOD2;CARD10;CASP1
prerank,adenylyltransferase activity (GO:0070566),0.2839930884597405,0.7519776967573811,0.758095238095238,0.9782072239184114,1.0,9/21,24.46%,PAPOLG;OASL;OAS2;TENT2;PAPOLB;FLAD1;TENT4B;SELENOO;PAPOLA
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.1884901983449183,0.7496202040214192,0.9675,0.9786643525130715,1.0,46/268,16.38%,SMAD3;STAT2;AMBRA1;TRAF5;PARP9;APBB1;IKBKE;BCL2;VCL;PTPN22;DTX1;CUL4A;FHIT;DTX3L;CCDC50;RNF20;NGFR;STAT1;GSK3B;TNFRSF14;SKI;SNX9;UBE2C;PSMA3;SUMO1;SLF2;SMAD6;TRIOBP;DIO2;DNM1L;SPOPL;SMG5;CUL3;EGR2;ARRB1;JAK1;RTN4;TRIB1;PML;FAF2;MUL1;CXCR4;POU5F1;HSPA9;SMAD2;AXIN2
prerank,ATP binding (GO:0005524),0.18678663080300387,0.746925194549211,0.9800249687890137,0.979474612457616,1.0,38/266,14.75%,ATP1A2;PRKAG2;ENPP1;OXSR1;KSR1;TSSK3;BMPR1A;MYO1B;DAPK1;RRM1;TOP1;LATS2;TGFBR1;MAP4K1;WNK4;STK3;SIK3;PDXK;TLK2;PFKM;AKT3;HACL1;OAS2;IRAK3;CLPX;ABCD3;DAPK2;SRPK1;MCM6;PIP4K2B;ERCC6;WNK1;ABCF1;TRIB1;TRNT1;P2RY1;NUAK2;ABCA1
prerank,ATPase activator activity (GO:0001671),0.2802490780911849,0.740509677899029,0.7956600361663653,0.9853761738473136,1.0,6/20,18.88%,DNAJA2;TOR1AIP1;DNAJC1;ATP1B2;DNAJB2;DNAJB6
prerank,single-stranded telomeric DNA binding (GO:0043047),0.3221537053100705,0.7401717963181215,0.762278978388998,0.9828612100238641,1.0,4/11,20.15%,RAD50;HNRNPA2B1;CTC1;NABP2
prerank,5'-3' exonuclease activity (GO:0008409),-0.2861354707564587,-0.7395444375103142,0.8158995815899581,0.97645084893332,1.0,9/14,32.49%,MRE11;XRN2;DCLRE1C;CPSF3;FAN1;EXO1;DCLRE1B;FEN1;TRIR
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.3121403616954846,-0.7382839948830617,0.7960954446854663,0.9741780468710429,1.0,6/10,40.59%,NAA50;BRCA2;USP22;MSL3;KAT8;HAT1
prerank,G protein-coupled receptor activity (GO:0004930),0.1871323765096035,0.7347506565301518,0.9736180904522613,0.9873539164669209,1.0,17/239,7.58%,LPAR1;ADGRD1;LGR4;FPR2;ADORA2A;GCGR;ADGRV1;F2RL3;GLP2R;MC2R;C5AR2;PDGFRB;QRFPR;RXFP2;BDKRB2;OPRD1;ADGRL1
prerank,MHC class I protein binding (GO:0042288),-0.28665449698224,-0.7342967092316459,0.8280254777070064,0.9752926115185243,1.0,3/13,14.24%,ATP5F1A;ATP5F1B;TUBB4B
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.3126069594343145,0.7330876583669949,0.7896749521988528,0.9866149731913333,1.0,3/13,18.20%,AGPAT4;AGPAT3;ABHD5
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.3238410023679168,0.7308428956686984,0.781496062992126,0.9864946989737412,1.0,2/11,14.61%,FBXO11;CARM1
prerank,BMP binding (GO:0036122),0.313116048411994,0.7306496709865614,0.7708737864077669,0.983881558187179,1.0,1/11,2.59%,NBL1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.2691656784648115,0.7302645340531635,0.8212389380530973,0.9815457827807218,1.0,1/24,0.82%,CMPK2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.28415134859871594,-0.7277911539866176,0.828693790149893,0.9796840896769075,1.0,7/14,25.38%,MTMR6;MTMR12;MTMR7;MTMR2;MTMR1;SYNJ1;MTMR9
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.2736219265449592,-0.7239466662541351,0.8231441048034934,0.9804939732011764,1.0,7/16,25.38%,MTMR6;MTMR12;MTMR7;MTMR2;MTMR1;SYNJ1;MTMR9
prerank,serine-type peptidase activity (GO:0008236),0.2059567020459622,0.7214317600535979,0.9388059701492537,0.9899500900948573,1.0,9/96,12.98%,DPP4;PRSS57;CORIN;CTSH;ACR;PLAU;ENDOU;CELA1;PLAT
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.27911586553150713,-0.7205455165056486,0.8478260869565217,0.9808441435216283,1.0,6/14,22.01%,MINDY3;USP13;MINDY2;YOD1;MINDY1;ATXN3
prerank,phosphatidate phosphatase activity (GO:0008195),-0.2852735617795287,-0.7202963822403072,0.8268041237113402,0.9773053118411208,1.0,6/13,18.89%,PLPPR1;PLPP5;PLPP1;PLPPR2;LPIN3;PLPPR5
prerank,lipid phosphatase activity (GO:0042577),-0.2783658066357199,-0.7200831857302956,0.8367346938775511,0.9737742017614253,1.0,6/14,18.89%,PLPPR1;INPP5K;PLPP1;PLPPR2;SGPP1;PLPPR5
prerank,ribonuclease P activity (GO:0004526),-0.3001198486657728,-0.7176268291329924,0.8311688311688312,0.9729557843210042,1.0,2/11,12.68%,PRORP;RPP30
prerank,deubiquitinase activity (GO:0101005),0.20618594823252515,0.7173454655628841,0.9340175953079178,0.9922390916673745,1.0,30/88,24.12%,USP18;USP27X;STAMBP;USP24;USP9X;USP8;USP47;STAMBPL1;MYSM1;USP40;USP35;USP34;USP36;USP45;USP12;USP15;USP32;USP10;JOSD1;USP39;BRCC3;USP4;USP7;PAN2;USP26;ZC3H12A;OTUD5;USP19;USP25;OTUD7B
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.21874457020949856,-0.7172226513071333,0.8934624697336562,0.969722143613659,1.0,7/35,15.77%,H3-3A;NPM1;SMARCB1;HDAC1;RRN3;PARK7;KLF10
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.24673521316491648,0.7163060261904012,0.8875838926174496,0.990679143408721,1.0,7/34,15.01%,UBE2U;UBE2Z;UBE2C;UBE2E3;UBE2Q2;BIRC6;UBE2R2
prerank,thioesterase binding (GO:0031996),0.31250756148624775,0.7161014172019171,0.796844181459566,0.9880801318686401,1.0,1/11,3.10%,TRAF5
prerank,ATPase regulator activity (GO:0060590),0.23901111791754026,0.7159759051782418,0.8735042735042735,0.9853937836167519,1.0,11/38,18.88%,SIL1;DNAJA2;TOR1AIP1;DNAJC1;FNIP1;ATP1B2;GRPEL1;DNAJB2;ATP5IF1;HSPH1;DNAJB6
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.2879406670110799,-0.7137822447834496,0.842741935483871,0.9660942077980618,1.0,5/11,24.78%,BAG1;HSPBP1;GRPEL2;BAG4;PFN1
prerank,adenyl nucleotide binding (GO:0030554),-0.2879406670110799,-0.7137822447834496,0.842741935483871,0.9660942077980618,1.0,5/11,24.78%,BAG1;HSPBP1;GRPEL2;BAG4;PFN1
prerank,DNA replication origin binding (GO:0003688),0.2695962047638709,0.7116341643068443,0.8336192109777015,0.9879386480209641,1.0,5/23,15.44%,ORC5;MCM4;MCM6;ORC3;ORC4
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.2975755651555273,-0.7114331454586983,0.8408602150537634,0.9648830559260794,1.0,3/11,12.13%,MAP3K5;MAP3K20;EGFR
prerank,aspartic-type endopeptidase activity (GO:0004190),0.3124097671207081,0.7103703102325765,0.8183673469387756,0.9865866133629022,1.0,12/12,68.78%,SPPL3;PSEN1;BACE2;SPPL2A;DDI2;BACE1;PGC;ASPRV1;SPPL2B;CTSE;NAPSA;HM13
prerank,carboxypeptidase activity (GO:0004180),-0.22205518226688778,-0.7102240942175633,0.9164619164619164,0.9625282070891388,1.0,10/35,22.12%,AGBL4;CPE;CPD;CPA6;ACE2;MINDY2;CPXM1;VASH1;MINDY1;CPZ
prerank,FMN binding (GO:0010181),0.3058296731473685,0.7099883030885797,0.8467583497053045,0.9842652679943412,1.0,3/11,13.81%,POR;NOS2;HAO1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.3038729521059569,0.7044065071428691,0.805019305019305,0.9875104382133937,1.0,12/12,69.64%,GEMIN5;CYFIP2;CYFIP1;LARP1;NCBP3;AGO2;EIF4E2;EIF4E3;NCBP2;NCBP1;EIF4E;DCPS
prerank,histone deacetylase activity (GO:0004407),0.2699248675830586,0.7029883081833648,0.8410714285714286,0.9861738707423725,1.0,3/19,6.29%,MIER3;MIER1;HDAC4
prerank,omega peptidase activity (GO:0008242),0.2029563408055404,0.7026039386315194,0.9451038575667656,0.983825845321435,1.0,31/89,24.12%,USP18;USP27X;STAMBP;USP24;USP9X;USP8;USP47;STAMBPL1;MYSM1;USP40;USP35;USP34;USP36;USP45;USP12;USP15;USP32;USP10;JOSD1;USP39;BRCC3;USP4;USP7;APEH;PAN2;USP26;ZC3H12A;OTUD5;USP19;USP25;OTUD7B
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.27171335520812623,-0.7014506249592305,0.8577405857740585,0.9681206491596731,1.0,6/13,24.51%,ZGRF1;DICER1;GEN1;ENDOV;FAN1;EXO1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.27649765880259586,0.7006709468778426,0.8486590038314177,0.9831697061939879,1.0,4/17,13.64%,DPYD;PTGR1;LBR;PECR
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.29568822245529197,0.6927450119011497,0.8307692307692308,0.9887051868649197,1.0,4/12,21.06%,NOCT;PAN3;PARN;PAN2
prerank,chloride channel regulator activity (GO:0017081),0.28820675112878885,0.6924747714716083,0.8348457350272233,0.9861953606702774,1.0,3/14,14.09%,WNK4;STX8;WNK1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.28911217976975273,0.6923364308730025,0.8445692883895131,0.9836056549707588,1.0,2/15,11.23%,AGPAT4;AGPAT3
prerank,death receptor binding (GO:0005123),-0.264233325427176,-0.6921499326200665,0.8596491228070176,0.9737016222217969,1.0,7/15,30.16%,DAB2IP;NGF;TMBIM1;NTF3;MYD88;FADD;PIDD1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.22032787096325862,0.6901087690820157,0.9247135842880524,0.9830675368546554,1.0,5/49,6.86%,ZFAND6;IKBKE;OPTN;DZIP3;PARP10
prerank,DNA polymerase binding (GO:0070182),-0.24930482969724568,-0.687806285650869,0.8972162740899358,0.9740514335871558,1.0,4/18,16.12%,HMGB1;HSP90AB1;HSP90AA1;RAD51
prerank,ribonuclease activity (GO:0004540),0.2118274336900634,0.6854297733748597,0.9555555555555556,0.984956541803471,1.0,16/56,23.79%,PIWIL4;NYNRIN;SND1;SMG6;ENDOU;SLFN14;ZC3H12B;ERN2;EXOSC10;RNASEH1;RNASE3;RNASEL;YBEY;ZC3H12A;KHNYN;RNASEH2A
prerank,Hsp70 protein binding (GO:0030544),-0.2153277544131523,-0.6850935156185393,0.9271070615034168,0.9729416102087374,1.0,16/31,42.20%,SNCA;RPS3;NOD2;GPR37;SACS;PACRG;DNAJA1;MVD;METTL21A;IQCG;CYP2E1;TSC1;DNAJC8;CYP1A1;FICD;HDAC8
prerank,tRNA binding (GO:0000049),0.2209216508991114,0.6849686639306011,0.9317073170731708,0.9826983494304457,1.0,10/43,16.09%,TERT;SEPSECS;PUS1;CTU1;TRNAU1AP;TRMT10B;TRNT1;ALKBH1;MRPS27;SSB
prerank,microtubule plus-end binding (GO:0051010),0.25938778712279453,0.6830868920525597,0.8576329331046312,0.9818641234413231,1.0,7/20,23.17%,CLASP1;CLIP4;FBXW11;TTBK2;MAPRE3;CLIP3;MAPRE2
prerank,ubiquitin-specific protease binding (GO:1990381),-0.23930371223562696,-0.6823677920865275,0.9171974522292994,0.97194044934768,1.0,4/19,14.75%,RAD23A;SART3;BAG6;PARK7
prerank,ribosome binding (GO:0043022),0.21645780649238394,0.6818441437153727,0.9208400646203554,0.9802721192418035,1.0,11/46,16.03%,SRP68;SBDS;CPEB1;NAA16;NAA15;SLFN14;EFL1;GEMIN5;MRPS27;CPEB3;SRP19
prerank,serine-type endopeptidase activity (GO:0004252),0.19928562940814498,0.6809850523361715,0.9561933534743202,0.9784526106064985,1.0,7/80,12.98%,DPP4;CORIN;CTSH;ACR;PLAU;CELA1;PLAT
prerank,ATP hydrolysis activity (GO:0140603),0.22284329199490494,0.6779286279634686,0.9237012987012987,0.9789040933012655,1.0,2/41,1.89%,RNF213;ABCA4
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.3087465718041027,0.6772571894137092,0.8667917448405253,0.9768848911487813,1.0,2/10,7.52%,DSE;GLCE
prerank,protein kinase regulator activity (GO:0019887),0.19301416330223597,0.6746135220044351,0.9751824817518249,0.9765383217679652,1.0,5/95,5.19%,CXCL10;PRKAG2;PARVA;TAOK3;CCND3
prerank,four-way junction DNA binding (GO:0000400),0.2670461342276479,0.6740801644321643,0.8845437616387337,0.9744451569629023,1.0,3/17,13.34%,WRN;FANCM;RAD51B
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.25461726937400464,0.6739549279290569,0.8957169459962756,0.9718945570342136,1.0,9/20,25.87%,USP9X;USP47;SENP3;SENP1;USP7;OTUD5;USP25;SENP2;DESI2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.22278144467272332,-0.6723112538461199,0.9114832535885168,0.9770214136573944,1.0,5/26,15.86%,CSGALNACT1;B3GNT2;CHSY3;B3GNT9;B3GALNT2
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.28916153851088156,-0.6693881056566313,0.8805031446540881,0.9759794145929974,1.0,5/10,30.97%,ANKRD13A;ANKRD13B;FAN1;LAPTM5;FAAP20
prerank,hydro-lyase activity (GO:0016836),-0.19460596107151612,-0.6656994083397707,0.9652406417112299,0.9754052051171727,1.0,8/41,16.00%,CA4;CA2;PARK7;FAHD2A;ENO1;HACD3;APIP;CYP2S1
prerank,O-methyltransferase activity (GO:0008171),-0.2852936121575267,-0.6643173123169023,0.8755102040816326,0.9729606287856575,1.0,3/10,22.45%,ASMT;FTSJ3;COQ3
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.2495165566927661,0.6592871841228471,0.8939929328621908,0.9819664736343725,1.0,3/22,6.86%,IKBKE;OPTN;PARP10
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.27703100093009686,-0.6581756547508361,0.8948497854077253,0.9742619136985025,1.0,5/11,39.58%,RDH11;DHRS13;RDH12;ALDH3A1;RDH13
prerank,RNA cap binding (GO:0000339),0.2667859665586967,0.6575782690022166,0.8971428571428571,0.980882652822075,1.0,5/16,25.93%,LSM1;GEMIN5;CYFIP2;CYFIP1;LARP1
prerank,3'-5' exonuclease activity (GO:0008408),0.20856638251683055,0.645156066423025,0.9613445378151261,0.9880865911887248,1.0,11/45,16.69%,WRN;RAD50;POLG;EXD1;NOCT;DIS3L;USB1;RAD9A;DIS3;EXOSC10;ERI3
prerank,enoyl-CoA hydratase activity (GO:0004300),0.29266635342217473,0.6375627019089636,0.8858800773694391,0.9909140852462963,1.0,5/10,31.07%,ECHDC3;HADHA;ECHS1;ECHDC2;HSD17B4
prerank,ATPase binding (GO:0051117),0.18851291737551942,0.6341908541427985,0.9810725552050473,0.9906740024093692,1.0,17/71,18.97%,TMTC4;SLC26A9;PTPN3;SNTA1;TOR1AIP1;TRPC1;ATP1B2;TCIRG1;ABCA1;CHMP4A;ATP6V1E1;PKD2;TAF9;NUFIP1;ATP5IF1;ANK2;PGR
prerank,sequence-specific mRNA binding (GO:1990825),0.2778063673567593,0.6309141013397371,0.8928571428571429,0.9903244919330525,1.0,5/10,30.62%,SSB;SHFL;DHX9;ETF1;FMR1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.2602418391028978,-0.6307496538491187,0.8968421052631579,0.9896846448570586,1.0,2/12,9.20%,H3-3A;HDAC1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.21455635507340587,0.6307190176508654,0.9598603839441536,0.9878422223886199,1.0,13/33,25.20%,DCP2;NOCT;XRN1;DIS3L;USB1;DIS3;EXOSC10;ERI3;PARN;PAN2;PNPT1;ANGEL1;EXOSC5
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.24369077224569727,-0.6290146798809068,0.9264705882352942,0.987247833669784,1.0,9/14,51.19%,PRORP;RPP30;POP7;TSEN34;ELAC2;RPP21;POP1;RPP40;POP5
prerank,death receptor activity (GO:0005035),0.2730365346287763,0.6246573227384513,0.9083333333333333,0.9893295026294692,1.0,2/11,7.90%,NGFR;TNFRSF14
prerank,transaminase activity (GO:0008483),0.27429765998302996,0.6237049892277468,0.8966861598440545,0.9873153457839365,1.0,3/11,22.27%,ABAT;AGXT;PSAT1
prerank,RNA methyltransferase activity (GO:0008173),-0.2178867167423319,-0.6202632008341437,0.9465478841870824,0.9892145717703528,1.0,9/19,42.02%,TRMT13;FTSJ3;TRMT9B;METTL8;BCDIN3D;FBL;TRDMT1;FBLL1;METTL4
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.17667263074681938,-0.602212494303293,0.9755434782608695,0.9951667290727298,1.0,19/42,37.67%,CCND1;CNPPD1;CDKN1A;CCNF;CCNG1;CCNC;CCNK;HEXIM2;CCNE2;CDK5R2;CCNE1;CCNQ;CDKN2D;INCA1;CKS1B;CCNB2;CCNT1;CCNA2;CCNB1
prerank,snRNA binding (GO:0017069),0.19587925953291746,0.5981361646939973,0.9682804674457429,0.9998101069312834,1.0,6/42,16.30%,RBM41;SNRPA1;SF3B3;RNPC3;GEMIN5;DDX21
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.24245588405535548,-0.5882987562694508,0.9413092550790068,0.9982116116508245,1.0,10/12,53.72%,GPR88;RRH;OPN1MW3;OPN1MW;ELOVL4;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.2431382257449122,0.5772675511551518,0.9468503937007874,1.0,1.0,5/13,24.33%,TRMT10B;THUMPD3;FTSJ1;METTL1;TARBP1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.19893354682269251,-0.5759537529224137,0.9557522123893806,0.9997788862258935,1.0,1/21,1.20%,GRIK2
prerank,5'-nucleotidase activity (GO:0008253),0.2401477205493322,0.5743392278746641,0.9401869158878504,1.0,1.0,2/13,10.23%,NT5C;NT5DC1
prerank,microtubule minus-end binding (GO:0051011),0.2397838597259734,0.5716912874499879,0.9555125725338491,1.0,1.0,3/13,15.12%,TUBGCP4;TUBGCP2;TUBGCP5
prerank,vitamin D receptor binding (GO:0042809),-0.21850086749661873,-0.5702537738221708,0.9566160520607375,0.9981979078227972,1.0,3/14,17.25%,MED30;TAF11;RXRA
prerank,mRNA methyltransferase activity (GO:0008174),0.2478187182223338,0.5670056141045757,0.9398496240601504,1.0,1.0,12/12,75.24%,METTL16;PCIF1;CMTR1;METTL3;CMTR2;TRMT61B;NSUN2;RNMT;TRMT61A;METTL14;TRMT10C;METTL8
prerank,GABA receptor binding (GO:0050811),0.250410015639004,0.5617927350847334,0.9488636363636364,1.0,1.0,2/11,11.94%,TRAK1;JAKMIP1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.18517220875318005,0.5523079049000962,0.9902120717781403,1.0,1.0,13/40,24.33%,HNMT;RRP8;COMT;THUMPD3;AS3MT;DNMT3A;PEMT;CARNMT1;LRTOMT;ICMT;METTL2B;METTL2A;TARBP1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.22568290103406688,-0.5453566514771477,0.9604166666666667,1.0,1.0,7/11,42.80%,RPS3;HMCES;NEIL2;APEX1;APLF;NEIL1;NEIL3
prerank,nuclear export signal receptor activity (GO:0005049),-0.22435121052018134,-0.5447646455059981,0.9468503937007874,0.9995508695461885,1.0,4/11,27.77%,XPO7;XPO1;NUP42;XPO6
prerank,nucleotidase activity (GO:0008252),-0.20556920802682116,-0.5427009517319122,0.973568281938326,0.9968089420323131,1.0,4/15,19.75%,BPNT2;NT5C2;NT5C3A;ACP3
prerank,exoribonuclease activity (GO:0004532),-0.22087942228305257,-0.5402963214537633,0.975051975051975,0.9940051990930965,1.0,7/12,45.38%,EXOSC2;EXOSC4;EXOSC1;EXOSC3;EXOSC8;EXOSC9;CNOT7
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.2412512694954264,0.5310100810324005,0.9651162790697675,1.0,1.0,2/10,15.47%,CDKN2B;KAT2B
prerank,UDP-galactosyltransferase activity (GO:0035250),0.23806695799640998,0.5270590876390364,0.9553072625698324,1.0,1.0,1/10,7.26%,B4GALT1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.22089089309096488,-0.5240406274556613,0.977366255144033,0.9950535126107324,1.0,6/11,35.09%,NUDT16L1;NUDT3;NUDT16;DCPS;NUDT11;NUDT1
prerank,N-acyltransferase activity (GO:0016410),0.18276992842939976,0.5206888045446892,0.9831932773109243,1.0,1.0,2/32,4.31%,CERS5;CERS6
prerank,endodeoxyribonuclease activity (GO:0004520),-0.18268388810707367,-0.517015003670546,0.9788732394366197,0.9931968514104627,1.0,8/20,31.39%,RPS3;MRE11;DCLRE1C;ENDOV;EXO1;APEX1;ENDOG;FEN1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.2294195949838888,0.5140260486562224,0.9581749049429658,1.0,1.0,4/11,25.44%,SLC22A4;SLC22A3;SLC25A20;SLC25A29
prerank,antiporter activity (GO:0015297),0.19748112089137726,0.5120035162374955,0.9813780260707635,1.0,1.0,4/20,15.15%,SLC35D1;SLC35D2;SLC35C1;SLC25A10
prerank,ubiquitin binding (GO:0043130),0.14965782098138286,0.5111055153201388,0.9955621301775148,1.0,1.0,2/73,3.41%,SMAD3;NEDD4
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.2068707885408782,-0.5013579071351164,0.9770833333333333,0.993005600002526,1.0,6/12,41.44%,NDUFS7;AIFM2;CRYZ;NQO1;CBR4;CBR1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.20253733697526682,0.4949623258783131,0.9662288930581614,1.0,1.0,3/15,16.78%,P2RX1;P2RY1;P2RX4
prerank,glutathione transferase activity (GO:0004364),0.16859588962082006,0.4624758012780363,0.9899497487437185,1.0,1.0,2/23,11.84%,GSTK1;GSTA3
prerank,methyltransferase activity (GO:0008168),0.1491271379385727,0.4601178268516816,0.9984447900466563,1.0,1.0,8/46,19.02%,METTL27;AMT;RRP8;COMT;AS3MT;MGMT;CARNMT1;LRTOMT
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.15637412999672698,0.4572306288699824,0.9982578397212544,1.0,1.0,11/35,27.22%,FTO;TRPT1;DTWD1;ALKBH1;TYW3;PUS10;FTSJ1;DUS3L;QRSL1;QTRT1;GATB
prerank,tRNA methyltransferase activity (GO:0008175),0.17455982631693817,0.4305403335274609,0.9889705882352942,1.0,1.0,6/16,24.33%,THUMPD3;TYW3;FTSJ1;METTL2B;METTL2A;TARBP1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.1765628922922422,0.40114275073089334,0.9945054945054945,1.0,1.0,11/11,82.36%,CHRNA5;CHRNB1;CHRNB2;CHRNA10;CHRNA2;CHRNA1;CHRNB4;CHRNA3;CHRNA9;CHRNA7;CHRNA4
prerank,N-acetyltransferase activity (GO:0008080),0.15641683292663927,0.3997325191938982,0.9946428571428572,0.9984599908096226,1.0,3/19,15.47%,ESCO1;NAT2;KAT2B
prerank,ribonuclease P RNA binding (GO:0033204),-0.1582159424284496,-0.3718209638079215,1.0,0.9996463306808134,1.0,6/10,51.19%,RPP30;POP7;RPP21;POP1;RPP40;POP5
